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CHAPTER 1 
GENERAL INTRODUCTION, 
AIM AND SCOPE OF THE THESIS 
IO Chapter 1 
GENERAL INTRODUCTION 
Rheumatoid arthritis [RA], a disease of unknown etiology, is characterized 
by joint inflammation and can cause cartilage destruction. Inflammatory 
mediators may exert both suppression of matrix synthesis as well as 
degradative effects on the cartilage matrix, which eventually leads to severe 
cartilage depletion. Systematically and locally produced growth factors and 
hormones regulate cartilage metabolism. Alterations in levels of these factors 
or in their activity may play important roles in the pathogenesis of articular 
cartilage destruction in arthritic joints. In the following introduction the 
architecture of the articular cartilage, the function of chondrocytes to maintain 
cartilage matrix intact and aspects of cartilage destruction during arthritis are 
described. Furthermore, potential inflammatory mediators or anabolic factors 
involved in pathologic cartilage destruction are discussed. Special emphasis is 
given to anabolic factors; insulin-like growth factor-1 [IGF-lj is the most 
important growth factor that balances chondrocyte proteoglycan [PG] synthesis 
and catabolism to maintain a functional cartilage matrix. Elucidation of IGF-1 
regulation of chondrocyte metabolic functions in normal cartilage and in 
diseased cartilage in particular, may provide insights in the mechanisms 
involved in arthritis-induced cartilage damage. These insights may promote 
development of therapeutic agents to arrest progressive destruction of articular 
cartilage in RA patients. 
Structure and function of articular joints and cartilage 
Articular joints enable movement between bones and are subjected to 
biomechanical forces. The joint is surrounded by a capsule, lined with 
synovium. The joint cavity is filled with acellular synovial fluid providing 
lubrication and nourishment of the articular cartilage. Articular cartilage 
forms the weight bearing surface of the articular joint providing a resilient, 
smoothly gliding surface. 
Articular cartilage is a relatively avascular, aneural connective tissue, that is 
essential for resistance of compressive forces and distribution of load. 
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Articular cartilage consists of a highly organized extracellular matrix in which 
specialized cells, chondrocytes, are embedded [79, 134]. The main function of 
chondrocytes is maintenance of the matrix by coordinate synthesis and break 
down of matrix molecules [165, 188J. 
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Figure 1 
The basic structure unit of aggrecan consisting of a core protein to which highly negatively 
charged glycosaminoglycan chains or oligosaccharides are bound The core protein is 
noncovalently attached to hyaluronic acid, which is reinforced by link proteins. 
Aggregating PGs and collagen fibrils are the two major structural components 
of the matrix that form a three-dimensional framework giving the tissue a 
unique architecture. Cartilage collagen, which consists mainly of the type II 
form and small amounts of the type V, VI, IX and X forms has a very slow 
basal rate of turnover and provides a permanent framework that gives the 
tissue tensile strength. PGs are complex macromolecules that consist of a core 
protein to which one or more glycosaminoglycan [GAG] side chains or N-O-
linked oligosaccharides are attached [68]. GAG chains are polymers of 
repeating dissacharides which mainly consist of chondroitin sulfate, heparan 
sulfate or heparin. GAG chains can vary in number of chains, their length as 
well as their pattern of sulfation; GAG chains play a dominant role in the 
determination of physical properties of the protein to which they are attached. 
High negatively charged GAGs entrap solvent, thus creating a high osmotic 
pressure which is restrained by collagen. The swelling pressure together with 
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low hydraulic permeability enables cartilage to resist compressive loads with 
minimal deformation [165]. 
The major PG found in articular cartilage is aggrecan [52, 73, 74]. Aggrecan 
molecules contain 3 globular domains [Gl, G2 and G3], of which the Gl 
domain can bind noncovalently to a single chain of hyaluronan, forming large 
Figure 2 
A) Schematic drawing of histological stained human cartilage, showing three striking 
heterogeneous cartilage layers that are generally recognized between articular surface and 
subchondral bone, namely surface [I], middle [II] and deeper zones [III]. Zonal subdivision is 
based on morphology, differences in cell density and orientation, nature, content and 
distribution of PCs as well as organization of the collagen fibrillar network, χ 390. 
В, С, D] Schematic drawing of chondrocytes in the three cartilage layers. Chondrocytes in the 
surface zone are small, flattened, orientated in parallel with the articular surface and are rather 
inert with respect to matrix synthesis [Β], χ 5.226. 
Chondrocytes in the middle zone are larger and round [С] χ 4.680, whereas chondrocytes in the 
deeper zones have the largest size and occur usually in groups. Chondrocytes in the middle and 
deeper zones of cartilage exhibit highest metabolic activity and are responsible for cartilage 
homeostasis [D]. χ 5.616. 
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macromolecular aggregates. This interaction is promoted and stabilized by link 
protein 172] [Figure 1] Furthermore, cartilage contains nonaggregated small 
PGs, biglycan, deconn and fibromoduhn [233] Deconn and fibromoduhn are 
thought to play a role in the organization of the extracellular matrix because 
each molecule interacts with the collagen type II and type I forms as well as 
with ribronectin Biglycan does not bind to collagen and its functional property 
is less clear [73] 
Three striking heterogeneous cartilage layers are generally recognized 
between articular surface and subchondral bone, namely surface, middle and 
deeper zones [Figure 2] [164] Zonal subdivision is based on morphology, 
differences in cell density and orientation, nature, content and distribution of 
PGs as well as organization of the collagen fibrillar network [8, 124, 125, 
178] Chondrocytes in the surface zone are small, flattened, orientated in 
parallel with the articular surface and are rather inert with respect to matrix 
synthesis. Chondrocytes in the middle zone are larger and round, whereas 
chondrocytes in the deeper zones have the largest size and occur usually in 
groups Chondrocytes in the middle and deeper zones of cartilage exhibit 
highest metabolic activity and are responsible for cartilage homeostasis 
An important aspect of the structural integrity of articular cartilage is the 
ability of chondrocytes to synthesize and degrade PGs to maintain a 
functionally intact cartilage [68] Small perturbations in cartilage metabolism 
may lead to increased or decreased local concentrations of matrix molecules 
which can alter physiological properties of the tissue This may lead to rapid 
loss of tissue function and deterioration of the joint [71]. 
Destruction of articular cartilage in rheumatoid arthritis 
RA is a systemic, chronic joint disease with symmetric polyarthritis as its 
most important clinical feature Progressive joint inflammation often results in 
irreversible cartilage destruction leading to erosion of the articular cartilage, 
injury of the surrounding tissue and eventually permanent loss of joint function 
[Figure 3] [75, 107]. The etiology of RA remains unknown, but genetic 
predisposition, altered immunity or exogenous stimuli have been reported as 
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Figure 3 
Schematic representation of the normal and 
rheumatoid arthritic knee joint. Joint inflammation 
is characterized by chronic synovitis leading to ir­
reversible destruction of the articular cartilage. 
F = femur, Τ = tibia, SL = synovial lining, 
AC = articular cartilage 
causal factors [31, 186]. A proper understanding of mechanisms underlying 
cartilage destruction is still lacking, despite the fact that much knowledge has 
been gained about cells and mediators in inflamed joints. 
For the study of processes that determine joint destruction in the arthritic joint 
of human patients, animal models have been developed in which arthritis is 
induced experimentally [215]. These studies have revealed that the main aspects 
of pathologic cartilage depletion are increased degradation of articular 
cartilage coupled with reduced matrix synthesis as well as chondrocyte death 
[65]. Connective tissue cells of the inflamed synovium, chondrocytes and large 
amounts of macrophages and lymphocytes that have infiltrated the joint 
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Figure 4 
Schematic representation of potential factors involved in cartilage destruction during arthritis. 
The importance for cartilage integrity to balance between suppressive mediators, such as 
cytokines, proteolytic enzymes or oxygen species, and anabolic factors, such as circulating 
hormones and locally produced growth factors is emphasized. 
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generate vast amounts of potential mediators during inflammation and cause 
cartilage destruction These mediators may include among others cytokines, 
proteolytic enzymes and reactive oxygen species [8, 49, 81, 176, 180, 200, 
215, 222] In addition, chronic interference with factors that upregulate 
synthesis of matrix components in chondrocytes may play an important role in 
cartilage destruction during joint inflammation [169, 170, 200] [Figure 4] 
Suppressive mediators produced by the inflamed synovium 
Cytokines 
Cytokines are believed to play an important role in the pathogenesis ot RA 
These messenger molecules mediate cell-cell interactions and are able to 
induce, amplify and perpetuate inflammation Cytokines are implicated in the 
release of enzymes capable of extensive cartilage damage [9], but also have 
strong effects on chondrocyte metabolic functions [85] High levels of 
interleukin-1 [1L-1], interleukin-6 [IL-6], interleukin-8 [IL-8], interleukin-10 
[IL-101, tumor necrosis factor α [TNFa], granulocyte-macrophage colony 
stimulating factor [GMCSF] and leukocyte inhibitory factor [LIF] have been 
detected in synovial fluid in arthritic joints, whereas interleukin-2 [IL-2J, 
interleukin-4 LIL-4] and interferon γ [IFN γ ] have not been found to be 
elevated in arthritic joints [28, 51, 58, 87, 141, 167, 223, 238] However, it has 
to be realized that levels of cytokines in synovial fluid or plasma may give only 
limited information with respect to their activity because their activity is the 
results of a balance between their amount and that of specific cytokine 
inhibitors [47, 86] Moreover, responses to cytokines are also dependent on the 
presence ot receptors on target cells 
Despite the complexity of the cytokine network involved in joint 
inflammation, IL-1 and TNFa are identified as key mediators in the 
pathogenesis of arthritis [7, 21, 22, 55, 80, 112, 201, 207, 216, 221] In 
experimental models of arthritis, it has been demonstrated that it depends on 
the arthntis-induung stimulus, whether TNFa drives IL-1 production, or 
whether IL-1 and TNFa are individually involved [210, 100] Moreover, IL-4 
and IL-10 are able to interfere with TNFa and IL-1 production, they 
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upregulate their inhibitors, i e IL-1 receptor antagonist [IL-lra] and soluble 
TNF receptor [88, 234] IL-1 has been shown to be a key mediator with 
respect to inhibition of chondrocyte PG synthesis in both antigen- and 
zymosan induced arthritis models [205, 206, 208] Systemic treatment in vivo 
with anti IL 1 antibodies or IL-lra has a major stimulatory effect on 
chondrocyte PG synthesis [205, 206, 118] In collagen-induced arthritis, 
systemic treatment in vivo with anti-IL-1 antibody or IL-lra not only reduces 
chondrocyte PG synthesis inhibition but also reduces cartilage destruction as 
well as joint inflammation [212, 235] Evidence for such roles m vivo of 
TNFa is still lacking [207], but TNFa can induce cartilage damage in vitro 
[228, 231, 162] The main effect of TNFa in these arthritis models is probably 
induction of joint inflammatory swelling [55] 
Pmteolytic enzymes 
High levels oí degrading enzvmes are known to cause breakdown of 
aiticular caitilage during joint inflammation Metalloproteinases, collagenase 
and stromelysin are important proteolytic enzymes involved in destructive 
processes [132, 138] In addition, cysteine and serine proteinases may also play 
a significant role [2, 57, 120, 220] Recently, some doubt was raised on the 
relevance of the above mentioned enzymes and it was hypothesized that a new 
enzyme, aggiecanase, is of more importance [59, 60, 89, 111] 
The activity of proteolytic enzymes is not only determined by the presence 
of the enzyme molecules but also by posttranslational activation processes and 
interactions of enzymes with their endogenous inhibitors [157] In joint 
inflammation posttranslational activation may be increased or an imbalance 
between the levels of matrix degrading enzymes and their inhibitors may occur 
[56 1261 
Reactive oxygen metabolites 
Degradation of the articular cartilage matrix may be induced by reactive 
oxygen species that are released in vast amounts by inflammatory and/or 
phagocytic cells [81, 156, 171, 172] In vitro exposure of articular cartilage to 
reactive oxygen species can cause severe inhibition of chondrocyte PG 
synthesis or degradation of the aggrecan PG [14] The exact role of reactive 
oxygen species in vivo still has to be established because their ultimate effects 
General introduction, aim and scope of the thesis 17 
depend not only on their release but also on levels of endogenous scavenger 
enzymes or antioxidants [171]. Treatment with antioxidants in animal models 
as well as in RA has no significant effect on cartilage destruction [81]. 
Nitric oxide [NO] is a reactive oxygen species that is produced by NO 
synthase. At present NO is receiving a lot of attention in arthritis research. 
There is increasing evidence that NO is involved in inflammatory joint 
destruction, probably because IL-1 is known to be involved in the synthesis of 
NO [34, 148, 184]. IL-1-induced inhibition of chondrocyte PG synthesis may 
at least in part depend on the production and action of NO [78, 98, 191]. 
Anabolic factors 
Chondrocyte PG synthesis and degradation in articular cartilage are the 
result of the effects of a number of circulating hormones and locally produced 
growth factors [62, 70, 117, 196]. Hormones such as steroids and several 
growth factors, such as basic fibroblast growth factor [bFGF], epidermal 
growth factor [EGF], platelet derived growth factor [PDGF], transforming 
growth factor β [TGFß] and insulin-like growth factor [IGF] are known to 
affect cartilage metabolism. IGF-1 is the most important growth factor that 
stimulates chondrocyte PG synthesis and inhibits PG catabolism [200]. In the 
following paragraphs, the role of steroid hormones and growth factors in 
chondrocyte PG metabolism will be briefly described and subsequently, the 
importance of IGF-1 in cartilage metabolism will be reviewed. 
Effect of growth factors and glucocorticoid steroid hormones on chondrocyte 
PG metabolism 
Growth factors, such as EGF, bFGF, PDGF, TGFß and IGF-1 are known to 
play a prominent role in the regulation of chondrocyte PG synthesis and 
degradation. It is believed that growth factors also are of importance in repair 
processes during joint diseases [41, 76, 143]. Controversial data exist with 
respect to the potency of these growth factors to modulate chondrocyte PG 
metabolism. This is largely due to differences in experimental culture 
conditions, the origin and species from which cartilage is obtained [30, 82, 
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103, 158] Most information has been gained from studies with isolated 
chondrocytes or cartilage expiants, whereas little data exist on the role of 
growth factors in anatomically intact cartilage [218] Even less is known of the 
function of growth factors in cartilage of diseased joints 
bFGF and EGF stimulate PG synthesis strongly in actively growing 
chondrocytes, but only to a limited extent in differentiated chondrocytes [96, 
105, 161, 199, 236] PDGF stimulates PG synthesis to a similar extent as 
IGF-1, whereas TGFß exerts both stimulating and inhibitory effects on 
chondrocyte PG synthesis [217, 218, 130, 131, 237, 145, 155] Furthermore, 
repeated intra-articular injections of TGFß into mouse knee joints induce 
strong and long-lasting stimulation of chondrocyte PG synthesis [203, 204] 
Synergistic interactions between growth factors have been described as well 
[92, 135 144] For example IGF 1 synergistically enhances chondrocyte PG 
synthesis induced by bFGF or EGF in cultured chondrocytes [104] 
Glucocorticoid steroid hormones are involved in the regulation of long-term 
metabolic functions ot chondrocytes, but effects ot steroid hormones on 
chondrocyte PG metabolism remain controversial Intra-articular injections of 
glucocorticoids suppress joint inflammation and result in pain relief and 
maiked preservation of joint function [66, 83, 84, 185, 225] Low levels of 
steroid hormones stimulate chondrocyte PG synthesis m vitro [19, 102, 189, 
190J, whereas steroids have chondroprotective effects on PG depleted-cartilage 
m \ i\n. such as relief of proteoglycan synthesis inhibition, decrease of 
chondrocyte PG loss and decrease of osteophyte formation [101, 211, 213, 
230] Steroid hormones also exert negative effects on chondrocyte PG synthesis 
in normal cartilage [5, 6, 13, 18, 36, 123, 226] IGF-1 and glucocorticoids 
have a synergistic effect on chondrocyte metabolic function [95] Steroids may 
have direct effects on chondrocytes or exert their actions via regulation ot 
production of inflammatory mediators [26, 50, 95, 152, 173, 175, 177, 179, 
187] 
Insulin-like growth factor 
IGFs, which were originally defined as somatomedins have been reported to 
be a growth hormone-dependent serum factor able to stimulate 15S-sulfate 
incorporation in cartilage in vivo ["sulfation factor", 163], a cotactor extracted 
from serum able to stimulate replication of cells ["multiple stimulating 
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activity", MSA, 106], or a factor in serum exerting insulin-like activity on 
target tissues ["nonsuppressible insulin-like activity , NSILA, 241] 
Isolation and purification of IGF revealed that two forms of IGF exist, 
IGF-1 with a molecular weight of 7 5 kDa and pi of 8 5 and IGF-2 with a 
molecular weight of 7 4 kDa and pi of 7 0 [37, 90] Structural analysis at 
biochemical and genetic levels revealed that IGF-1 and IGF-2 are single 
polypeptides with significant sequence similarity and also sequence similarity 
to insulin [1, 46, 159, 209] IGF biosynthesis appears to be regulated by 
various hormones such as growth hormone, adrenocorticotropic hormone, 
luteinizing hormone, follicle stimulating hormone and thyroid stimulating 
hormone and growth factors such as PDGF and bFGF IGF is produced in 
significant amounts after tissue injury or during malnutrition [93, 140, 181] 
IGF was originally considered to be produced by the liver and to act via an 
endocrine mode of action [67] Now it is generally recognized that IGF is 
synthesized by numerous types of cells and tissues, suggesting that IGF acts via 
autocrine/paracrine as well as endocrine modes of action [11, 45, 94, 99, 116, 
129, 149] IGF levels in the circulation [20-80 nM] are higher than tissue 
levels, but in serum IGF is largely bound to specific IGF binding proteins 
[IGFBPs] that prolong the half life of IGF [1] Therefore, the physiologically 
relevant levels of IGF may be tissue levels rather than plasma levels IGF 1 has 
been suggested to be an important postnatal growth factor affecting growth and 
metabolism of many other tissues besides cartilage [48] IGF-2 is suggested to 
have a regulatory role in glucose metabolism and to be more important as a 
foetal growth factor [25] 
IGF leceptors 
Biological action of IGF-1 and IGF-2 is initiated by binding to their distinct 
cell surface receptors differing markedly in structure and peptide binding 
specificity [Figure 5] [43, 182, 240] IGF-1 binds preferentially to the type 1 
receptor, and IGF 2 to the type 2 receptor, although both receptors can bind 
the other IGF with lower affinity [114, 194] Type 1 receptor is a hetero-
tetrameric glycoprotein consisting of 2 extracellular α subunits with a 
molecular weight of 130kDa and 2 transmembrane β subunits with a molecular 
weight of 95 kDa The α and β subunit are held together by disulfide bonds 
forming a tetramer, consisting of 2 αβ dimers [115, 136, 202] Type 1 
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Figure 5 
Structure of the type 1 and type 2 IGF receptor. The type 1 receptor is a heterotetrameric 
complex composed of 2 extracellular α subunits and 2 transmembrane β subunits held together 
by disulfide bonds. The α subunits bind IGF-1 and the β subunits contain tyrosine kinase 
activity in their cytoplasmic domain The type 2 receptor has a short cytoplasmic tail and a large 
extracellular domain, consisting of many cysteine rich regions. 
receptor is formed as a precursor protein that needs a number of 
posttranscriptional and posttranslational modifications including glycosylation, 
dimerization and proteolytic processing to yield the mature complex consisting 
of 2 α β subunits [133, 154]. The ligand binding site is located in the 
extracellular α subunit, whereas the intracellular β subunit contains a tyrosine 
kinase domain responsible for signal transduction [109, 242]. Association of 2 
αβ dimers is required for receptor signal transduction after ligand binding 
[91, 183, 195, 229]. IGF-1 binding to the α subunit of the receptor results in 
intracellular signal transduction by autophosphorylation of the β subunit and 
activation of the receptor tyrosine kinase. Tyrosine kinase is responsible for 
intracellular signal transduction initiating a cascade of phosphorylation steps 
including activation of serine and threonine kinases [40]. Recently, mechanisms 
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of action of IGF-1 type 1 receptor via tyrosine kinase receptor have been 
linked with the G protein-associated phosphatidyl inositol hydrolysis pathway 
in a similar way as described for other growth factor receptors [32, 122]. 
After IGF binding, the type 1 receptor is internalized and recycled to the cell 
surface. The number of type 1 receptors at the cell surface are downregulated 
by increased amounts of IGF-1 [168]. 
Type 2 receptor is a single chain polypeptide with a molecular weight of 250 
kDa consisting of a single transmembrane region and a large extracellular 
domain [44]. The receptor is identical to the cation-independent mannose-6-
phosphate receptor, which binds lysosomal proteins and mediates their 
transport to the lysosomes [150]. The type 2 receptor mechanism of action was 
also found to be mediated via the G protein-associated phosphatidyl inositol 
hydrolysis pathway [139]. 
IGF binding proteins 
Besides binding to its receptors, IGF can also bind to IGFBPs and these 
interactions also play an essential role in modulating biological functions of 
IGF [15]. Multiple IGFBPs have been detected in plasma, other biological 
fluids, such as amniotic fluid or spinal fluid and in a variety of tissues. Despite 
a large similarity of their structure, the different IGFBPs have distinctly 
different properties that might provide clues to elucidate their exact functions 
[16, 110]. Six classes of IGFBP, designated IGFBP-1 to IGFBP-6, have been 
purified and cloned so far [24, 54]. In serum, IGFBP functions as a storage 
depot allowing ready supply of IGF to tissues. Furthermore, depending on 
their binding affinity IGFBPs can bind IGF and sequester it so that IGF is not 
capable of binding to its receptors, or they can present IGF via the IGF-IGFBP 
complex to the receptor improving ligand-receptor interaction. The ability of 
IGFBPs to adhere to the cell surface appears to be important in the latter 
process. IGFBP-1 and IGFBP-2 have RGD sequences [Arg-Gly-Asp] in their 
terminal region and are therefore structurally capable to bind to the cell 
surface integrin receptors [29, 160]. The agonistic or antagonistic nature of 
IGFBP modulation of the biological functions of IGF depends on the cell or 
tissue types involved [17, 166]. 
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Effects of IGF on PG metabolism in cartilage 
IGF-1 is the major growth factor that balances biosynthesis and catabolism 
of chondrocyte PG to maintain a steady state of PG in the cartilage matrix [42, 
63, 77, 119, 128, 129, 170, 174] IGF-1 is able to maintain elevated levels of 
chondrocyte PG synthesis in culture in the absence of fetal calf serum [12, 27] 
Moreover, IGF-1 can directly inhibit both basal and cytokine-induced 
degradation of PG in cartilage [200] IGF-2 is less potent than IGF-1 requiring 
50 100 times higher concentrations to achieve similar effects [119] Selective 
elimination of IGF-1 from serum or synovial fluid with neutralizing antibodies 
results in a marked decrease in cartilage PG synthesis and enhanced PG 
breakdown [170] IGF-1 has been suggested to exert an inhibitory effect on 
production and release of degradative proteases or protease activators to 
enhance synthesis or upregulation of enzyme inhibitors, although evidence is 
not conclusive yet [10, 33, 147] 
IGF binding sites that have been identified on chondrocytes in articular 
cartilage appeared to be specific IGF receptors [97, 121 151, 197, 198, 224, 
239] Trippel et al [1988] calculated that an average 3 104 type 1 receptors are 
present on the surface of chondrocytes with a binding affinity to IGF-1 of 
4 10 κ M Moreover, chondrocytes have been shown to produce IGFBPs [35, 
64, 146, 193] Osteoarthntic cartilage exhibits a marked elevation of IGFBP-3 
production This might indicate that IGFBPs play an important role in 
pathologic cartilage destruction [53] 
IGF 1 and IL-1 show counteracting activities, e g IGF-1 is able to increase 
the recovery rate from IL-1-induced inhibition of chondrocyte PG synthesis 
and IL 1 promotes cartilage pathology by inhibiting IGF-1-mediated anabolism 
[23, 61, 137, 153, 192] IL-1 downregulates IGF mRNA levels in chondrocytes 
and induces secretion of IGFBP and IGF-1 receptor [113, 127] These findings 
suggest that disturbed effects of IL-1 and IGF on cartilage play a significant 
role in the pathogenesis of inflammatory joint diseases 
IGF 1 nonresponsiveness of chondrocytes 
Despite the importance of IGF in the regulation of PG metabolism in 
chondrocytes, only a limited number of studies has focused on the role of IGF 
in RA Measurements of IGF levels in serum or synovial fluid of patients with 
various arthntides yielded conflicting results [3, 4, 20, 38, 39, 108, 142] 
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However, it becomes clear that a lower secretion level and availability of IGF 
on its own is not a regulatory factor in altered cartilage metabolism 
Recently, it was demonstrated in our laboratory that IGF-1 is essential to 
maintain chondrocyte PG synthesis during culture of murine anatomically 
intact cartilage [170] However, during experimentally-induced arthritis, 
articular cartilage exhibits nonresponsiveness towards stimulation of 
chondrocyte PG synthesis by IGF-1 [169] This phenomenon is not caused by a 
total nonresponsiveness of the chondrocytes, since forskohn, which is an 
upregulator of the adenylate cyclase pathway, is still able to enhance 
chondrocyte PG synthesis in arthritic cartilage Therefore, it was suggested 
that this nonresponsiveness to IGF may contribute to cartilage destruction in 
experimental arthritic cartilage [169, 214] 
AIM AND SCOPE OF THE THESIS 
The aim of the present thesis was to further identify the exact role of IGF-1 
and mechanism by which IGF 1 regulates chondrocyte PG metabolism in 
normal cartilage and to further characterize the phenomenon of IGF-1 
nonresponsiveness in arthritic cartilage of mice after experimental induction of 
arthritis 
In Chapter 2, the effects of stimulation by IGF-1 and the glucocorticoid 
triamcinolone acetonide [TA] both on the amount and hydrodynamic size of 
newly synthesized PGs were investigated in normal and arthritic mouse 
cartilage Apart from inhibition of chondrocyte PG synthesis it was found that 
in the absence of proper IGF-1 stimulation the chondrocytes produce aberrant 
PGs 
In Chapter 3, the role of other growth factors, such as bFGF, EGF, 
PDGF, TGFß was studied on chondrocyte PG metabolism under normal and 
pathologic conditions These factors were studied in order to investigate 
whether arthritic cartilage also displays nonresponsiveness towards these 
growth factors or whether these factors would compensate tor IGF 1 
nonresponsiveness, either during repair, or during early and/or later phases of 
experimental arthritis 
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Because a compensatory action of other growth factors was not found in 
arthritic cartilage, the mechanisms underlying the disturbed IGF-1 response m 
arthritic cartilage was evaluated At first involvement of suppressive mediators 
such as IL-1, TNFa, proteolytic enzymes and reactive oxygen species in the 
induction and/or maintenance of the nonresponsive state of chondrocytes to 
IGF-1 during experimental arthritis was investigated [Chapter 4] 
Then, attention was focused on IGF-1 receptor distribution patterns in 
normal and arthritic mouse cartilage In order to analyze the amounts of 
IGF-1 receptor on chondrocyte cell membranes a microscopical approach was 
established that allowed detection and quantification of low fluorescence levels 
[Chapter 5] IGF-1 receptor was detected ïmmunohistochemically in cryostat 
sections of intact mouse patellar cartilage with the use of antibodies against the 
α subunit of the receptor and analyzed with confocal laser scanning 
microscopy |CLSMJ [Figure 5] 
The technology that is described in Chapter 5 was further used to compare 
staining ot IGF-1 binding sites with anti-IGF-1 receptor antibody and 
biotinylated IGF-1 in the different zones of cartilage from normal and arthritic 
mouse knee joints CLSM analysis allowed detailed determination of 
membrane-associated and intracellular staining Comparison of anti IGF-1 
receptor antibody staining with biotinylated IGF-1 staining was performed in 
order to obtain information on relative amounts of IGFBP in cartilage during 
arthritis because biotinylated IGF-1 but not antibodies against IGF-1 
demonstrated IGFBPs [Chapter 6] 
Finally, distribution patterns of the IGF-1 receptor and IGF-1 stimulation of 
chondrocyte PG synthesis in articular cartilage during various phases of 
experimental arthritis were investigated It was analyzed whether a relation 
exists between IGF-1 receptor expression and IGF-1 chondrocyte PG synthesis 
[Chapter 7] 
In Chapter 8, chondrocyte PG synthetic activity and chondrocyte IGF-1 
receptor localization was analyzed in samples of human cartilage Specimens 
were obtained post mortem from human knees within 18 hours after death 
from donors without a known history of osteoarthritis fOA] The samples were 
taken from macroscopically normal looking regions as well as from damaged 
regions yielding a range of cartilage destruction 
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Figure 6 
A) A confocal laser scanning microscope [CLSM] collects images that are almost free of out-of-
focus signals. CLSM analysis results in improved spatial resolution compared with 
conventional light microscopy and allows optical sectioning of the specimen [227, 232]. 
B) The possibility to make optical sections through the entire chondrocyte is used to analyze 
IGF-1 receptor staining on the chondrocyte cell surface in the middle optical section. 
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In Chapter 9 a review is presented on the use of CLSM to analyze healthy 
and pathologic cartilage. 
In Chapter 10, the above mentioned investigations are summarized and the 
conclusions concerning the role and regulating effects of IGF-1 on 
chondrocyte metabolic functions in normal and experimentally arthritic 
cartilage are discussed. 
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ABSTRACT 
During experimentally-induced arthritis, inhibition of proteoglycan [PG] 
synthesis is one of the mechanisms leading to cartilage destruction Disturbed 
anabolic signaling might contribute to this impaired chondrocyte PG synthesis 
In the present study we investigated the effects of insulin-like growth factor-1 
[IGF 1] and the glucocorticoid, triamcinolone acetonide [TA], on in vitro 
chondrocyte PG synthesis of articular cartilage obtained from normal and 
arthritic mouse knee joints 
PG synthesis was measured by 35S-sulfate incorporation and the hydro-
dynamic volume of newly synthesized PGs was analyzed with gel-
chromatography 
Cultunng normal cartilage with IGF 1 resulted in significant enhancement 
of chondrocyte PG synthesis Concerning the hydrodynamic volume of newly 
synthesized PGs after culture with IGF-1, PG monomers with large 
hydrodynamic size, similar to those synthesized immediately after dissection 
were observed In arthritic cartilage, IGF-1 failed to stimulate PG synthesis 
and only PGs with relatively small dimensions were produced However, in the 
presence of the steroid TA, synthesis of hydrodynamically large PGs were 
found in arthritic as well as normal cartilage 
These observations indicate that steroids may play a critical role in 
maintaining cartilage integrity in both normal and arthritic cartilage 
INTRODUCTION 
Rheumatoid arthritis [RA], is a joint disease characterized by perpetuating 
inflammation, which leads to erosion of the articular cartilage and injury of 
the surrounding tissue [56] The mechanisms underlying tissue damage remain 
largely unknown Experimentally-induced arthritis models have revealed that 
during joint inflammation degradation of matrix proteoglycans [PGs] together 
with an inhibited synthesis of new PGs, results in depletion of the cartilage 
matrix [23, 31, 47] Inhibition of PG synthesis is presumed to be caused by 
inflammatory mediators, such as interleukin-1 [6, 7, 44, 45, 46, 52] and tumor 
necrosis factor [30, 32] In addition, we recently demonstrated that also a lack 
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of anabolic signaling might contribute to impaired chondrocyte PG synthesis 
during arthritis [33, 49] 
Chondrocyte matrix synthesis is thought to be controlled by interactions 
between circulating hormones and locally produced growth factors Insulin-
hke growth factor-1 [IGF-1], is known to be the major growth factor stimulus 
for cartilage PG synthesis [16, 24, 26, 34, 43] We demonstrated that IGF-1 is 
essential to maintain the PG synthesis rate of normal anatomically-intact 
murine cartilage in culture at in vivo levels [33] Without IGF-1, PG synthesis 
in vitro decreases to about 50 % of the in vivo level, within 24 hours 
However, when experimentally-induced arthritic cartilage was cultured with 
IGF-1, no stimulation of PG synthesis was observed The cartilage showed a 
complete lack of IGF-1 responsiveness Furthermore, this phenomenon of non-
responsiveness was not caused by a general inhibition of chondrocyte 
metabolism [33, 49] In addition, non-responsiveness to IGF-1 stimulation of 
human osteoarthntic cartilage has been reported [14] Although it should be 
noted that in contrast to arthritic cartilage, ex vivo PG synthesis of 
osteoarthntic cartilage is at a high level 
For the past two decades intra-articular injections of glucocorticoids have 
been used in the treatment of many kinds of joint diseases [11, 17, 18, 27, 39,] 
Intra-articular corticosteroid injections suppress the joint inflammation, 
resulting in an evident pain relief and a marked preservation of joint function 
[15, 54] However, the effects of steroids on chondrocyte metabolism remain 
controversial Steroid hormones, in low concentrations have been reported to 
stimulate PG synthesis in vitro [5, 22, 41, 42] Concerning in vivo studies, 
steroid hormones mainly induced negative effects on chondrocyte function of 
normal cartilage [1, 2, 3, 4, 10, 25, 53] On PG depleted cartilage, steroids 
appeared to have chondroprotective effects, ι e , relief of PG synthesis 
inhibition as well as decrease in chondrocyte loss and osteophyte formation 
[12, 20, 28, 36, 50, 51, 55,] Combination of IGF-1 with glucocorticoids has 
been described to exert synergistic actions on chondrocyte metabolism [5, 19] 
These observations indicate that the exact effect and interaction of steroid 
hormones and growth factors on chondrocyte metabolism of normal and 
damaged articular cartilage are still controversial 
The aim of the present study was to investigate the effect of IGF-1 and the 
synthetic glucocorticoid, triamcinolone acetonide [TA], on in vitro 
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chondrocyte PG synthesis of normal and arthritic murine cartilage The effect 
on PG synthesis of IGF-1 and TA was measured by incorporation of 
35S-sulfate and the hydrodynamic volume of newly synthesized PGs was 
determined by gel-chromatography on a Sephacryl S-1000 column 
MATERIALS AND METHODS 
Animals 
Male 10-12 weeks old [20-25 g] C57 black/10 mice were used in this study 
They were maintained under routine laboratory conditions The animals were 
kept in boxes with sawdust bedding in an air conditioned room [21-22 С 
relative humidity 60%] and a 12 hours light-dark cycle The mice were fed a 
standard commercial pellet diet [RHM. Hope Farms, The Netherlands] and 
were given acidified tap water ad libitum 
Induction of arthritis 
Arthritis was induced in the mouse knee joint with two different methods 
The first was arthritis induction by intra-articular injection of yeast particles, 
zymosan Arthritis was induced in the right knee joint by injecting 180 μg 
sterilized zymosan [Sigma, St Louis, MO, USA] in pyrogen-tree saline This 
model, is characterized in the acute phase [days 1-5], by a polymorphonuclear 
cell rich infiltrate in the joint space, cartilage damage and inhibition of 
chondrocyte metabolism [33, 47] The second was the antigen-induced arthritis 
model, which develops shortly after intra-articular injection of the antigen in 
previously immunized mice Mice were immunized with 100 μg methylated 
BSA [Sigma] emulsified in Freund's Complete Adjuvant [Difco laboratories, 
Detroit, M 1 , USA] divided into four subcutaneous injections into the flank 
and footpads of the forehmbs As an additional adjuvant 2 χ IO9 heat killed 
Bordetella pertussis organisms [National Institute ot Public Health, Bilthoven, 
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The Netherlands] were injected intraperitoneally. After 7 days the mice were 
boosted with 100 μg mBSA emulsified in Freund's Complete Adjuvant, divided 
into two subcutaneous injections in the back. At day 21 arthritis was induced 
by intra-articular injection of 60 μg mBSA in 6 μΐ phosphate buffered saline 
[PBS] into the right knee joint. The antigen-induced arthritis model is 
characterized by an acute synovial inflammation with numerous granulocytes, 
which later changes into a chronic type of inflammation, characterized by 
mononuclear cells [9]. Similar to zymosan-induced arthritis, antigen-induced 
arthritis shows severe depletion of the cartilage matrix and inhibition of 
chondrocyte metabolism in the acute phase of the disease. 
Cartilage cultures 
Three days after zymosan injection and three days after elicitation of 
antigen-induced arthritis, the cartilage matrix is severely depleted and the 
chondrocyte PG synthesis is significantly suppressed [33, 47]. Moreover, at day 
three of both arthritides chondrocyte PG synthesis of cartilage from the 
contralateral control joint can be significantly enhanced by IGF-1, while 
cartilage from the inflamed knee joint can not be stimulated by IGF-1 [33]. At 
this stage of arthritis the mice were killed by cervical dislocation. Whole 
patellae were dissected from the right arthritic and left control knee joints, 
with a standard amount of surrounding tissue. The patellar ligaments were cut, 
leaving the cartilage fully intact, which enables us to study the chondrocyte 
metabolism in anatomically intact articular cartilage [47, 48]. Patellae were 
cultured in medium alone, i.e., RPMI 1640 [Flow Laboratories, Irvine, 
Scotland] containing 2 mM glutamine, 40 μg/ml gentamycin, 0.1% BS A 
[ultrapure bovine serum albumin, Sigma], or medium supplemented with 
recombinant human IGF-1 [Boehringer Mannheim, Germany] 0.25 μg/ml, or 
triamcinolone acetonide [Sigma] [0.03 mM, 0.3 mM], or with the combination. 
All incubations were performed for 48 hours in 24 well cluster dishes at 37 С 
in a humidified atmosphere containing 5% carbon dioxide. 
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Proteoglycan synthesis in vitro 
Chondrocyte PG synthesis of patellar cartilage was measured by the 
incorporation of 35S-sulfate as previously described [12, 48]. Briefly, cartilage 
was incubated in RPMI 1640 medium [0.1% BS A, glutamine, gentamycin] with 
6 MBq 35S-sulfate [Na 2 3 5 S0 4 , Amersham Buckinghamshire, U.K] for 2 hours 
at 37 C. Thereafter, the tissue was washed three times with physiological saline 
to remove non-incorporated radiolabel. Subsequently, patellae were fixed in 
96% ethanol and decalcified in 5% formic acid for 3 hours, followed by 
stripping of the articular cartilage layer from the remainder of the patella. The 
patellar cartilage was digested in Lumasolve [Perstop Analytical, Oud-
Beyerland, The Netherlands] at 60 C. The quantity of incorporated radioactive 
sulfate was assayed by liquid scintillation counting and is expressed per patella. 
Characterization of the hydrodynamic volume of newly synthesized 
proteoglycans 
After a 48 hours culture period with various incubation media [IGF-1 0.25 
[igfm], TA 0.03 mM, 0.3 mM, the combination or medium alonel, the patellae 
were incubated for 4 hours in RPMI 1640 medium containing 6 MBq 
35S-sulfate. Thereafter, patellae were thoroughly rinsed in physiological saline. 
Subsequently, patellae were decalcified in 3.5% Na2 EDTA [Merck, 
Darmstadt, Germany] for 4 hours and the cartilage layer was stripped from the 
bone. The stripped cartilage was grounded with a glass mortar and pestle and 
the PGs were extracted at 4°C with 4 M CuCl [Merck], in the presence of 
protease inhibitors, 0.01 M EDTA, 0.1M 6-aminocaproic acid [Sigma], 0.005 
M benzamidine hydrochloride [Sigma], 5 mg/ml trypsin inhibitor [Sigma], 
0.005 M iodoacetate [Sigma]. Extracted PGs were supplemented with 1 mg of 
an unlabeled bovine PG mixture as a carrier and applied on a Sephacryl 
S-1000 column, 1.6 χ 100 cm [Pharmacia, Upsala, Sweden]. The column was 
equilibrated and eluted with 4 M GuCl under dissociative conditions. The flow 
rate was 6 ml/hour and fractions of 3 ml were collected. The fractions were 
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assayed for radiolabeled PGs using a liquid scintillation analyzer. V0 was 
determined using bovine proteoglycan aggregates, whereas Vt was assayed with 
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Statistics 
Statistical evaluation of the experiments was performed by the Kruskall-
Wallis test in combination with the Wilcoxon rank-sum test. A ρ value of less 
than 5% was considered to be significant. 
RESULTS 
Effect of IGF-1, steroid or the combination on PG synthesis in 
vitro 
PG synthesis was measured in patellar cartilage by incorporation of 
35S-sulfate, after a 48 hours culture period. When normal patellae were 
cultured for 48 hours in medium without serum or growth factors, PG 
synthesis rapidly declined to about 50%, compared to synthesis immediately 
after isolation of the cartilage. Table 1 shows that culturing the cartilage with 
Table 1. 
The effect of triamcinolone acetonide [TA], IGF-1, or the combination on proteoglycan 
synthesis of normal murine articular cartilage 
Normal patellae 
TA [mM] - IGF-1 + IGF-1 
0 21401564 8283 ±1346* 
0.03 16101206 636011096 
0.3 17281554 723611096 
Murine patellae were cultured for 48 hours with TA [0.03 mM or 0.3 mM], IGF-1 [0.25 
цв/ті], medium alone or combination of TA and IGF-1. The cultures were pulsed for 2 hours 
with 35S-sulfate, to measure proteoglycan synthesis. All experiments were performed three 
times and expressed are the means 1 SD per patella of one representative experiment. [n=6, 
*p<0.05] 
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0.25 Д£/т1 IGF-1 induced significant stimulation of PG synthesis, in contrast 
to synthesis after culture without IGF-1. Addition to the culture medium of the 
glucocorticoid triamcinolone acetonide, in concentrations 0.03 raM and 0.3 
mM, did not significantly affect PG synthesis. The concentration ТА used in 
this study was based on known effects of growth factors and steroids on 
chondrocyte PG synthesis of both anatomically intact cartilage and isolated 
chondrocytes or cartilage expiant cultures. TA added in combination with 
IGF-1 did not induce a further stimulation or inhibition of PG synthesis, 
compared to stimulation effected by IGF-1 alone. 
Incubation of arthritic patellae with 0.25 μg/ml IGF-1 did not result in 
stimulation of PG synthesis [Table 2], which is in agreement with earlier 
observations [33]. Table 2 shows a representative experiment of this finding, 
using cartilage of the mouse knee joint with antigen-induced arthritis. The 
same effects were noted in zymosan-induced arthritis. Moreover, TA alone did 
not stimulate PG synthesis of the arthritic cartilage as well. Interestingly, the 
combination of IGF-1 and both concentrations TA, i.e. 0.03 and 0.3 mM, 
exerted a significant stimulation of PG synthesis. 
Table 2. 
The effect of triamcinolone acetonide [TA]. IGF-1, or the combination on proteoglycan 
synthesis of murine arthritic articular cartilage. 
Arthritic patellae 
TA [mM] - IGF-1 + IGF-1 
0 2671 ±950 2783 ±1110 
0 03 26331838 6 7 7 8 1 1 0 4 2 * 
0 3 28691709 5543 1 1 8 4 3 * 
At day three of antigen-induced arthritis, mouse patellae were isolated from the arthritic knee 
joint. The patellae were treated as described in the legend of Table I Expressed are the means 
1 SD per patella of one representative experiment out of three [n=6, * ρ < 0 05] 
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Effect of IGF-1, steroid or the combination on the hydrodynamic 
volume of newly synthesized PGs 
After extraction of PG from the cartilage, the hydrodynamic volume of 
newly synthesized PGs was determined with gel-chromatography. The 
efficiency of the extraction was about 90% and no significant differences were 
noted between the various groups. The murine PG monomer synthesized 
directly after dissection appeared to be smaller than monomers from bovine 
articular cartilage, having a Kav of respectively 0.43 and 0.25. 
Characterization of newly synthesized PGs from normal patellae cultured 
for 48 hours in medium without serum or growth factors indicated that only 
PG monomers with a relatively small hydrodynamic volume were synthesized 
[Figure 1]. Furthermore, figure 1 shows that culturing the patellae for 
48 hours in the presence of 0.25 μg/ml IGF-1 caused a shift to PG monomers 
with a larger hydrodynamic volume, resembling the PGs synthesized 
immediately after dissection [data not shown]. 
1000 
eoo 
600 
400 
200 
CPM/fraction 
30 45 60 75 90 105 120 135 150 165 180 195 210 
elution volume 
Figure 1. 
The effect of IGF-1 on the hydrodynamic volume of newly synthesized proteoglycans in 
normal murine articular cartilage. 
Normal murine patellae were cultured for 48 hours with or without IGF-1 (0.25 μg/ml] and 
subsequently incubated with 1sS-sulfate for 4 hours. Proteoglycans were extracted and applied 
to a Sephacryl S-1000 column as described in Materials and Methods. Column fractions were 
collected and radioactive labeled proteoglycans were measured. All experiments were carried 
out three times. Shown is a representative experiment of three [n=15] [.J no IGF-1, [+] IGF-1. 
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Likewise, the hydrodynamic volume of PG synthesized by experimentally-
induced arthritic cartilage was investigated. Concerning different models of 
arthritis induction, i.e. zymosan-induced arthritis [Figure 2A] and antigen-
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Figure 2. 
The effect of IGF-1 on the hydrodynamic volume of newly synthesized proteoglycans in 
arthritic murine articular cartilage. 
At day three after the induction of zymosan arthritis [Figure 2A] or antigen-induced arthritis 
[Figure 2 B], patellae were isolated and cultured with or without IGF-1 [0.25 μg/ml] The 
experiment was performed as described in the legend of Figure 1. 
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induced arthritis [Figure 2B], no remarkable difference in the dimension of 
newly synthesized PGs was observed. In both arthritides, after culture in 
medium without serum or growth factors, PG monomers with relatively small 
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Figure 3. 
The effect of triamcinolone acetonide [TA] in the absence or presence of IGF-1 on the 
hydrodynamic volume of newly synthesized proteoglycans in normal murine articular cartilage 
Normal mouse patellae were cultured for 48 hours with ТА [0 03 raM or 0 3 raM] in the 
absence [A] or presence [B] of IGF-1 [0.25 ця/ті] See Figure 1 for further definitions. 
Figure ЗА. [.] medium alone, [+] ТА 0 03 raM, [*] ТА 0.3 mM 
Figure 3B:[.] IGF-1; [+] ТА 0.03 mM + IGF-1; [*] ТА 0.3 mM +IGF-1 
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hydrodynamic volume were synthesized, similar to PGs produced by cultured 
patellae from the normal knee joint. However, when the arthritic patellae were 
cultured in the presence of IGF-1 no monomers with large hydrodynamic 
volume were synthesized. The results clearly show that in contrast to normal 
cartilage, in arthritic cartilage IGF-1 failed to maintain the synthesis of large 
PG monomers. 
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Figure 4. 
The effect of triamcinolone acetonide [TA] in the absence or presence of IGF-1 on the 
hydrodynamic volume of newly synthesized proteoglycans in mouse arthritic articular cartilage. 
Three days after arthritis induction, ι e zymosan arthritis [Figure 4A and B] or antigen-induced 
arthritis [Figure 4C and D], patellae were dissected from the arthritic knee joint and cultured 
with ТА [0 03 mM or 0 3 raM] alone [Figure 4A and C] or in combination with IGF-1 
[0 25 μg/mll [Figure 4B and D] See Figure 1 for further definitions 
Figure 4A and С [.] medium. [+] ТА 0 03 raM, [*] ТА 0 3 mM 
Figure 4В and D [.] IGF-1, [+] TA 0 03 mM + IGF-1, [*] TA 0 3 mM + IGF-1 
Furthermore, we evaluated the effect of the steroid compound triamcinolone 
acetonide [TA] on dimensions of newly synthesized PGs. Remarkably, when 
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normal cartilage was cultured with TA without IGF-1, the effect of 0.3 mM 
TA on the dimension of newly synthesized PGs was comparable to the effect of 
IGF-1 alone [Figure ЗА]. With 0.03 mM ТА still a discernible part of the 
synthesized PGs was smaller than those produced in the presence of IGF-1. 
Combination of ТА with IGF-1 induced synthesis of hydrodynamically large 
PGs [Figure 3B], as was observed after culture of the normal cartilage with 
IGF-1 alone. 
It was striking that when the zymosan-induced arthritic cartilage [Figure 4A 
and B] as well as antigen-induced arthritic cartilage [Figure 4C and D] was 
cultured with ТА without IGF-1, the steroid was able to induce synthesis of 
large PGs. In arthritic cartilage, ТА showed the same dose-dependence as in 
normal cartilage. In the presence of IGF-1, culture of arthritic cartilage with 
low concentration of ТА [0.03 mM], resulted in the synthesis of small as well 
as large PGs [Figure 4A and C], whereas incubation with a moderate 
concentration [0.3 mM] plus IGF-1 led to the production of mainly large PGs 
[Figure 4B and D]. Similar results were noted in all three experiments that 
were performed with both arthritides. Figure 4 shows the results of one 
representative experiment out of three. 
DISCUSSION 
Investigation of cartilage PG synthesis inhibition during arthritis mainly has 
been focused on potential suppressive mediators. However, we have recently 
shown that a lack of anabolic stimuli might as well contribute to impaired 
chondrocyte PG synthesis [33]. Growth factors as well as steroid hormones are 
known to play a regulating role in chondrocyte metabolism. In the present 
study we investigated the effects of IGF-1 and triamcinolone acetonide on 
chondrocyte PG synthesis in normal cartilage as well as in experimentally-
induced arthritic murine cartilage. 
Our data indicate that IGF-1 stimulation of ,5S-sulfate incorporation in 
normal cartilage reflects the synthesis of hydrodynamically large PGs. 
Furthermore, the results obtained show that failure of IGF-1 to stimulate PG 
synthesis in arthritic cartilage accompanies synthesis of PG monomers with 
only small dimensions. Earlier observations [33, 49], demonstrated that IGF-1 
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plays an important role in normal chondrocyte metabolism and that during 
arthritis there may be disturbed IGF-1 signalling, resulting in defective 
chondrocyte function. The findings of the present study demonstrate that in 
arthritis the quality of synthesized PGs is deficient as well. While incubation of 
normal patellae with IGF-1 resulted in stimulation of PG synthesis as well as 
synthesis of PGs with predominantly large hydrodynamic volumes, culture 
with TA led to the synthesis of large PGs without an overall stimulation of 
35S-sulfate incorporation. This indicates that IGF-1 both maintains the 
chondrocyte differentiated phenotype and is an anabolic factor in stimulating 
PG synthesis, while the effect of TA is confined to conserving the 
differentiation stage of the patellar chondrocytes. Steroids have been described 
to modulate cell metabolism, by binding to specific cytoplasmic receptors, 
forming receptor complexes which influence gene expression [8, 35, 38]. 
These steroid receptors have been demonstrated in various tissues, including 
mouse growth-plate cartilage and articular cartilage of rabbits and humans f8, 
35, 38]. In addition, the effect of steroids on chondrocyte matrix synthesis may 
depend on other factors, i.e., locally produced growth factors. For instance, 
steroids are known to have a priming effect on the biological action of IGF-1 
[19, 29]. The combination of TA and IGF-1 did not induce distinct 
supplementary effects on 13S-sulfate incorporation or the dimensions of PGs 
synthesized in normal cartilage, compared to stimulation by IGF-1 alone. Most 
probably, culturing with IGF-1 already led to a plateau stimulation in normal 
patellae, explaining the absence of an additive effect when IGF-1 and TA are 
combined. 
Chase experiments have indicated that the chromatographic profiles obtained 
immediately after labeling and after a 24 hours chase period were essentially 
similar [data not shown ]. The chase period did not result in formation of small 
PGs. This indicates that the observed effects by steroid and IGF-1 on PG 
volume are not mediated by decreased PG breakdown, but implicate an effect 
on newly synthesized PGs. Moreover, the effect of labeling for different time 
periods, i.e., 1, 2, 3 and 4 hours, on the chromatographic profiles was 
evaluated. It was found that variation in pulse labeling time did not effect the 
elution profiles of extracted PGs. In addition, we have sliced the cartilage from 
the patella immediately after labeling, in stead of first decalcifying the patella. 
These experiments showed that either with or without decalcification the same 
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chromatographic profiles were obtained. Therefore, degradation of the PGs 
prior to the addition of GuCl and protease inhibitors does not seem very likely 
to us. 
Regarding arthritic patellae, only TA was able to induce synthesis of 
hydrodynamically large PGs. The anabolic signal of IGF-1, both on quantity 
and size of PGs, is lost while the effect of TA is maintained in arthritic 
cartilage. This can be related to a defect in the extracellular IGF-1 receptor 
during arthritic conditions while the intracellular steroid receptor retains its 
function. In contrast to the effect on normal patellae, the combination of IGF-1 
and TA had a striking additive effect on PG synthesis in arthritic cartilage. 
This effect may be caused by an indirect effect of steroids on the metabolism 
of chondrocytes in arthritic cartilage. 
Steroids may regulate the production of inflammatory mediators in our 
system. Steroids are known to be potent inhibitors of IL-1 synthesis. 
Elimination of suppressive mediators by steroids might induce restoration of 
PG synthesis in arthritic cartilage [37, 40, 50, 51]. In conjunction with a direct 
effect of steroids on chondrocyte metabolism, elimination of suppressive 
mediators, may also lead to restoration of IGF-1 receptor signaling. Non-
responsiveness of arthritic cartilage to IGF-1, previously described by our 
group [21, 33, 49], may be caused by suppressive mediators, that prevent 
IGF-1 anabolic signalling. Down-regulation of inflammatory mediators by 
steroids will result in repair of IGF-1 responsiveness. Moreover, steroids have 
been described to enhance mRNA synthesis of IGF-1 receptor [29]. In this 
regard, the supposed defective IGF-1 receptor signalling in arthritic cartilage 
might be overcome by a steroid-induced overproduction of IGF-1 receptors. 
In conclusion, our results show that in normal cartilage IGF-1 preserves 
synthesis of PG monomers with large dimensions, similar to those synthesized 
immediately after dissection. Chondrocytes from an arthritic background 
appear to have lost their ability to respond to IGF-1 stimulation. However, the 
steroid TA is able to effect synthesis of hydrodynamically large PGs in 
arthritic as well a in normal cartilage. Our data indicate that steroids are 
valuable in maintaining cartilage integrity. In clinical and experimental in vivo 
studies of joint diseases, steroid treatment has been described to be beneficial, 
although steroids are reported to have suppressive effects on chondrocyte 
function in normal joints. Experimental in vivo studies may help unraveling 
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events that take place in normal and arthritic knee joints and might gain better 
insight in the therapeutic value of steroid usage. 
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ABSTRACT 
Disturbed anabolic signaling might contribute to the decreased chondrocyte 
proteoglycan [PG] synthesis during joint inflammation Articular cartilage 
obtained from mouse knee joints with experimentally-induced arthritis exhibits 
a state of nonresponsiveness towards stimulation of chondrocyte PG synthesis 
by insulin-like growth factor-1 [IGF-1] We investigated the role of other 
growth factors apart from IGF-1 on regulation of chondrocyte PG synthesis 
under pathological conditions, ι e during repair after IL-1 exposure as well as 
during early and later arthritis 
Mouse patellae were obtained from normal knee joints and joints injected 
with IL 1 or zymosan The patellae were cultured with basic fibroblast growth 
factor [bFGF], platelet-derived growth factor [PDGF], epidermal growth 
tactor |EGF| or transforming growth factor β [TGFß] for 24 hours in the 
presente or absence ot IGF-1 Chondrocyte PG synthesis was measured by 
1SS sulfate incorporation 
In normal cartilage none of the tested growth factors elicited stimulatory 
effects on the chondrocyte PG synthesis as caused by IGF-1 EGF and TGFß 
even caused significant inhibition of chondrocyte PG synthesis Combination of 
bFGF or PDGF with IGF-1 exerted significant additional stimulation ot the 
^S sulfate incorporation IL-1 exposed cartilage displayed reactivity to IGF-1 
as well as to the other growth factors similar to control cartilage Cartilage 
obtained from joints with experimentally-induced arthritis exhibited a state of 
nonresponsiveness towards all individually tested growth factors as well as 
growth factor combinations 
Arthritis causes nonresponsiveness to stimulation of chondrocyte PG 
synthesis by the tested growth factors, which might be caused by a general 
receptor function defect 
INTRODUCTION 
In inflammatory joint diseases, such as rheumatoid arthritis [RA], the 
articular cartilage is severely destructed [19, 48] Disturbance of the 
equilibrium between synthesis and degradation of matrix proteoglycans [PG's] 
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is thought to be the main cause of this deterioration of the cartilage matrix 
Investigation of the phenomenon of PG synthesis inhibition has mainly been 
focused on the search for suppressive mediators produced by the inflamed 
synovium, such as interleukin-1 [IL 1] [1,2, 40, 46] and tumor necrosis factor 
α [30, 32] These cytokines are highly potent in effecting inhibition of PG 
synthesis as well as causing degradation of the cartilage On the other hand, a 
lack of anabolic signaling [34] might contribute to decreased chondrocyte PG 
synthesis during joint inflammation 
The precise nature by which growth factors regulate chondrocyte 
metabolism in normal and pathophysiological conditions is not fully 
understood Insulin-like growth tactor-1 [IGF-1] is the most important 
anabolic factor for PG synthesis in normal articular cartilage [10, 20, 21, 33, 
36] Most information on this subject is gained from studies with isolated 
chondrocytes or cartilage expiants Variability in responsiveness of cartilage 
upon culture with various growth factors, ι e basic fibroblast growth factor 
[bFGFl, platelet-derived growth factor [PDGF], epidermal growth factor 
[EGF], transforming growth factor β [TGFß] and IGF-1 is thought to rely on 
differences in culture conditions or cartilage origin and species [3, 11-17, 22, 
23, 25, 27-29, 35, 44, 45, 47] However, little information is available about 
the role of these growth factors in the metabolism of chondrocytes in 
anatomically intact articular cartilage [44] Even less has been reported about 
the function of growth factors on chondrocyte PG synthesis of articular 
cartilage from diseased knee joints 
We previously demonstrated that IGF 1 is able to maintain PG synthesis of 
murine anatomically intact cartilage during culture at the in vivo level 
Conversely, during experimentally-induced arthritis articular cartilage 
exhibited a state of non-responsiveness towards stimulation of chondrocyte PG 
synthesis by IGF-1 [34] The aim of the present study was to investigate 
whether arthritic cartilage also displays nonresponsiveness to other growth 
factors apart from IGF-1, or whether these growth factors can compensate for 
IGF 1 under pathological conditions Therefore, we studied the effects of 
bFGF, PDGF, EGF and TGFß, in the presence or absence of IGF-1 on the in 
vitro chondrocyte PG synthesis of intact normal murine patellar cartilage as 
well as during repair after IL-1 exposure and during early and later arthritis 
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MATERIALS AND METHODS 
Animals 
Female 8-12 week old C57 black/6 mice were used for this study. They 
were maintained under routine laboratory conditions. The animals were kept 
in boxes with sawdust bedding in an airconditioned room [21-22 C, relative 
humidity 60%] and a 12 hours light-dark cycle. The mice were fed a standard 
commercial pellet diet [RHM, Hope Farms, The Netherlands] and were given 
acidified tap water ad libitum. 
Intra-articular IL-1 injections 
Murine recombinant IL-1 [300 U] [kindly supplied by Dr I. G. Otterness, 
Pfizer Central Research, Groten, CT, USA] was injected in a volume of 6 μΐ 
into the joint cavity of the right knee. The left contralateral joint received an 
equal volume of phosphate buffered saline [PBS]. The biological activity of 
IL-1 was determined using the lymphocyte-activation factor assay [LAF1. 
Consistently, 10-40 pg/ml IL-1 corresponded to 1 Unit biological activity. The 
IL-1 batch was stored at -20 C, and showed constant LAF activity over the 
period studied. 
Induction of arthritis 
Arthritis was induced in the right knee joint of the animals by intra-articular 
injection of 180 μg sterilized zymosan [Sigma, St. Louis, MO, U.S.A] in 
pyrogen-free phosphate buffered saline. This model, which is characterized by 
a polymorhonuclear cell rich infiltrate and by cartilage damage in the acute 
phase [days 1-4], has been described in earlier studies [34, 42]. 
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Cartilage cultures 
Two and five days after induction of zymosan-induced arthritis as well as 
one, two, three and four days after injecting IL-1, mice were killed by cervical 
dislocation Whole patellae were dissected from the right arthritic and left 
control knee joints, with a standard amount of surrounding tissue The fully 
intact cartilage [42, 431 was subsequently used for radiosulfate incorporation 
studies Radiosulfate incorporation was measured either directly at t=0, 
reflecting the in vivo situation, or after culture for 24 hours Patellae were 
cultured in medium, ι e RPMI 1640 [Flow Laboratories Irvine, Scotland, 
U K ] supplemented with 2 mM glutamine, 40 μg/ml gentamycin, 0 1% 
ultrapure bovine serum albumin [Sigma] In addition, patellae were cultured in 
medium containing bFGF, PDGF or EGF in concentrations ranging from 
0,015 μg/ml to 2 μ&ιη], or TGFß 2 5 to 20 ng/ml [Serva, Germany], in the 
absence or presence of 0 25 |ig/ml recombinant human IGF-1 [Boehnnger 
Mannheim, Germany] The concentration range for bFGF, PDGF and EGF is 
based in analogy with known dose-response effects of IGF 1 on chondrocyte 
PG synthesis of anatomically intact murine articular cartilage The 
concentrations used for TGFß are in analogy to those used by van der Kraan et 
al [1992] in studies with murine articular cartilage All incubations were 
performed for 24 hours in 24 well cluster dishes at 37 С in a humidified 
atmosphere containing 5% carbon dioxide 
In vitro radiosulfate incorporation 
Chondrocyte PG synthesis in patellar cartilage was measured by the 
incorporation of 15S-sulfate as previously described [43] Briefly, cartilage was 
incubated in RPMI 1640 medium with 1 48 MBq 3SS-sulfate [ N a 2 3 5 S 0 4 , 
Amersham, Buckinghamshire, U K] for 3 hours at 37 С Thereafter, the tissue 
was washed three times in physiological saline, to remove non incorporated 
radio label Subsequently, patellae were fixed in 4% buffered formaldehyde 
and decalcified in 5% formic acid for three hours The patellar cartilage was 
then removed from the surrounding tissue and digested in lumasolve [Perstop 
Analytical, Oud Beyerland, The Netherlands] at 60 С The quantity of 
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incorporated radioactive sulfate was assayed by liquid scintillation counting 
[42]. 
Statistics 
Statistical evaluation of the experiments was tested by "one way" analysis of 
variance in combination with Student's t-test. A ρ value of less than 5% was 
considered to be significant. 
RESULTS 
Effect of growth factors on normal cartilage 
PG synthesis was measured in patellar cartilage by 3 hours culture with 
35S-sulfate, either directly after isolation of the cartilage, or after a 24 hours 
culture period. After culture in medium without serum or growth factors, the 
PG synthesis rapidly declined. Recombinant human IGF-1 [0.5-2 μ§/πι1] dose-
dependent stimulated PG synthesis of normal murine patellar cartilage [34]. 
PG synthesis [%] 
200-, 
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IGF-1 
t=0 
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Figure 1 
In vitro response of normal murine cartilage 
to IGF-1. 
Chondrocyte PG synthesis of normal 
murine patellar cartilage was determined by 
35S-sulfate incorporation either immediately 
after isolation of the patellae [t=0] or after 24 
hours culture with medium alone or medium 
containing IGF-1 [0.25 μg/ml]. The experi­
ments were performed three times, in each 
experiment five patellae were measured; 
shown are the pooled data of these three ex­
periments, mean ± SEM, expressed as 
percentage of the control value at t=0. 
* ρ < 0.05 compared to radiosulfate 
incorporation after culture with medium 
alone. 
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During the present study we used 0.25 μg/ml IGF-1 which is close to the 
murine plasma level [37]. At this IGF-1 concentration PG synthesis could 
easily be maintained at the in vivo level [Figure 1]. 
It was tested whether other growth factors, i.e. bFGF, PDGF, EGF or 
TGFß could exert stimulatory effects comparable to stimulation by IGF-1. The 
growth factors bFGF, PDGF and EGF were tested in a concentration range of 
0.015-2.0 μg/ml whereas TGFß was examined in the range 0.0025-0.02 μg/ml. 
bFGF PG synthesis Γ%1 PDGF P6 synthesis l%| 
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TGFß PG synthesis I%1 
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0.06 0.125 0.5 0.06 0.125 0.5 0.01 0.015 0.02 0.01 0.015 0.02 
Figure 2 
Effect of growth factors on PG synthesis of normal murine articular cartilage. 
Murine normal patellae were cultured for 24 hours with bFGF, PDGF, EGF in a concentration 
range of 0.015 - 2.0 μg/ml whereas TGFß was examined in the range 0.0025 - 0.02 μg/ml. 
Shown are bFGF [A], PDGF [B] or EGF [C] [concentrations 0.06 - 0.125 - 0.5 μg/ml] or 
TGFß [D] [0.015-2.0 μg/ml] in the absence or presence of IGF-1 [0.25 μg/ml]. The patella 
cultures were pulse-labeled with ,5S-sulfate for 3 hours to measure PG synthesis. PG synthesis 
is expressed as % of ex vivo PG synthesis of the cartilage immediately after dissection. The 
experiments were performed three times, in each experiment five patellae were measured; 
shown are the pooled data of these three experiments, mean ± SEM, expressed as percentage of 
the control value at t=0. * ρ < 0.05 versus radiosulfate incorporation after culture with IGF-1. 
: Chondrocyte PG synthesis after culture for 24 hours with medium only 
: Chondrocyte PG synthesis after culture for 24 hours with IGF-1 [0.25 μ§/πι1] 
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None of the growth factors tested individually were able to induce stimulation 
of the 35S incorporation as observed for IGF-1, whereas EGF and TGFß 
significantly inhibited the chondrocyte PG synthesis [Figure 2]. bFGF and 
PDGF, 0.06 and 0.125 μg/ml, caused a slight but not significant stimulation 
compared with the PG synthesis after culture in medium without serum or 
growth factors [Figure 2]. 
Furthermore, we studied the effects of the same set of growth factors in 
combination with 0.25 μg/ml IGF-1. As shown in Figure 2, bFGF and PDGF 
at 0.125 μg/ml in the presence of 0.25 [ig/mi IGF-1 were able to significantly 
stimulate articular cartilage PG synthesis above stimulation caused by IGF-1. 
In contrast, the combination of EGF or TGFß with IGF-1 did not elicit such 
stimulatory effects, but caused a considerable decrease in chondrocyte PG 
synthesis [Figure 2]. 
Effect of growth factors on cartilage from IL-1 injected joints 
Within 24 hours after intra-articular injection of IL-1 into the mouse knee 
joint, ex vivo chondrocyte PG synthesis was reduced to about 50% of 
chondrocyte PG synthesis in cartilage from the control joint [Figure 3]. Three 
days after injecting IL-1 the PG synthesis was almost restored to the level of 
the control joint and after four days an overshoot in PG synthesis was 
observed. 
—-a— t=o Figure 3 
PG synthesis [%] * IGF_1 In vitro response of patellar cartilage 
from IL-1 injected knee joints. 
Chondrocyte PG synthesis of patellar 
cartilage at one, two, three and four 
days after a single intra-articular IL-1 
injection [300 U] was determined by 
35S-sulfate incorporation either imme-
diately after isolation of the patellae 
[t=0] or after 24 hours culture in 
medium containing 0.25 μg/ml 
IGF-1. The experiments were 
performed three times, in each ex­
periment five patellae were measured; 
shown are the pooled data of these 
three experiments, mean ± SEM, 
expressed as percentage of the control 
value at t=0. 
100 -a. 
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Figure 4 
Effect of growth factors on ex vivo recovery of PG synthesis of murine articular cartilage from 
IL-1 injected knee joints. 
Three days after a single intra-articular injection of IL-1 [300 U] mouse patellae were isolated 
from the left control joint [A] and IL-1 injected inflamed joint [B]. The patellae were cultured 
for 24 hours with medium, bFGF or PDGF [0.125 μg/ml] in the absence or presence of 
IGF-1 [0.25 μg/ml] and further treated as described in the legend of figure 2. PG synthesis is 
expressed as % of PG synthesis of the normal cartilage immediately after dissection. At the start 
of the culture 35S-sulfate incorporation in cartilage from the IL-1 injected joint was 497 ± 86 
[cpm] and in the control cartilage 569 ± 40 [cpm]. The experiments were performed three times, 
in each experiment five patellae were measured; shown are the pooled data of these three 
experiments, mean ± SEM, expressed as percentage of the control value at t=0. * ρ < 0.05 
versus radiosulfate incorporation afterculture with IGF-1. 
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At different stages after IL-1 injection, culture of the cartilage with IGF-1 
induced significant stimulation of chondrocyte PG synthesis [Figure 3] Though 
at day four after IL-1 injection ex vivo PG synthesis was already at such a high 
level that no further stimulation by IGF-1 could be effected Since in normal 
cartilage bFGF and PDGF in combination with IGF-1 were able to 
significantly stimulate chondrocyte PG synthesis, we studied the effects of 
bFGF and PDGF in the presence and absence of IGF-1 on PG synthesis of IL-1 
exposed cartilage In line with findings on normal cartilage bFGF or PDGF 
individually caused no stimulation of chondrocyte PG synthesis in IL-1 
exposed cartilage [Figure 4] Likewise, the combination of bFGF or PDGF 
with IGF-1 stimulated PG synthesis on top of the stimulation caused by IGF-1 
alone Moreover, combination of the three growth factors did not cause 
further stimulation of 35S-sulfate incorporation in IL-1 exposed cartilage as 
compared to cartilage cultured with bFGF or PDGF with IGF-1 The same 
observations were noted when these experiments were performed at days 2 and 
4 after IL 1 injection [data not shown] 
Effect of growth factors on arthritic cartilage 
At day two after zymosan-induced arthritis ex vivo PG synthesis in arthritic 
cartilage was markedly reduced [50%1 After culture of the arthritic cartilage 
in medium without serum or growth factors the chondrocyte PG synthesis 
stayed at the same low level as the ex vivo synthesis Figure 5 shows that 
addition of 0 25 μg/ml IGF 1 did not significantly stimulate PG synthesis We 
then investigated whether other growth factors apart from IGF-1 could 
stimulate PG synthesis of chondrocytes during the acute phase of 
experimentally-induced arthritis Figure 5A shows that after a 24 hours culture 
period with bFGF, PDGF, EGF [0 125 μ^ιτιΐ] or TGFß [0 015 μ^πιΐ] the rate 
of radiosulfate incorporation remains at a low level These data indicate that 
during joint inflammation none of the tested growth factors could significantly 
stimulate PG synthesis In addition, when the growth factors were added in 
combination with IGF-1 no stimulatory effect on chondrocyte PG synthesis 
was observed either [Figure 5A] 
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Figure 5 
Effect of growth factors on PG synthesis of murine arthritic articular cartilage. 
At day two [A] and day five [B] after zymosan-induced arthritis mouse patellae were dissected 
from the right arthritic and left control knee joint. The patellae were cultured for 24 hours with 
medium, bFGF, PDGF, or EGF [0.125 \Lglm\] or TGFß [0.015 μg/ml] in the absence or 
presence of IGF-1 [0.25 μg/ml] and further treated as described in the legend of Figure 2. The 
ex vivo PG synthesis during the acute phase of arthritis [day 2] or a later phase of arthritis [day 
5] was respectively 50 % and 80 % compared with PG synthesis of the control cartilage. The 
experiments were performed three times, in each experiment five patellae were measured; 
shown are the pooled data of these three experiments, mean ± SEM, expressed as percentage of 
the control value at t=0. * ρ < 0.05 versus radiosulfate incorporation after culture with IGF-1. 
Five days after arthritis induction ex vivo PG synthesis was already restored 
to 80% of the level observed in control cartilage [data not shown]. As shown in 
figure 5B, after culture in the presence of IGF-1 stimulation of PG synthesis 
was almost restored to the level of ex vivo control cartilage PG synthesis. 
Culture with bFGF, PDGF, or TGFß did not result in enhanced 35S-sulfate 
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incorporation. Furthermore, combination of bFGF, PDGF or TGFß with 
IGF-1 did not induce stimulation above effects found after culture with IGF-1 
alone. 
DISCUSSION 
At present there is substantial evidence indicating that one of the 
mechanisms leading to cartilage destruction in inflammatory joint diseases is 
inhibition of chondrocyte PG synthesis [31, 42]. It is still not precisely known 
how this inhibition is effected, although suggestive evidence is accumulating 
that IL-1 plays a crucial role in this process f 1, 2, 40, 41, 46]. We previously 
suggested that inhibition of chondrocyte metabolism might also be caused by 
inadequate anabolic regulation of PG synthesis [34]. In the present study we 
investigated the role of other growth factors apart from IGF-1 in the 
regulation of chondrocyte PG synthesis in cartilage from normal and arthritic 
mouse knee joints. 
It is generally accepted that IGF-1 is an important growth factor in the 
regulation of normal cartilage PG synthesis [10, 20, 21, 33, 36]. Our data 
indicate that in normal cartilage none of the individually tested growth factors 
possessed the capacity to induce stimulatory effects on chondrocyte PG 
synthesis similar to stimulation by IGF-1. However, in combination with 
IGF-1, bFGF and PDGF induced pronounced enhancement of PG synthesis. In 
contrast, EGF and TGFß even significantly decreased chondrocyte PG 
synthesis. Controversial results have been described concerning the ability of 
various growth factors or combinations of growth factors to stimulate articular 
cartilage matrix synthesis, depending either upon differences in culture 
conditions or in cartilage origin and species [13-15, 45]. bFGF has been shown 
to markedly stimulate PG synthesis of actively growing chondrocytes [13, 15, 
17, 18], whereas other studies showed that bFGF as well as EGF alone did not 
or only moderately effect PG synthesis of differentiated chondrocytes in 
culture. Likewise, Wroblewski & Edwall [1992] showed that PDGF had no 
appreciable effect on PG synthesis of rat differentiated chondrocytes, whereas 
regarding confluent chondrocyte cultures it has been reported that PDGF 
stimulates PG synthesis to the same extent as IGF-1 [12, 14, 26]. However, we 
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show that both under normal and pathological physiological conditions 
exogenous exposure of intact cartilage to bFGF, PDGF, EGF or TGFß did not 
elicit stimulation of the chondrocyte PG synthesis within 24 hours 
Our findings that TGFß significantly inhibited the chondrocyte PG synthesis 
of intact patellar cartilage are in line with previous studies [44] It was shown 
that for intact mouse patellar cartilage neutralization of endogenous produced 
TGFß with a specific anti-TGFß antibody caused stimulation of PG synthesis, 
indicating that TGFß itself inhibits PG synthesis However, other studies 
described either minimal effects of TGFß on PG synthesis of intact articular 
cartilage during short-term culture [8, 38], or stimulation of PG synthesis after 
prolonged incubation in basal medium supplemented with TGFß, but not in 
medium containing insulin or IGF-1 [4, 38] Moreover, the effects of TGFß on 
isolated chondrocytes are contradictory [12, 22, 25, 27-29, 35, 45] Recently 
we have shown that the response of isolated chondrocytes to TGFß correlates 
with the size of the TGFß type II receptor [7] It is tempting to speculate that 
changes in chondrocyte phenotype cause differences in growth factor receptor 
expression and chondrocyte responsiveness 
During the acute phase of arthritis, chondrocytes from the arthritic joint did 
not respond to IGF-1 nor to one of the other growth factors, either 
individually tested or in combination with IGF-1 Schalkwijk et al [1989] 
suggested that the inflammatory response in the arthritic joint might have 
caused IGF-1 non-responsiveness by inactivation or down-regulation of the 
IGF-1 receptor Our results do not indicate that the inflammatory process in 
the joint might simultaneously induce an upregulation of receptors for other 
growth factors It may be suggested that chondrocytes from the diseased joint 
display a general receptor function defect 
Moreover, we wondered if and which growth factors are concerned with 
repair processes after IL-1 injection in the mouse knee joint Our data show 
that in IL-1 exposed cartilage IGF-1 stimulation of PG synthesis equaled 
synthesis of the control cartilage, cultured in the same way This may implicate 
that the phenomenon of IGF-1 non-responsiveness as observed during 
experimentally-induced arthritis, not only depends upon IL-1-induced PG 
synthesis inhibition Inflammatory processes in the joint during arthritis, 
leading to PG synthesis inhibition, seem to be more complex than processes 
induced by IL-1 injection However, anti-IL-1 treatment of arthritic mice leads 
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to restoration of PG synthesis and almost normal IGF responsiveness, 
indicating that IL-1 is indirectly involved in the process of IGF-1 
nonresponsiveness [41] IL-1 exposed cartilage displayed similar reactivity to 
stimulation by growth factors apart from IGF-1 as control cartilage In 
contrast, Harvey et al 1993 reported that during the repair phase after IL 1 
induced PG depletion, culture with PDGF induced an overshoot in PG 
synthesis 
It is widely speculated that growth factors might play a role in repair 
processes during degenerative joint diseases [3, 6, 9, 24, 28] We have recently 
described that multiple intra-articular TGFß injections into the mouse knee 
joint induced strong, longlasting stimulation of chondrocyte PG synthesis [39] 
Moreover, TGFß injection could counteract IL-1 induced effects [38] 
However, the results obtained in the present study indicate that in contrast to 
normal and IL 1 exposed cartilage cartilage derived from joints with 
experimentally-induced arthritis shows a general state ot nonresponsiveness 
towards growth tactor stimulation These findings indicate that before anabolic 
growth factors are considered to be used as therapeutic agents to stimulate 
repair, chondrocyte responsiveness during various pathological stages need to 
be further investigated 
In conclusion, exogenous exposure of normal intact mouse articular 
cartilage to bFGF, PDGF, EGF or TGFß did (ι) not elicit stimulatory effects 
on chondrocyte PG synthesis, as caused by IGF-1 (u) EGF and TGFß even 
caused a significant inhibition of chondrocyte PG synthesis (in) In 
combination with IGF-1, bFGF and PDGF exerted significant additional 
stimulation of chondrocyte PG synthesis (iv) IL-1 induced inflammation did 
not cause IGF-1 non-responsiveness and (v) IL-1 exposed cartilage showed 
similar reactivity to growth factor stimulation as found in control cartilage 
(\i) During the acute or later phases ot arthritis, cartilage showed a state of 
non responsiveness towards all individually tested growth factors as well as 
(vu) to combination of growth factors with IGF-1 Inhibition of PG synthesis 
during experimentally-induced arthritis, seems to be more complex than the 
processes caused by injecting IL-1 into the knee joint It is tempting to 
speculate that arthritis causes a non responsive state to chondrocyte growth 
tactor stimulation, which may be effected by a general receptor function 
defect 
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ABSTRACT 
Chondrocyte nonresponsiveness to IGF-1 stimulation may contribute to 
cartilage destruction in murine arthritic knee joints. We investigated the 
involvement of IL-1, in the induction, or maintenance of the chondrocyte 
nonresponsive state during experimental arthritis. 
IGF-1 nonresponsiveness during arthritis was further characterized. 
Chondrocyte proteoglycan [PG] synthesis was measured by assaying 35S-sulfate 
incorporation into mouse patellar cartilage, obtained from normal and 
experimentally-induced arthritic knee joints cultured with IGF-1. We 
investigated whether suppressive mediators produced by the arthritic synovium 
or chondrocytes abolish the IGF-1 stimulation of normal cartilage. Moreover, 
these experiments were performed with IL-1 primed cartilage to mimic the 
arthritic in vivo-state. Secondly, we searched for specific inflammatory 
mediators responsible for the maintenance of the suppressed IGF-1 response. 
We measured IGF-1 responsiveness in normal and arthritic patellae cultured 
with antibodies against TNF, IL-Ια/β, IL-Ira, and a whole range of inhibitors 
of proteolytic enzymes or reactive oxygen species. Finally, we analyzed the 
role of IL-1 in the development of IGF-1 nonresponsiveness, by studying 
IGF-1 responses in cartilage treated with anti-IL-1 antibodies in vivo, at the 
onset of arthritis. 
Mediators from the surrounding tissue of both normal and arthritic cartilage 
suppress chondrocyte IGF-1 responses. Priming the cartilage with IL-1 did not 
completely induce IGF-1 nonresponsiveness, but enhanced the ability of 
suppressive mediators from synovium or chondrocytes to downregulate the 
IGF-1 responsive state. Neither anti-IL-1 α/β antibody, IL-lra, anti-TNF 
antibody, nor the tested inhibitors markedly improved the disturbed IGF-1 
response. However, anti-IL-1 antibody treatment at the onset of arthritis 
abolished generation of IGF-1 nonresponsiveness. 
It was concluded that IL-1 alone does not induce IGF-1 nonresponsiveness 
and is not critical in the maintenance of this phenomenon. However, IL-1 does 
appear to be a pivotal cofactor in the generation of the IGF-1 nonresponsive 
state. 
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INTRODUCTION 
Chondrocytes regulate the equilibrium between synthesis and degradation of 
cartilage matrix molecules in articular cartilage [11] Insuhn-hke growth 
factor-1 [IGF-1] is the most important anabolic growth factor for chondrocyte 
metabolism [12, 22, 25 27, 13, 41], whereas interleukin-1 [IL-1] is essential 
for chondrocyte catabolism [3, 4, 28, 10, 36] 
In joint diseases such as rheumatoid arthritis [RA] protracted inflammation 
leads to severe destruction of the articular cartilage and injury of surrounding 
tissue Degradation oí the matrix proteoglycans [PGs] and inhibition of PG 
synthesis are the main features ot experimentally-induced arthritis [46] There 
is compelling evidence that IL-1 and tumor necrosis factor [TNF] act as key 
mediators in the pathogenesis of inflammatory joint diseases [1,8, 14, 20, 40, 
51, 56, 57] Moreover, IL-1 has been shown to be a pivotal mediator in 
caitilage destruction, having a major effect on chondrocyte PG synthesis [43 
45, 49, 50] 
The lack of anabolic signaling might contribute to decreased chondrocyte 
PG synthesis during experimentally-induced arthritis [34, 48] We previously 
reported that, in contrast to the ability of IGF-1 to sustain chondrocyte PG 
synthesis in normal murine articular cartilage during culture, chondrocytes 
from experimentally-induced arthritic knee joints do not respond to IGF-1 [33, 
34, 48, 52, 53] This IGF-1 nonresponsneness during arthritis was not caused 
by general impairment ot chondrocyte metabolism [34] 
IL-1 and IGF-1 show counteracting activities, eg IGF-1 has been reported 
to increase the recovery rate from IL 1 induced inhibition of chondrocyte PG 
synthesis [31], IL-1 promotes cartilage pathology by inhibiting IGF-1 mediated 
anabolism [19], IL-1 down regulates IGF-1 mRNA levels [21], while 
Matsumoto et al [1994] described that IL 1 induced secretion of IGF binding 
proteins [IGFBPs] and IGF 1 receptor numbers This suggests that the IL-1 
induced inhibition of chondrocyte PG synthesis as well as the defective IGF-1 
stimulation of chondrocyte PG synthesis in experimental arthritis may act in 
concert 
The present study was carried out to elucidate to what extent IL-1 is 
involved in the IGF-1 nonresponsive state during experimentally-induced 
arthritis in murine knee joints 1] We examined the contribution of suppressive 
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mediators produced by the synovium that may abolish the IGF-1 stimulation in 
the m vitto culture system Co-cultures were performed with normal and 
arthritic patellae and PG synthesis was measured in normal cartilage To 
mimic arthritic cartilage in vivo, co-cultures were performed with IL-1 
primed cartilage 2] We investigated a number of specific inflammatory 
mediators produced in the in vitro culture system that may interfere with the 
IGF-1 responsiveness IGF-1 responses were measured in both normal and 
arthritic cartilage cultured with antibodies against IL-loc/ß, IL-1 receptor 
antagonist [IL-Ira], an antibody against TNF, or a whole range of inhibitors of 
proteolytic enzymes or reactive oxygen 3] The role of IL-1 in the induction 
phase of IGF 1 nonresponsiveness was also analyzed IGF-1 responses were 
studied in cartilage that was treated with anti IL 1 antibodies in vivo, at the 
onset of arthritis 
MATERIALS AND METHODS 
Animals 
Sexually mature female C57 black/6 mice [8-12 weeks old, 20-25 gj were 
used The animals were kept under routine laboratory conditions [21-22 C, 
relative humidity 60% and a 12 hours light-dark cycle] The mice were led a 
standard commercial pellet diet [RHM, Hope Farms, The Netherlands] and 
given acidified tap water ad libitum 
Intra-articular IL-1 injections 
Murine recombinant IL-1 [10 ng] [kindly supplied by Dr I G Otterness, 
Pfizer Central Research, Groten, CT, USA] was injected in a volume of 6 μΐ 
into the joint cavity of the right knee The left contralateral joint received an 
equal volume of phosphate buffered saline [PBS] The biological activity of 
IL 1 was determined using the NOB1 assay [43] The IL-1 batch was stored at 
20°C, and showed constant activity over the period studied The cartilage was 
studied at day 1 after intra-articular injection of IL 1 
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Induction of arthritis 
Arthritis was induced in mouse knee joints by intra-articular injection of 
yeast particles. To this end right knee joints were injected intra-articularly 
with 180 μg sterilized Zymosan [Sigma, St. Louis, MO, USA] in pyrogen-free 
saline. This experimental arthritis model is characterized by the development 
of an exudate in the early phase [2-3 days after induction of arthritis] 
containing large amounts of polymorphonuclear cells in the joint space, a loss 
of cartilage PGs and inhibition of chondrocyte PG synthesis. Inflammation 
subsides within a week and because the damage to cartilage is reversible, the 
matrix is repaired afterwards [34, 46, 47]. In subsequent experiments the 
cartilage was examined two days after induction of Zymosan-induced arthritis. 
In vivo anti-IL-1 treatment 
One hour before induction of arthritis mice were injected intravenously 
with a standard dose of 0.6 mg/ml purified rabbit anti-murine IL-la and 
IL-1 β antibodies [antibodies were prepared in our own laboratory by dr. AAJ 
Van de Loo]. Consistently 1 μg anti-IL-1 α/β has a total neutralizing capacity 
of 50-100 pg of both IL-1 subtypes tested in the NOBl-assay [43]. As a 
control, mice were injected intravenously with rabbit IgG. Anti-IL-1 antibody 
treatment before the onset of arthritis normalizes the inhibition of chondrocyte 
PG synthesis as observed during arthritis but has no effect on joint swelling 
and cell influx [43]. 
Cartilage cultures 
Mice were killed by cervical dislocation and whole patellae were dissected 
from the right arthritic and left control knee joints, leaving the cartilage fully 
intact. [46]. The patellae were isolated from the knee joints with minimal 
amounts of surrounding tissue. The fully intact cartilage 146, 47] was used for 
radiosulfate incorporation studies. Radiosulfate incorporation was measured 
either directly at t=0, reflecting the in vivo situation, or after culture for 24 
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hours or 48 hours Patellae were cultured in medium, ι e RPMI 1640 [Flow 
Laboratories Irvine, Scotland, U К ] supplemented with 2 mM glutamine, 40 
μg/ml gentamycin, 0 1% ultrapure bovine serum albumin [Sigma] in the 
presence or absence of 0 25 μg/ml recombinant human IGF-1 [Boehnnger 
Mannheim, Germany], this concentration is close to those in murine plasma 
[42] The incubations were performed in 24 well cluster dishes at 37 С in a 
humidified atmosphere containing 5% carbon dioxide 
Suppressive mediators 
The relative contribution of suppressive mediators produced during culture 
by the patella specimen was investigated comparing cultures of patellae 
containing small amounts of surrounding tissue with patellae containing large 
amounts of surrounding tissue Moreover, co-cultures of normal and arthritic 
patellae were performed in 6 5 mm transwell systems with a porous cell 
culture insert [Costar Cambridge UK] Normal patellae were cultured with 
arthritic patellae in the culture insert and the synthetic level was measured in 
the cartilage of the normal patellae 
1L-1 and TNF in vitto 
Patella cultures were performed in medium containing a mixture of rabbit 
anti-munne antibodies against IL Ια and IL Iß, prepared in our own 
laboratory [43], or rat anti-munne TNFa [Vlq hybndoma cells, kindly given 
by Dr Krammer German Cancer Research Center, Heidelberg, FRG], or 
recombinant human IL-Ira [Synergen, Boulder Colorado, USA] The 
concentrations used in the present study for anti IL 1, IL-1 ra and anti-TNF 
are based on positive effects that have been described [5, 14, 20, 36, 40, 43, 
56, 57] In the mixture of antibodies against IL Ια and IL Iß both were used 
at concentrations of 0 06 mg/ml and anti-TNFa antibody was used at 30 000 
U/ml [1U of the antibody has a neutralizing capacity of 90 pg TNFa in the 
L929 bioassay] IL-Ira was tested in a concentration range of 0 3-100 μg/ml 
As control for the anti-IL-la, IL-Iß and anti-TNFa antibodies, patellae were 
cultured with rabbit IgGs and rat IgGs respectively 
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Enzymes and reactive oxygen species 
Moreover, patella cultures were performed in the presence or absence of 
enzyme inhibitor Leupeptin [Boehringer] or recombinant human tissue 
inhibitor of metalloproteinases [TIMP] [a kind gift of AMGEN, Thousend 
Oaks, CA USA], the oxygen scavenger, Catalase together with horse radish 
peroxidase [Sigma] or the NO synthase inhibitor, L-NG-monomethyl-arginine 
[L-NMMA] [Calbiochem., San Diego, California, USA]. The inhibitor 
concentrations that are used in the present study are on the analogy of 
concentrations that are known to be effective [9, 10, 15, 32, 35]. Recent studies 
showed positive effects of L-NMMA and TIMP in patellae from arthritic knee 
joints. Probably these inhibitors are able to penetrate the cartilage matrix of 
diseased cartilage, whereas they can hardly reach the chondrocytes in intact 
cartilage [paper in preparation by AAJ Van de Loo]. Leupeptin and TIMP 
were examined in concentrations of 0.5 μg/ml and 20 μg/ml respectively, 
Catalase and horse radish peroxidase were used together at a concentration of 3 
mg/ml and 12 mg/ml respectively and L-NMMA was used at 100 μΜ or 1000 
μΜ. 
In vitro radiosulfate incorporation 
Chondrocyte PG synthesis in patellar cartilage was measured by the 
incorporation of 35S-sulfate as previously described [47]. Briefly, cartilage was 
incubated in RPMI 1640 medium with 1.48 MBq 35S-sulfate [Na 2 3 5 S0 4 , Du 
Pont, 's-Hertogenbosch, the Netherlands] for 3 hours at 37 C. Thereafter, the 
tissue was washed three times in physiological saline, to remove non-
incorporated radiolabel. Subsequently, patellae were fixed in 4% buffered 
formaldehyde and decalcified in 5% formic acid for three hours. The patellar 
cartilage was then removed from the surrounding tissue and digested in 
Lumasolve [Lumac, Landgraaf, The Netherlands] at 60 C. The quantity of 
incorporated radioactive sulfate was assayed by liquid scintillation counting. 
[46]. 
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Statistics 
Statistical evaluation of the experiments was tested by "one way" analysis of 
variance in combination with Student's t test A ρ value of less than 5% was 
considered to be significant 
RESULTS 
IGF-1 nonresponsiveness in arthritic cartilage 
In keeping with previous observations, PG synthesis in patellar cartilage from 
normal knee joints declined to approximately 50% within 24 hours culture in 
the absence ot IGF-1, whereas metabolic activity was maintained or even 
enhanced with physiologic concentrations of IGF-1 [Figuie 1A] [34, 52, 53] 
Caitilage trom arthritic knee joints demonstrated suppressed chondrocyte PG 
synthesis and did not respond to further stimulation with IGF-1 [Figure IB] 
This nonresponsive state of arthritic chondrocytes was maintained at supra-
physiological concentrations of IGF-1 [2 μg/ml, data not shown] IGF-1 
binding proteins have similar affinity tor IGF-1 as the IGF-1 receptor and are 
therefore able to diminish IGF-1 bioavailability We assume that the supra-
physiological concentrations of IGF-1 saturated IGF-1 binding proteins that 
might be present, excluding a dominant role of IGF-1 binding proteins in this 
phenomenon This nonresponsiveness of arthritic chondrocytes may be caused 
by abolishing suppressive mediators produced by the cartilage or synovial 
tissue or by an intrinsic defect in IGF-1 signaling 
Suppressive mediators 
To obtain an impression oí the contribution of suppressive mediators produced 
during culture by the synovial tissue surrounding the patella, cultures were 
performed with patellae containing either small or large amounts of 
surrounding synovial tissue IGF-1 responses were significantly lower in both 
normal and arthritic patellar cartilage embedded in large amounts of tissue 
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Figure 1 
In vitro response to IGF-1 in normal [A] and arthritic [B] murine cartilage embedded in minimal 
or large amounts of surrounding tissue. Mouse patellar cartilage containing small or large 
amounts of surrounding tissue were isolated from right zymosan injected arthritic and left 
contralateral control joints. Chondrocyte PG synthesis of the cartilage was determined by 
35S-sulfate incorporation either immediately after isolation of the patellae [t=0]. or after 24 hours 
culture with medium alone or medium containing IGF-1 [0.25 μg/ml]. Data from 3 experiments 
[5 patellae per group] are presented as the mean percentage of the control value at t=0 
[mean ± SEM]. *p < 0.05 compared with radiosulfate incorporation after culture with medium 
alone. #p < 0.05 compared with radiosulfate incorporation after culture with IGF-1 in cartilage 
embedded in small amounts of surrounding tissue. 
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[Figure 1]. This indicated that substances in the surrounding tissue from both 
normal and arthritic cartilage suppress IGF-1 stimulation of chondrocyte PG 
synthesis. 
Secondly, we investigated the potency of suppressive factors. We performed 
co-culture studies of normal and arthritic patellae and measured the synthetic 
level in only the normal cartilage. IGF-1 stimulation of normal cartilage was 
reduced in the presence of arthritic specimens, but a complete lack of IGF-1 
responsiveness was not achieved [Figure 2A]. 
To mimic the in vivo state of arthritic cartilage, normal cartilage was first 
primed in vivo with IL-1. The PG synthesis of murine knee joints that were 
injected with IL-1 was significantly reduced, but IGF-1 could still enhance the 
synthetic rate in a subsequent 24 hours culture period. However, when this 
culture was performed in the presence of arthritic patellae, a pronounced 
reduction of IGF-1 stimulation was noted. In fact, IGF-1 stimulation of IL-1 
PG synthesis [cpm] 
Ζ 0 0
° η Α : Control 
1500 
1000· 
500-
coculture with 
normal patellae 
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Figure 2 
The effect of co-culture with mouse arthritic patellae on IGF-1 stimulation of chondrocyte PG 
synthesis in normal [A] or IL-1 exposed [B] murine cartilage. Radiosulfate incorporation was 
determined in patellae immediately after isolation of cartilage from normal, or IL-1 injected 
joints or after co-culture for 24 hours with patellae isolated from normal or arthritic joints in 
medium containing 0.25 μg/ml IGF-1. Data from 3 experiments [5 patellae per group] are 
presented as the mean cpm ± SEM. 
*p < 0.05 versus radiosulfate incorporation after co-culture with normal patellae 
#p < 0.05 versus radiosulfate incorporation at t=0 
IGF-1 stimulation of chondrocyte PG synthesis of IL-1 primed cartilage is not 
significantly different from synthesis in IL-1 primed cartilage at t=0, whereas this is the case for 
normal cartilage. 
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primed cartilage cultured with arthritic patellae was not significantly different 
when compared with the ex vivo PG synthetic rate of IL-1 primed cartilage 
[Figure 2B1 
Role of IL-1 and TNF in vitro 
To identify which suppressive factors from the arthritic specimen suppressed 
the IGF-1 response, normal and arthritic patellae were cultured in the presence 
of neutralizing antibodies against TNF or IL-1, or IL-1 receptor antagonist 
The latter may have additional effects, since this small protein has access to the 
chondrocytes, whereas the larger antibodies would be minimal penetrating the 
articular cartilage Figure 3 shows the effect of IL 1 and TNF modulation, 
respectively During 24 hours culture periods no significant effect was noted 
for both cytokines The synthetic rate was significantly higher when the IL-1 
and TNF neutralizing culture was extended to 48 hours However, this effect 
was observed in both normal as well as arthritic specimens Moreover, the 
degree of IGF-1 stimulation in the arthritic cartilage was still marginal and PG 
synthesis remained clearly reduced when compared with synthesis in normal 
cartilage 
Involvement of enzymes and reactive oxygen species 
Proteolytic enzymes and reactive oxygen are potential candidates to induce 
changes in chondrocyte signaling, thereby interfering with IGF-1 responses 
The effect of a range of inhibitors was examined in the patella cultures [Table 
1] Leupeptin, an inhibitor of cysteine and serine proteinases, as well as TIMP, 
a well known metalloproteinase inhibitor, did not affect IGF-1 responses in a 
24 hours culture period Similarly, the combination of the scavengers, Catalase 
and horse radish peroxidase, did not alter the IGF-1 stimulation in normal and 
arthritic cartilage We also tested the potent NO synthase inhibitor L-NMMA, 
at concentrations of 100 μΜ or 1000 μΜ Again, this inhibitor did not affect 
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the 1GF-1 stimulation in normal cartilage, nor the poor IGF-1 stimulation in 
arthritic cartilage. 
Normal 
• IGF-1 
Π IL-lra + IGF-1 
alL-1 + IGF-1 
aTNF + IGF-1 
t= 24 h t= 24 h t= 48 h 
Figure 3 
The role of endogenous IL-1 or TNF in the IGF-1 response in cartilage from normal [A] or 
arthritic [B] mouse knee joints. Radiosulfate incorporation was determined in patellar cartilage 
isolated from normal or arthritic knee joints after culture for 24 hours or 48 hours with 
neutralizing antibodies against TNF. IL-Ια and IL-Iß or IL-lra in medium containing IGF-1 
[0.25 μg/ml]. Anti-TNF was used in a concentration of 30.000 U/ml, anti-IL-Ια and IL-1 β 
antibodies both were used at a concentration of 0.06 mg/ml and IL-lra was tested in a 
concentration range of 0.3-100 μg/ml [the effect of 10 μg/ml is shown]. The IL-1 or TNF data 
represent separate experiments with their individual controls. Data from 3 experiments [5 
patellae per group] are presented as the mean cpm ± SEM. The enhanced chondrocyte PG 
synthesis after culture of intact cartilage with anti-IL-1 and anti-TNF is probably specific for 
anti-cytokines. This effect may be caused by the fact that small amounts of cytokines released 
from the tissue during isolation. 
*p < 0.05 compared with radiosulfate incorporation after culture with IGF-1 alone. 
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Table I. Effect of a selected range of inhibitors of proteolytic enzymes or reactive oxygen 
species in vitro on IGF-1 stimulation of chondrocyte PG synthesis in cartilage from normal [A] 
or arthritic [B] mouse knee joints. 
A. Normal patellae 
RPMI 
Leupeptin 
TIMP 
Catalase/HRPO 
L-NMMA [ 100 μΜ] 
L-NMMA [ΙΟΟΟμΜ] 
- IGF-1 
258 ± 24 
233 ± 3 8 
258 ±41 
282 ± 34 
232 ± 4 0 
251 ±51 
+ IGF-1 
709 ± 65 
820 ±91 
627 ± 27 
640 ± 88 
670 ± 70 
859 ± 95 
B. Arthritic patellae 
RPMI 
Leupeptin 
TIMP 
Catalase/HRPO 
L-NMMA [100 μΜΙ 
L-NMMA [ΙΟΟΟμΜ] 
- IGF-1 
168 ± 4 6 
171 ± 14 
215 ± 36 
141 ± 3 4 
97 ± 6 4 
115 ± 21 
+ IGF-1 
218 ± 87 
187 ± 44 
223 ± 30 
203 ± 42 
179 ± 3 2 
164 ± 2 0 
Radiosulfale incorporation [cpm] was determined immediately after isolation of the cartilage or 
after culture for 24 hours with either Leupeptin [0.5 μg/ml], TIMP [20 μg/ml], Catatase 
together with horse radish peroxidase [HRPO, 3 mg/ml and 12 mg/ml, respectively] or 
L-NMMA [100 μΜ, 1000 μΜ] in the presence or absence of IGF-1 [0.25 μg/ml]. Data from 3 
experiments [5 patellae per groupj are presented as the mean ± SEM. 
Role of IL-1 in vivo 
The results reported indicated that the use of antibodies against IL-1, T N F 
or a whole range of inhibitors did not interfere with the IGF-1 response 
during existing arthritis. We further investigated IGF-1 responses in mice 
treated with anti-IL-1 α/β antibodies at the onset of arthritis. Anti-IL-1 
treatment almost normalized ex vivo chondrocyte PG synthesis [Figure 4]. In 
the absence of IGF-1, PG synthesis declined, but culturing arthritic cartilage 
from anti-IL-1 treated mice with IGF-1 resulted in a highly significant 
stimulation of chondrocyte PG synthesis. This indicated that although, during 
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already existing arthritis, anti-IL-1 antibodies were not able to abolish IGF-1 
nonresponsiveness in the in vitro culture system, anti-IL-1 antibody treatment 
at the onset of arthritis averts defective IGF-1 signaling. 
200-, 
150-
100-
PG synthesis [%] 
t=24 h 
A r t h r i t i s 
anti- IL-1 
Figure 4 
The in vitro response to IGF-1 of murine patellar cartilage from normal knee joints or arthritic 
joints from mice injected with a standard dose of 0.6 mg/ml anti-IL-1 α and IL-Iß antibodies 
one hour before the onset of arthritis. Chondrocyte PG synthesis was determined by 35S-sulfate 
incorporation either directly after isolation of the patella [t=0] or after 24 hours culture in 
medium with or without IGF-1 [0.25 μ§/ιη1]. The experiments were performed three times; in 
each experiment five patellae were measured. Results from a representative experiment are 
presented. Radiosulfatc incorporation is expressed as a percentage of the control value at t=0. 
*p < 0.05 compared with radiosulfate incorporation after culture with RPMI. 
DISCUSSION 
IGF-1 plays a key role in regulating chondrocyte biosynthetic functions [12, 
22, 25, 33]. During experimentally-induced arthritis, articular cartilage does 
not respond to IGF-1 stimulation of chondrocyte PG synthesis [34, 48, 52, 53]. 
Furthermore, IGF-1 nonresponsiveness also results in the production of 
alternative PG monomers, implicating that IGF-1 is essential in the 
maintenance of cartilage integrity [53]. Moreover, nonresponsiveness of 
arthritic chondrocytes is not restricted to IGF-1 but also extends to a range of 
IL 1 has no direct role in the IGF-1 nonresponsive state 93 
other growth factors, such as basic fibroblast growth factor, platelet derived 
growth factor, epidermal growth factor, or transforming growth factor β [52] 
This lack of anabolic signaling during arthritis may contribute to cartilage 
destruction In the present study we investigated to what extent IL-1 is 
involved in the generation and/or maintenance of the IGF-1 nonresponsive 
state during arthritis 
IL 1 is a potent inhibitor of chondrocyte PG synthesis and is thought to act 
as key mediator in the pathogenesis of cartilage destruction in arthritic 
disorders [1, 14, 28, 30, 51] In experimental arthritis models IL-1 has been 
shown to be a more potent cartilage destructive mediator than TNF [17, 43-
45] The results of the present study reveal that unidentified mediators from 
the surrounding tissue of both normal and arthritic cartilage were able to 
suppress IGF-1 responses Treatment with anti-IL-1 α/β antibodies, IL-Ira or 
anti-TNF antibody did not abolish IGF-1 nonresponsiveness, suggesting that 
IL 1 or TNF are not the key mediators that maintain IGF-1 nonresponsiveness 
It is likely that the impact of the inflammatory process on the chondrocyte is 
complex and not expected to be modulated by eliminating one single factor 
Although IL-1 exposure of the cartilage did not cause IGF-1 
nonresponsiveness, the cartilage became more susceptible to reduction of the 
IGF-1 response by other suppressive mediators in the synovium or the 
chondrocytes, when compared with the ex vivo PG synthetic rate of IL-1 
primed cartilage In addition, anti-IL-1 treatment at the onset of arthritis 
abolished generation of IGF-1 nonresponsiveness These data imply that IL 1 
plays an important role in the onset of IGF 1 nonresponsiveness, but that once 
the IGF 1 nonresponsiveness is generated the importance of IL 1 is lost 
Degrading enzymes and reactive oxygen species have been implicated in the 
apparent breakdown of articular cartilage during joint inflammation [5, 6, 13, 
17, 18, 23, 26, 29, 37, 38, 49] It is still not understood whether these 
degradative effects are partly achieved via inhibition of growth factor 
signaling In this context, the absence of an IGF-1 response could be due to 
IGF-1 receptor stripping or receptor damage caused by proteolytic enzymes or 
oxygen metabolites Our results show that the metalloproteinase inhibitor 
TIMP, as well as the serine and cysteine proteinase inhibitor Leupeptin, were 
unable to influence IGF-1 responses in normal and arthritic cartilage 
Moreover, the oxygen scavengers Catalase and horse radish peroxidase, or the 
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NO synthase inhibitor L-NMMA did not effect IGF-1 responsiveness Our data 
implicate that enzymes or oxygen species can not be indicated as key factors in 
IGF-1 nonresponsiveness Alternatively, at the time the inhibitors were added 
to the culture system the irreversible damage may already have taken place In 
keeping with the findings that enzymes or oxygen species do not play a key 
role in IGF nonresponsiveness, we have previously shown that the transient 
chondrocyte IGF-1 nonresponsiveness found after H 2 0 2 exposure was not 
related to IGF-1 receptor damage and that H 2 0 2 mediated inhibition of 
chondrocyte PG synthesis was not associated with disturbed IGF-1 signaling 
[16, 32] Moreover, in a previous study we described that the amounts of 
IGF-1 receptors on the chondrocyte cell membrane were not decreased during 
the stage of experimental arthritis in which IGF-1 nonresponsiveness is 
manifest [54, 551 Thus it seems likely that joint inflammation impaired 
chondrocyte receptor mediated signal transduction, causing a modified 
biological response It is of interest that IGF-1 nonresponsiveness is not caused 
by total unergy of the chondrocytes, since torskohn a stimulator of the 
adenylate cyclase pathway is still able to enhance chondrocyte PG synthesis in 
experimentally induced arthritic cartilage [34] 
Increased IGF I binding protein production may affect IGF-1 
nonresponsiveness during arthritis [2, 7, 39] Dore et al [1994] demonstrated 
that the impaired biological ι espouse to IGF 1 by articular chondrocytes from 
human osteoarthntic [OA] cattilage is related to increased production of 
IGFBPs However it should be noted that m contrast to the suppressed 
chondrocyte PG s>nthesis in arthritic cartilage ex vivo PG synthesis in OA 
cartilage is at a supra-normal level In our experimental design the 
nonresponsive state of arthritic chondrocytes was maintained at supra-
physiological concentrations of IGF-1 [2 μg/ml] If IGFBPs are secreted in 
very high concentrations they may be of importance 
In conclusion, lack of IGF-1 responses during arthritis are affected by a 
complex interaction of suppressive mediators [Figure 5] Modulation of one 
individual mediator in the in \itio culture system does not influence the IGF-1 
nonresponsive state during arthritis Priming of the cartilage with IL-1 does 
not fully cause IGF-1 nonresponsiveness, but clearly makes the cartilage more 
susceptible to suppressive mediators Moreover, anti-IL-1 treatment at the 
onset of arthritis averts defective IGF-1 signaling We propose that IL 1 does 
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not induce IGF-1 nonresponsiveness, but is indirectly involved in the 
generation of this phenomenon. 
Upregulation Downregulation 
Figure 5 
Schematic representation of the interplay of IL-1 and IGF-1 in chondrocyte metabolism. 
Cartilage chondrocyte proteoglycan synthesis is dependent on the balance of anabolic effects of 
IGF-1 and catabolic effects of IL-1. During arthritis, chondrocyte PG synthesis is inhibited due 
to excess IL-1, which is sustained by IGF-1 nonresponsiveness. IL-1 is not able to induce 
IGF-1 nonresponsiveness, but is indirectly involved [together with unknown factor X] in 
generation of the phenomenon, since anti-IL-1 treatment can abolish development of IGF-1 
nonresponsiveness. 
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ABSTRACT 
Insulin-like growth factor-1 [IGF-1] is an essential anabolic growth factor in 
the regulation of cartilage metabolism and exerts its effects by binding to the 
IGF-1 type 1 receptor on the chondrocyte membrane We have localized and 
quantified in situ IGF-1 receptor expression in murine intact articular cartilage 
oí normal mice The IGF-1 receptor was detected immunohistochemically 
using antibodies to the IGF-1 receptor and visualized with conventional light 
microscopy and confocal laser scanning microscopy [CLSM] CLSM analysis 
enabled us to distinguish IGF-1 receptor immunoreactivity on the chondrocyte 
cell membrane from intracellular staining We have established two approaches 
to quantify in confocal images low levels of fluorescence intensity of the 
immunolocalized IGF-1 receptor at the chondrocyte membrane, ι e mean pixel 
measurement and area measurement It was shown that the majority of IGF-1 
receptor fluorescence intensity was localized on chondrocytes in the middle 
and deeper zones of cartilage, whereas chondrocytes in the surface zone 
exhibited negligible fluorescence The variable distribution of IGF-1 receptor 
in chondrocytes of articular cartilage suggests that effects of IGF-1 on 
chondrocytes may be distinctly heterogeneous in the different mouse articular 
cartilage zones 
INTRODUCTION 
Articular cartilage consists of proteoglycans [PGs] attached to the collagen 
network of the extracellular matrix Chondrocytes are embedded in the 
extracellular matrix and regulate the continuous turnover of PGs within the 
matrix Control of the chondrocyte biosynthetic function is essential in 
maintaining the integrity of articular cartilage Systemic as well as locally 
pioduced growth factors are known to regulate cartilage metabolism [10] 
Insulin-like growth factor-1 [IGF-1] is the most important growth factor 
that regulates PG synthesis in human, bovine and murine chondrocytes [9, 16, 
18, 31] Sex hormones and growth hormone are known to influence the IGF-1 
plasma and tissue levels, although in a previous study it has been reported that 
for sexually matured male or female animals, IGF-1 responses on cartilage 
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metabolism are relatively the same [14, 38]. IGF-1 initiates its biological 
response by high affinity binding to specific receptors, localized on the 
chondrocyte plasma membrane, such as the IGF-1 type 1 and type 2 receptors 
[7, 15, 21, 22]. The type 1 receptor binds IGF-1 with higher affinity than the 
type 2 receptor. The type 2 receptor regulates chondrocyte PG synthesis 
during embryological development, whereas the type 1 receptor mainly 
controls PG synthesis of adult cartilage [15]. This IGF-1 type 1 receptor is a 
transmembrane glycoprotein, consisting of two α and β subunits, that are 
coupled by disulfide bridges and linked in an oc2 ß2 heterotetrameric 
configuration. The extracellular α subunits are involved in ligand binding 
whereas the β subunits traverse the cell membrane and contain a tyrosine 
kinase domain in their cytoplasmic region [26, 37]. 
Specific binding of IGF-1 to the IGF-1 type 1 receptor has been 
demonstrated in human and animal growth plate chondrocytes with competitive 
binding studies [5, 33, 36]. Moreover, the IGF-1 type 1 receptor has been 
identified immunohistochemically on human intact articular cartilage [19]. 
However, it is not known yet whether chondrocytes in the different articulai-
cartilage zones express heterogeneously different amounts of receptor, 
although these zones are known to display differences in metabolic activity [2-
4, 17, 30, 34]. 
The aim of the present study was to investigate in situ IGF- 1 receptor 
expression by examining chondrocytes in the different zones of intact murine 
articular cartilage. To this end, the IGF-1 receptor was detected by 
immunofluorescent means in cryostat sections of the intact normal mouse 
patella using antibodies against the α subunit of the IGF-1 receptor [13, 23, 28, 
29, 35]. We examined mouse patellar cartilage because in previous studies 
much information has been gained about the chondrocyte metabolism of the 
intact mouse patella [41]. In addition to conventional fluorescence microscopy, 
confocal laser scanning microscopy [CLSM] was used to determine the in situ 
IGF-1 receptor expression in intact cartilage. The CLSM collects images that 
are almost free of out-of-focus signals, which results in an improved spatial 
resolution as compared with conventional microscopy 146-48]. Moreover, 
CLSM allows optical sectioning of the specimen and 3D reconstruction of the 
microscopical object. Therefore, CLSM provides the tools of choice for image 
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analysis to localize and quantify accurately IGF-1 receptor expression in 
articular cartilage 
MATERIALS AND METHODS 
Animals 
Sexually matured female C57 black/6 mice [8-12 weeks old, 20-25 g] were 
used The animals were kept under routine laboratory conditions [21-22 C, 
relative humidity 60% and a 12 hours light-dark cycle] The mice were fed a 
standard commercial pellet diet [RHM, Hope Farms, The Netherlands] and 
were given acidified tap water ad libitum 
Preparation of the tissues 
The mice were killed by cervical dislocation and whole patellae were 
dissected from the knee joints The patellar ligaments were cut, leaving the 
cartilage fully intact [41] The patellae were embedded in an aqueous gelatin 
solution of 8% gelatin white [Sigma, St Louis, MO, USA] frozen in liquid 
nitrogen and kept at -80°C until sectioning [1] 
Preparation of cryostat sections 
Sections of fresh frozen undecalcified mouse patellae were cut [7 μτη thick] 
in the sagital plane, on a motor-driven Bright cryostat fitted with a microtome 
with a tungsten carbide-tipped knife at a cabinet temp of -25 С [11, 24] and 
attached to adhesive tape [Scotch tape 800, 3M, St Paul, MN] [27, 42, 45] 
Sections were kept over silica gel and stored at -25 С until further use 
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Immunohistochemistry 
Immunoperoxidase method 
Sections were briefly fixed in acetone [analytical grade, Merck, Darmstadt, 
Germany] for 7 seconds and air dried [6, 45]. Then they were incubated for 
30 minutes at 37 С in a solution of 2 mg/ml testicular hyaluronidase [Sigma] 
diluted in phosphate-buffered saline [PBS1 to obtain a better antibody 
penetration into the cartilage matrix. Subsequently, the slides were rinsed with 
PBS and finally treated with 10% fetal calf serum and 1 % BS A in PBS for 30 
minutes to block aspecific binding. Thereafter, the sections were incubated for 
24 hours at 4 С with primary antibodies, i.e. biotinylated mouse monoclonal 
antibody or polyclonal rabbit antibody respectively, both in a concentration of 
5 μg/ml in PBS in the presence of 1% BSA. At this concentration the 
immunoreactivity signal was saturated. The mouse monoclonal antibody alR-3 
which recognizes human type 1 IGF-1 receptor was obtained from Oncogene 
Science [Manhasset, NY, USA] [13, 28, 35], whereas the polyclonal rabbit anti-
human type 1 IGF-1 receptor was obtained from UBI [New York, NY, USA] 
[23, 29]. Both antibodies show cross reactivity with mouse type 1 IGF-1 
receptor. After incubation with the primary antibodies, the slides were washed 
thrice in PBS. Sections that were incubated with rabbit polyclonal antibody 
were subjected to a three step immunostaining procedure, i.e. incubated with 
biotinylated goat anti-rabbit secondary antibody [Vector Laboratories, 
Burlingame, USA] for one hour in a dilution of 1:500 in PBS in the presence 
of 1% BSA and 1% normal mouse serum, washed thrice in PBS and exposed to 
streptavidin-peroxidase conjugate [Boehringer, Mannheim, Germany] diluted 
1:1000 in PBS for 30 minutes. Sections that were incubated with the 
biotinylated monoclonal anti-lGF-1 receptor antibody were used in a two step 
immunostaining procedure, i.e. incubated with streptavidin-peroxidase 
conjugate. After washing in PBS, peroxidase activity was demonstrated by 
incubation for 10 minutes with 0.5 mg/ml 3.3'-diaminobenzidinetetra 
hydrochloride [DAB; Sigma] dissolved in 1 ml 0.05 M Tris-HCI buffer, pH 
7.6, containing 0.02% H 2 0 2 . The sections were counterstained with Mayer's 
Haematoxylin and embedded in gelatin-glycerin. Light microscopic evaluation 
of the slides was performed with a Leitz microscope. Control sections were 
incubated with either an IgG fraction of normal rabbit serum or biotinylated 
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mouse IgG 1, both used in the same dilution as the primary antibody, or in the 
absence of primary antibody. 
Immunofluorescence method 
The cryostat sections were fixed for 10 minutes in 4% paraformaldehyde 
[Sigma], diluted in PBS, pH 7.4, and subsequently washed in PBS containing 
10% bovine serum albumin [BSA; Sigma], 10% gelatin and 0.3% glycine 
[Pharmacia, Upsala, Sweden]. All further incubations were performed as 
described above. Thereafter, the slides were exposed to streptavidin-FlTC 
[Boehringer] in a concentration of 40 μg/ml in PBS. Subsequently, the slides 
were mounted in glycerolphenylenediamine solution [Sigma] to avoid fading of 
the fluorescence. The slides were kept at -25 С until evaluation with the 
CLSM. 
Fluorescence CLSM and Image Analysis 
Sections were examined with a Leica CLSM fitted to a Leica Fluovert 
microscope, equipped with a PL АР0 63/1.40 oil-immersion objective. 
Chondrocytes situated in the different zones of the cartilage [deep, middle and 
surface zones] were randomly selected with the use of a raster. For excitation 
of FITC, the 488 nm line of an Argon Krypton laser was used fitted with a 
510 nm dichroic mirror and a 530 nm band pass filter. The pinhole aperture 
was set at 100 giving an optimized image [48]. With fixed pinhole, filter 
combination and a laser power setting adjusted to give minimal fading, the 
photomultiplier gain and photometric offset were optimized. These settings 
were rigorously maintained within each experiment. Immunolabelled cryostat 
sections were subjected to optically serial sectioning offering images in the 
X-Y plane. Images of optical sections were recorded with intervals of 0.5 \im 
in the Ζ direction. For analysis, each optical section was averaged eight times. 
Images were recorded in a 512 χ 512 pixel format. The size of each pixel 
represented 0.015 ц т 2 in the object. 
For quantification, the largest optical cross section of each chondrocyte was 
selected and stored on optical disc for subsequent display and analysis, using 
standard Leica CLSM instrument software. Quantification of the immuno-
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fluorescence signal indicating IGF-1 receptor expression was performed in two 
ways. One approach was point measurement by determining fluorescence 
intensity of eight pixels evenly distributed at the chondrocyte periphery. The 
mean fluorescence intensity in these pixels represented the immunoreactivity 
obtained from in situ detection of the IGF-1 receptor. To assess the 
contribution of autofluorescence and aspecific binding, the fluorescence signal 
in sections stained with control non-immune-serum was measured as well. The 
second approach was area measurement by determination of fluorescence 
intensity of the chondrocyte periphery by manually setting a window over the 
chondrocyte periphery. The CLSM instrument software provides the averaged 
intensity [χ/μπι21 as found in the window. The distance between the outer rims 
of these two windows was kept at about 0.2 μιη. Again, nonspecific 
fluorescence was determined in control sections. 
In each cartilage zone the fluorescence intensity was measured in ten 
chondrocytes in each of two serial sections. The chondrocytes were randomly 
selected in horizontal direction with the use of a microscopical eyepiece grid. 
The average fluorescence intensity of ten chondrocytes was expressed as the 
percentage of the highest value measured in each cartilage zone. Data represent 
the mean ± SEM of four independent experiments. Statistical evaluation of the 
experiments was performed with the Wilcoxon rank test. A ρ value of less than 
5% was considered to be significant. 
RESULTS 
Immunohistochemical localization of IGF-1 receptor 
Light microscopic evaluation of immunoperoxidase and immuno­
fluorescence staining of cartilage sections revealed that the fluorescence 
staining was more sensitive for the detection of IGF-1 receptor than the 
peroxidase staining. However, fluorescence stained sections showed a veil of 
green autofluorescence that obscured the view somewhat. Chondrocytes within 
the articular cartilage showed the presence of IGF-1 receptor whereas the 
cartilage matrix remained negative [Figure ΙΑ, В and C]. Immunoreactivity 
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Figure 1. 
Photomicrographs of mouse patellar cryostat 
sections stained by the immunoperoxidase 
method to detect rabbit polyclonal antibody 
[A] and mouse monoclonal antibody, ocIR-3 
[B]. Both antibodies are directed against the 
α subunit of the IGF-1 receptor. Control 
sections were treated with either biotinylated 
mouse IgGl or an IgG fraction of normal 
rabbit serum [C]. Bars = 12.7 μπι 
[A] Chondrocytes [CH] within the articular 
cartilage [AC] were distinctly stained, 
whereas the cartilage matrix [CM] remained 
negative. Incubation with the polyclonal 
antibody against the IGF-1 receptor showed 
a homo-geneously spread immunolabeling. 
Staining was not restricted to the cell mem­
brane but diffuse intracellular staining was 
found as well. 
[B] Incubation with the monoclonal anti­
body, aIR-3, revealed a rather dot-like 
staining pattern mainly at the chondrocyte 
membrane. 
[C] Control staining showed a low amount 
of nonspecific background staining. This is 
an example of treatment with biotinylated 
mouse IgG. 
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was not restricted to the chondrocyte cell surface but a diffuse intracellular 
staining was observed as well 
Immunostaining of the IGF-1 receptor, with the use of the mouse 
monoclonal antibody, aIR-3, resulted in a rather dot-like staining pattern 
mainly at the chondrocyte membrane, as shown in Figure IB Incubation with 
rabbit polyclonal anti-lGF-1 receptor resulted in a more homogeneous staining 
pattern at the chondrocyte membrane as well as intracellularly [Figure 1A] 
Sections that were treated with either non-immune rabbit serum or biotinylated 
mouse IgG showed a low proportion of background staining In Figure 1С 
background staining after treatment with biotinylated mouse IgG is shown At 
the light microscopic level it was difficult to determine exactly the amount of 
in situ IGF-1 receptor immunoreactivity on the chondrocyte plasma 
membrane 
CLSM analysis 
Figure 2 shows consecutive optical sections of a chondrocyte taken with 
intervals of 0 5 μιτι The images demonstrated enhanced spatial resolution of 
the localized receptor detected with immunofluorescence as compared with 
light microscopic evaluation For further CLSM analysis the polyclonal 
antibody was used The chondrocyte membrane showed IGF-1 receptor 
immunoreactivity, but intracellularly, chondrocytes displayed a rather 
granular fluorescence staining as well A considerable amount of background 
fluorescence due to aspecific binding as well as autofluorescence was often 
observed along the cartilage surface edge, as observed in Figure 3 The use of 
the anti-fading agent phenylenediamine largely prevented fading of the 
fluorescence as caused by laser light excitation Even after accumulation and 
averaging of eight scans, no attenuation of fluorescence signal was noted 
CLSM analysis revealed that IGF-1 receptor staining at the chondrocyte cell 
surface was particularly found in chondrocytes of the middle cartilage zone 
[Figure 3] The cells showed bright positive staining at the chondrocyte 
periphery [Figure 4A] Chondrocytes located in the deeper zones exhibited a 
distinct heterogeneity of cell surface staining [Figure 4B] Chondrocytes in the 
surface zone displayed apparently less bright staining [Figure 4D] 
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Figure 2 
CLSM evaluation of 
eight consecutive 
optical sections [1-8] 
of a chondrocyte 
recorded at 0.5 μπι 
intervals after being 
immunohistochemi-
cally stained for the 
IGF-1 receptor. The 
chondrocyte mem­
brane contained in­
tense IGF-1 receptor 
immunoreactivity 
[arrow], whereas in-
tracellularly a weak 
granular staining was 
displayed. 
Bar= 3.5 μπι 
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Figure 3 
Immunolocalization of the IGF-1 receptor on chondrocytes located in the different zones of 
mouse cartilage as visualized by CLSM. Overview of the articular cartilage, showing 
chondrocytes in the surface zone [SZ], middle zone [MZ] and deeper zone [DZ]. Bar = 5 μπι 
Quantification of IGF-1 receptor expression 
Quantification of the immunofluorescence intensity in the confocal images 
was performed in two ways as described in Materials and Methods. Following 
the first approach, the mean fluorescence intensity at the periphery of 
randomly selected chondrocytes located in each of the three cartilage zones was 
similar for either mouse monoclonal antibody or rabbit polyclonal anti-lGF-1 
receptor antibody. The fluorescence intensity as determined by mean pixel 
measurement on the chondrocyte membrane in surface, middle or deeper zones 
of cartilage yielded values of 57 ± 16, 100 ± 17 and 78 ± 19, respectively 
[Table 1 A ]. Fluorescence as determined by area measurement revealed that 
similar results were obtained as with mean pixel measurement, as shown in 
Table IB and Figure 5. Quantification of the nonspecific fluorescence intensity 
showed a constant background in all cartilage layers with no significant 
variation between the independent experiments of either point or area 
measurement [Figure 5]. The fluorescence intensity level in chondrocytes in 
the surface zone was similar to the nonspecific fluorescence intensity. 
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Figure 4 
Enlargement of the IGF-1 receptor immunolocalization on chondrocytes located in the different 
zones of mouse cartilage as visualized by CLSM. The cell surface of chondrocytes located in 
the middle zone [A] an deeper zone [B] show bright positive staining. Cell surface staining of 
chondrocytes in the surface zone [C] was apparently less bright. Bars = 1.3 μιτι 
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Table 1. 
Quantification of the fluorescence intensity from IGF-1 receptor immunolocalization on the 
chondrocyte membrane of confocal images 
A Point measurement 
Experiment 1 
2 
3 
4 
Surface zone 
4 7 + 17 
5 9 ± 18 
49 ± 17 
72 ± 12 
Middle zone 
100 ± 2 9 * 
100 ± 13 * 
100 ± 15 * 
100± 12* 
Deep zone 
77 ± 19* 
87 ± 16* 
65 ± 23 * 
83 ± 16* 
Background 
54 ± 14 
55 ± 12 
46 ± 9 
64 ± 12 
57 ± 16 100 ± 17 78 ± 19 55 ± 12 
B. Area measurement 
Experiment 1 
2 
3 
4 
Surface zone 
74 ± 4 2 
43 ± 14 
50 ± 2 5 
40 ± 13 
Middle zone 
95 ± 5 3 * 
100 ± 5 0 * 
100± 13 * 
100 ± 13 * 
Deep zone 
100 ± 5 3 * 
86 ± 54 * 
63 ± 1 3 * 
93 ± 27 * 
Backgroui 
42 ± 2 1 
71 ± 4 3 
50 ± 2 5 
53 ± 13 
mean 52 ±23 99 ±32 86 ±37 54 ±26 
Fluorescence intensity values represent the means of ten chondrocytes in each zone selected 
with a raster. Background fluorescence intensity represents the mean value of the surface, 
middle and deeper zones The presented values are expressed in % of the highest value of each 
experiment. * means ρ < 0.05 versus the intensity in the surface zone by Wilcoxon rank test. 
Both quantification methods clearly demonstrated that the fluorescence 
intensity of chondrocytes located in middle or deeper zones of the cartilage 
was significantly higher than that of chondrocytes located in the surface zone. 
The fluorescence signal of chondrocytes in the surface zone was similar to 
background fluorescence intensity, whereas chondrocytes in the middle zone 
exhibited highest fluorescence intensity. Chondrocytes in the deeper zones 
showed a mean specific fluorescence intensity that was approximately 50% 
lower than that of cells in the middle zone. Area measurement yielded a 
somewhat higher signal in chondrocytes of the deeper layers than point 
measurements. However, the difference was statistically not significant. 
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Fluorescence signal 
Area measurement 
tv Point measurement 
100 
Surface zone Middle zone Deep zone Background 
Figure 5 
Quantification of the fluorescence signal of IGF-1 receptor immunoreactivity on the 
chondrocyte membrane as detected in ccnfocal images after incubation with polyclonal anti-
IGF-1 receptor antibody. Nonspecific fluorescence is assessed in images of chondrocytes 
incubated with cither biotinylated mouse IgG or non-immune rabbit serum. Point measurement 
of fluorescence intensity on chondrocytes located in the different zones of the cartilage, i.e. the 
surface, middle and deeper zones, is compared with area measurement. Fluorescence intensity 
was measured in ten chondrocytes in each cartilage layer in two serial sections. The data are the 
mean ± SEM of four independent experiments, expressed as percentage of the highest value of 
each experiment. *. mean value is significantly different from the mean value in the surface 
zone fp < 0.05] by Wilcoxon rank test. 
DISCUSSION 
IGF-1 is known to play a key role in the regulation of chondrocyte 
biosynthetic function [9, 16, 18, 31]. IGF-1 initiates its biological response by 
binding to a specific receptor, the IGF-1 type 1 or type 2 receptor [7, 21]. In 
the present study, we have analyzed IGF-1 type 1 receptor expression in situ in 
patellar cartilage of sexually matured female mice, because in adult cartilage 
binding to the IGF-1 type 1 receptor is known to be metabolically of utmost 
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importance [15] Immunostaining and confocal laser scanning microscopy were 
used to localize and quantify receptor expression 
We demonstrated the localization of the IGF-1 receptor in articular cartilage 
chondrocytes The two types of IGF-1 receptor antibodies, that were used to 
detect IGF-1 receptor expression, displayed a different staining pattern This 
may imply that either the antibodies do not recognize exactly the same epitopes 
of the α subunit of the IGF- 1 receptor or the antibodies react differently after 
the fixation procedures used Investigations at light microscopic level of 
receptor expression after immunoperoxidase staining showed lmmuno-
reactivity on the chondrocyte cell surface as well as intracellular staining 
Therefore immunoperoxidase staining of the IGF-1 receptor did not allow 
accurate examination of receptor immunoreactivity on the chondrocyte 
membrane On the other hand, CLSM optical sectioning of the specimen 
demonstrated improved localization of the IGF-1 receptor by eliminating glare 
from structures above or below the focus plane [46, 47] The method applied 
in the present study to measure the fluorescence intensity of CLSM images 
from the immunolocalized IGF-1 receptor in the chondrocyte periphery 
enabled us to distinguish membrane staining from intracellular staining It 
remains undecided what is represented by the intracellular staining, but it is 
likely that it is either internalized and/or newly synthesized IGF-1 receptor 
The amount of intracellular receptor in comparison with the amount present 
on the chondrocyte membrane could give valuable information with respect to 
the regulation of the chondrocyte biosynthetic activity under various 
physiological or pathophysiological conditions such as growth and joint 
inflammation The quantitative histochemical method using CLSM to 
differentiate between membrane and intracellular compartments is an excellent 
tool to study cellular metabolic dynamics 
The present study demonstrates that the application of CLSM is 
advantageous to study in situ receptor immunolocalization on intact cartilage 
tissue, where discrimination against background staining is a serious problem 
It should be noted that chondrocytes contain only a low level of IGF-1 
receptors Moreover, we studied ciyostat sections of intact cartilage, in which 
the amount of receptors detected on chondrocytes may be even less than the 
amount of receptors in isolated chondrocytes Wotton et al [1991] already 
described the advantage and versatility of using confocal microscopy in 
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conjunction with immunofluorescent localization, but did not describe the use 
of CLSM in quantifying the immunolocalized fluorescence signal Good et al 
[1992] described a method to quantify binding of a fluorescence-labeled 
growth factor to its receptor on single cells in situ using confocal microscopy 
Other aspects of quantitative immunohistochemical detection by CLSM have 
been described [ e g , 8, 20, 25, 43] Our study describes a fast and specific 
approach to analyze and quantify in situ immunohistochemically localized 
IGF-1 receptor on intact tissue sections Two approaches were performed to 
quantify the fluorescence signal from confocal images, ι e point measurement 
and area measurement In general, both methods yielded comparable and 
reproducible results demonstrating the validity of the quantitative approach 
The amount of background fluorescence as quantified in the different cartilage 
layers with both methods [Table 1] was relatively high as compared with the 
total fluorescence signal, but this is an inherent problem of low levels of 
antigen 
The use of a CLSM was essential to study the immunohistochemically 
localized IGF-1 receptor in different zones of the cartilage CLSM analysis 
revealed that the majority of labeling was localized on chondrocytes in the 
middle and deep zone of the cartilage, whereas fluorescence intensity of 
chondrocytes in the surface zone was indistinguishable from the background 
fluorescence In human, pig and bovine cartilage it is known trom either 
investigations ot the metabolic functions of isolated chondrocytes from 
different zones of the cartilage or in situ autoradiography, that chondrocytes in 
the different zones vary in their metabolic state [2-4, 17, 34] However, in 
mouse cartilage these findings have not been confirmed as yet Our findings 
point out that IGF-1 receptor immunoreactivity is not homogeneously 
distributed throughout the different cartilage zones It may be suggested that 
IGF-1 receptor expression in the different cartilage layers reflects 
heterogeneity in IGF 1 stimulation and activity of the chondrocytes in these 
layers We have demonstrated previously that in contrast to the ability of 
IGF-1 to sustain chondrocyte PG synthesis of normal murine articular 
cartilage during culture, chondrocytes from experimentally-induced arthritic 
knee joints do not respond to IGF-1 [31] During arthritis suppressive 
mediators, such as interleukin-1 [IL-1 ] and tumor necrosis factor [TNF], are 
produced by the inflamed synovium and are known to be potent inhibitors of 
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chondrocyte metabolism [39, 40, 44]. It remains a matter of speculation 
whether inflammatory mediators are involved in the nonresponsive state to 
IGF-1 stimulation during experimentally-induced arthritis. CLSM analysis of 
IGF-1 receptor expression in cartilage during different stages of arthritis is 
recently investigated [Verschure et al. in preparation]. 
In conclusion, we have used immunohistochemistry, light and confocal laser 
scanning microscopy to visualize and quantify in situ IGF-1 receptor 
expression in mouse articular cartilage. Using CLSM, IGF-1 receptor 
immunoreactivity on the chondrocyte membrane could be distinguished from 
intracellular staining. CLSM analysis confirmed the visual interpretation with 
conventional light microscopy. However, confocal microscopy enabled us to 
quantify chondrocyte membrane receptor expression in chondrocytes located 
in the different zones of the cartilage. 
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ABSTRACT 
Insulin-like growth factor-1 [IGF-1] plays a key role in regulation of 
chondrocyte metabolism. We examined the localization of IGF-1 binding sites 
on chondrocytes in cartilage from normal and experimentally-induced arthritic 
mouse knee joints. Cryostat sections from patellar cartilage were incubated 
either with ocIGF-1 receptor antibody or biotinylated IGF-1. Subsequently 
confocal laser scanning microscopy [CLSM] was applied to compare the two 
staining procedures qualitatively and quantitatively. This CLSM approach 
allowed detailed analysis of membrane associated and intracellular staining. 
Using aIGF-1 receptor antibody, IGF-1 receptors were found on the cell 
membrane of chondrocytes in the middle and deeper cartilage zones, whereas 
intracellular staining was highest in chondrocytes of superficial zones. After 
incubation with biotinylated IGF-1, distinct membrane staining was not present 
and fluorescence was localized homogeneously in middle and deeper zones but 
not in superficial zones. In cartilage from inflamed knee joints staining with 
the use of aIGF-1 receptor antibody did not change significantly, whereas a 
pronounced increase in staining was noted with biotinylated IGF-1 in 
chondrocytes of middle and deeper zones of cartilage. 
It is concluded that the staining patterns obtained with the use of aIGF-1 
receptor antibody and biotinylated IGF-1 are remarkably different, suggesting 
that the latter also detects IGF-binding proteins. The results suggest that joint 
inflammation has no consistent effect on IGF-1 receptor expression but may 
induce a significant upregulation of IGF-binding proteins in chondrocytes of 
middle and deeper zones of cartilage. 
INTRODUCTION 
Articular cartilage is a highly specialized connective tissue consisting of 
chondrocytes embedded in an extensive extracellular matrix of collagen and 
proteoglycans [PGs] [10, 11]. Chondrocytes keep the equilibrium between 
synthesis and degradation of matrix molecules and maintain the integrity of the 
matrix [9]. 
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Biosynthetic function of chondrocytes is regulated by interactions between 
circulating and locally produced growth factors [13, 26] Insulin-like growth 
factor-1 [IGF-1] is an important anabolic stimulus that regulates chondrocyte 
biosynthesis by binding to the IGF-1 type 1 receptor [4, 12, 18, 20, 21, 24, 28, 
34, 38, 40] Compelling evidence exists that destruction of the articular 
cartilage during joint inflammation results at least in part from a lack of 
anabolic signaling [33, 34, 42, 46, 48] Therefore, analysis of IGF-1 receptor 
expression may give valuable information about the chondrocyte biosynthetic 
function [11] 
Expression of IGF 1 receptors has been studied extensively in various tissues 
after incubation with radiolabeled IGF 1 followed by autoradiography [1,7, 
19] However, there is increasing evidence that chondrocytes also express 
substantial amounts of IGF-binding proteins [IGFBPs] [5, 37], which flaws the 
relevance of data obtained from studies concerning hgand binding Alternative 
approaches to analyze receptor expression are the isolation of cells and 
subsequent examination of receptors and binding proteins with Scatchard 
analysis and affinity cross linking [14, 32, 38, 49] Apart from potential shifts 
in receptor expression related to isolation and culture procedures, the latter 
techniques give at best an overall impression of receptors in a particular tissue 
and do not allow for a detailed analysis of site specific expression 
In the present study, we examined the localization of IGF-1 binding sites on 
chondrocytes in cartilage from normal and inflamed knee joints We used both 
biotinylated IGF-1 and an antibody against the extracellular, hgand binding α 
subunit of the IGF-1 receptor Therefore, cryostat sections were taken from 
patellar cartilage of normal mice and mice with experimentally-induced 
arthritis Confocal laser scanning microscopy [CLSM] was applied to compare 
the two staining procedures both qualitatively and quantitatively [47] This 
CLSM approach also allows for detailed analysis of membrane associated and 
intracellular staining Since it is known that the metabolism of chondrocytes 
may vary considerably in different cartilage areas [3, 31, 35], IGF-1 binding 
sites were analyzed in superficial, middle and deeper zones of the patellar 
cartilage 
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MATERIALS AND METHODS 
Animals 
Sexually mature female C57 black/6 mice [8-12 weeks old, 20-25 g] were 
used. The animals were kept under routine laboratory conditions [21-22°C, 
relative humidity 60% and a 12 hours light-dark cycle]. The mice were fed a 
standard commercial pellet diet [RHM, Hope Farms, The Netherlands] and 
given acidified tap water ad libitum. 
Arthritis induction and determination 
Arthritis was induced in mouse knee joints by intra-articular injection of 
yeast particles. To this end right knee joints were injected intra-articularly 
with 180 μg sterilized zymosan [Sigma, St. Louis, MO, USA] in pyrogen-free 
saline. This experimental arthritis model is characterized by the development 
of an exudate in the early phase [day 1-3] containing large amounts of 
polymorphonuclear cells in the joint space, a loss of cartilage PGs and 
inhibition of chondrocyte PG synthesis. Inflammation subsides within a weak 
and because the damage to cartilage is reversible the matrix is repaired 
afterwards [33, 44, 43]. Joint inflammation was determined two days after 
induction of arthritis by evaluating histological sections stained with 
Haematoxylin/eosin as well as with Safranin O/Fast Green [Figure 1]. Safranin 
О is a metachromatic dye that stains the amounts of PG in the cartilage. 
Figure 1 
Histological changes after induction of arthritis in mouse knee joints. Sections were stained 
with Haematoxylin/eosin [A, B, C, D] or Safranin O/Fast Green [E, F] The experimental 
arthritis at day two after induction is characterized by large thickening of the .synovial lining, a 
polymorphonuclear cell rich infiltrate in the joint space as well as loss of proteoglycans in the 
upper cartilage layer. Patella [P]; Femur [F]; Joint space [asterisk]; Synovial lining [arrow]. 
Microscopical image of a Haematoxylin/eosin stained section of a contralateral control joint [A] 
[Magnification 10 x], as well as of an arthritic knee joint [B] [Magnification 10 x]; Control joint 
[A] at higher magnification [C] [Magnification 20 x] as well as arthritic joint [B] at higher 
magnification [D] [Magnification 20 x]. 
Microscopical image of a Safranin О stained section of control joint [E] [Magnification 20 x] as 
well as of an arthritic knee joint [F] [Magnification 20 x] 
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Preparation of tissues 
Mice were killed by cervical dislocation and whole patellae were dissected 
from knee joints Patellar ligaments were cut, leaving the cartilage fully intact 
[431 The patellae were embedded in an aqueous solution of 8% gelatin white 
[Sigma] frozen in liquid nitrogen and kept at -80°C until sectioning [2] 
Preparation of cryostat sections 
Sections [7 μπι thick] of fresh frozen undecalcified mouse patellae were cut 
in the sagital plane on a motor-driven Bright cryostat fitted with a tungsten 
carbide-tipped knife at cabinet temp of -25 С [15, 27] and attached to adhesive 
tape IScotch tape 800, 3M, St Paul, MN. USA] [29, 45] Sections were kept 
over silica gel and stored at -25 С until further use 
Immunohistochemistry 
Cryostat sections were fixed for 10 minutes in 4% [w/v] paraformaldehyde 
[Sigma], dissolved in phosphate-buffered saline [PBS] pH 7 4, and subsequently 
washed in PBS containing 10% [w/v] bovine serum albumin [BSA, Sigma, St 
Louis, MO, USA], \0σΑ [w/v] gelatin and 0 3% [w/v] glycine [Pharmacia, 
Upsala, Sweden] Sections were incubated lor 30 m at 37 С in a solution of 
2 mg/ml testicular hyaluronidase [Sigma] dissolved in PBS to obtain a better 
penetration of antibodies into the cartilage matrix Subsequently, sections were 
rinsed in PBS and finally treated with 10 % [w/v] fetal calf serum and 1 % 
[w/vj BSA in PBS for 30 minutes to block aspeciftc binding Thereafter, 
sections were incubated for 24 hours at 4 С either with primary antibody, or 
biotinylated IGF-1 [as listed in Table 1] in concentrations of 5 |ig/ml and 
10 μg/ml, respectively, in PBS containing 1% BSA [UBI, New York, NY, 
USA] Primary rabbit polyclonal antibody is directed against the extracellular 
α subunit of human IGF-1 type 1 receptor and shows cross leactivity with 
mouse IGF-1 type 1 receptor [25, 30] Recombinant human IGF-1, 
[Boehnnger Mannheim, Germany] was conjugated to biotin Alter incubation 
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with the primary antibody or biotinylated IGF-1, the slides were washed thrice 
in PBS. Sections that were incubated with antibody were subjected to a three-
step immunostaining procedure, i.e. incubated with biotinylated goat anti-
rabbit secondary antibody [Vector Laboratories, Burlingame, USA] for one 
hour in a dilution of 1:500 in PBS containing 1% BS A and 1% normal mouse 
serum, whereas sections that were incubated with biotinylated IGF-1 were 
incubated in a two-step immunostaining procedure. Biotin was demonstrated 
by exposing sections to streptavidin-FlTC [Boehringer] in a concentration of 
40 μg/ml in PBS and subsequently mounted in glycerol phenylenediamine 
solution [SigmaJ to avoid fading of fluorescence. As control for aIGF-1 
receptor antibody staining, sections were incubated with non-immune rabbit 
serum or in the absence of primary antibody. As control for biotinylated 
IGF-1 staining, sections were either treated with biotinylated irrelevant 
proteins, having similar isoelectric points and molecular weights as 
biotinylated IGF-1 or preincubated with a 100-fold excess of IGF-1. In control 
incubations [as listed in Table 1] the same dilution as for the primary antibody 
or biotinylated IGF-1 were used. Sections were kept at -25 С until evaluation 
with the use of the CLSM. 
Table 1. Primary incubations in this study with biotinylated IGF-1 and the respective controls 
used 
isoelectric point molecular weight [kDa] 
Biotinylated IGF-1 8.0 7.0 
Biotinylated BSA 4.5 6 7 
Biotinylated cytochiome с 10.0 12.0 
Biotinylated lysozyme 110 14.5 
Biotinylated myoglobulin 8 5 17.5 
Fluorescence CLSM and Image Analysis 
Sections were examined with a Leica CLSM attached to a Leica Fluovert 
microscope, equipped with a PL Apo 63/1.40 oil-immersion objective. For 
excitation of FITC, the 488 nm line of an Argon Krypton laser was used fitted 
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with a 510 nm dichroic mirror and a 530 nm band pass filter. The pinhole 
aperture was set at 100 yielding an optimized image [51]. With fixed pinhole, 
filter combination and a laser power setting adjusted to give minimal fading, 
the photomultiplier gain and photometric offset were optimized. These settings 
were rigorously maintained within each experiment. Immunolabelled cryostat 
sections were subjected to optical serial sectioning, providing images in the 
X-Y plane. Images of optical sections were recorded with intervals of 0.5 μπι 
in the Ζ direction. For analysis, each optical section was averaged eight times. 
Images were recorded in a 512 χ 512 pixel format. The size of each pixel 
represented 0.015 \im2 in the object. 
Quantification of immunofluorescence signal 
Quantification of immunofluorescence was performed by area measurement 
as previously described [47, 50]. In brief, fluorescence intensity of each 
cartilage zone was measured in ten chondrocytes in each of two serial cryostat 
sections. The chondrocytes were randomly selected in horizontal direction with 
the use of an eyepiece grid. The largest optical cross section of each 
chondrocyte was selected and stored on optical disc for subsequent display and 
analysis using standard Leica CLSM software. Fluorescence intensity was 
determined manually by area measurement. A window was set over the 
chondrocyte periphery and over the internal part of the chondrocytes [Figure 
2]. Distance between the outer rims of the windows was kept at approximately 
Figure 2 
Digital image of cartilage after staining 
with ocIGF-1 receptor antibody. 
Fluorescence intensity was determined 
manually by area measurement. 
Windows were set over the chondrocyte 
periphery and over the internal part of the 
chondrocytes [indicated by stipped lines]. 
Distance between the outer rims of the 
windows was kept at approximately 
0.2 μπι. Bar = 2.3 μπι 
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0.2 ц т . The area of the whole chondrocyte, i.e. the sum of the area within the 
peripheral window and the internal window, respectively yielded values in the 
surface, middle or deeper zones of 29 ± 5, 30 ± 4 and 48 ± 10 [Ι/μιη2]. To 
assess the contribution of autofluorescence and aspecific binding, fluorescence 
signals in control sections were measured as well. 
In experiments to compare fluorescence signals in the different cartilage 
zones, the highest average fluorescence intensity of ten chondrocytes was 
measured in each particular zone and the highest value was set at 100%. The 
fluorescence signals in the other zones was expressed as a percentage of this 
value. This procedure was performed for both the chondrocyte periphery and 
internal part, for sections incubated with odGF-1 receptor antibody. In sections 
stained with biotinylated IGF-1 fluorescence of the entire chondrocyte was 
measured. Data represent the mean ± SEM of 4 independent experiments. 
Statistical evaluation of the experiments was performed with the Wilcoxon 
rank test. A ρ value of less than 5% was considered to be significant. 
RESULTS 
Normal articular cartilage 
Incubations of normal mouse articular cartilage with the antibody against the 
α subunit of the IGF-1 receptor resulted in a clear staining mainly at the 
chondrocyte membrane. Intracellular, staining was weak, showing a granular 
pattern [Figure ЗА]. In contrast, IGF-1 binding as detected with biotinylated 
IGF-1 resulted in a more diffuse staining pattern over the entire cytoplasm of 
chondrocytes. In addition, some strongly reactive dots were often observed in 
the cytoplasm [Figure 3B]. Distinct staining at the chondrocyte membrane was 
not observed after staining with biotinylated IGF-1. Control sections incubated 
with non-immune rabbit serum showed only weak and nondistinct fluorescence 
due to autofluorescence and nonspecific binding. The sections that were 
incubated with a series of nonrelated biotinylated proteins with similar 
molecular weights and isoelectric points as IGF-1 [Table 1] also showed 
nondistinct background staining patterns. Furthermore, the binding of 
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biotinylated IGF-1 was blocked completely after preincubation of the sections 
with 100-fold excess of IGF-1 [data not shown]. 
The clear differences in staining patterns when using aIGF-1 receptor 
antibody, or biotinylated IGF-1 were further substantiated after analysis of 
Figure 3 
Digital images of cryostat sections of 
normal mouse patellar cartilage incubated 
with rabbit polyclonal antibody against 
the α subunit of the IGF-1 receptor [A] 
or with biotinylated IGF-1 [B]. Binding 
was detected with FITC labeling and 
evaluated with CLSM. Surface edge of 
the cartilage is indicated by arrows; 
cartilage zones are shown surface zone 
[S], middle zone [M], deeper zone 
[D].The staining was mainly localized at 
the surface of chondrocytes after 
incubation with ocIGF-1 receptor 
antibody and was diffusely distributed 
over the entire chondrocytes, showing 
marked dot-like staining as well after 
staining with biotinylated IGF-1. 
Bars = 8 μιη 
consecutive optical sections. Figure 4 shows 4 consecutive optical sections of a 
chondrocyte located in the middle zone of the cartilage, stained with either 
ocIGF-1 receptor antibody [Figure 4A] or biotinylated IGF-1 [Figure 4B]. 
Intracellular staining was observed after incubation with biotinylated IGF-1 
[Figure 4B], whereas incubations with otIGF-1 receptor antibody resulted 
consistently in staining the periphery of the chondrocyte only [Figure 4A]. 
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Figure 4 
Four consecutive optical 
sections of a chondrocyte lo­
cated in the middle zone of 
mouse normal articular carti­
lage after staining with a 
polyclonal antibody against 
the α subunit of the receptor 
[A] or after staining with 
biotinylated IGF-1 [B]. 
Intracellular staining was 
higher when using biotiny­
lated iGF-1 than when using 
ocIGF-1 receptor antibody. 
The chondrocyte membrane 
contained large amounts of 
IGF-1 receptor but intracel­
lular staining was weak. 
Bars = 4 μτη 
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Analysis of IGF-1 binding sites in the different cartilage zones 
Chondrocytes located in the different cartilage zones are known to exhibit 
heterogeneity in their metabolic state [3, 31, 35]. We therefore analyzed the 
presence of IGF-1 binding sites in the different zones of cartilage using both 
aIGF-1 receptor antibody and biotinylated IGF-1. IGF-1 receptor antibody 
staining was mainly found in chondrocytes in the middle and deeper cartilage 
layers [Figure ЗА, Table 2]. In these cartilage layers chondrocytes showed 
bright positive staining at the chondrocyte membrane. However, chondrocytes 
in the surface zone of the cartilage exhibited high fluorescence intensities 
Table II. Staining ofIGF-1 binding siles with cither aIGF-1 receptor antibody or biotinylated IGF-1 
Normal cartilage Arthritic cartilage 
Surface zone Middle zone Deeper zone Surface zone Middle zone Deeper zone 
aIGF-1 receptor anUbody 
membrane-bound ~ + + + + ~ + + + + 
intracellular + + + + + + 
blollnvlaled IGF-1 
entire celb + + + + - + + + + + + 
Huorescence signal al Ihc chondorcyte membrane, or lntracellularly or in enure chondrocytes 
was analyzed in the different zones of patellar cartilage from normal and arthritic mouse knee joints 
Grading -, fluorescence intensity similar to background fluorescence, +, weak fluorescence signal, 
++ marked fluorescence intensity, +++ bright fluorescence signal 
intracellularly. Biotinylated IGF-1 staining was mainly found in chondrocytes 
in the middle and deeper zones of cartilage, while chondrocytes in the surface 
zones displayed only low levels of staining [Figure 3B, Table 2]. 
Quantification of IGF-1 binding fluorescence 
For quantification of the fluorescence signal a window was set over the 
chondrocyte periphery and over the internal part of the chondrocytes [Figure 
2]. Quantification of fluorescence intensity at the chondrocyte membranes, 
when incubated with aIGF-1 receptor antibody, revealed high intensities on 
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IGF-1 receptor antibody 
Fluorescence signal [%] 
* * * 
• membrane-bound 
И intracellular^ 
1 2 3 4 
Surface zone Middle zone Deeper zone Background 
В 
Biot inylated IGF-1 
Fluorescence signal [%] 
* * 
entire cells 
1 2 3 4 
Surface zone Middle zone Deeper zone Background 
Figure 5 
Quantification of the fluorescence signal expressed as percentage in normal mouse patellar 
cartilage after incubation with polyclonal anti-IGF-1 receptor antibody [A] or biotinylated 
IGF-1 [B]. Nonspecific fluorescence was assessed in images of chondrocytes incubated with 
non-immune rabbit serum. Fluorescence intensity was measured in the different zones of 
cartilage [surface, middle and deeper zones]. The highest fluorescence intensity measured in 
any particular zone was taken as 100% and fluorescence in the other zones was expressed as a 
percentage of this value. For anti-IGF-1 receptor antibody, fluorescence intensity was measured 
at the periphery of chondrocytes and intracellularly; for biotinylated IGF-1, fluorescence of the 
entire chondrocyte was measured. The data are the mean ± SEM of four independent 
experiments, including 5 patellae in each experiment. In all cartilage layers background 
fluorescence was similar. * = mean value is significantly different from background 
fluorescence, [p < 0.05] as determined by Wilcoxon rank test. 
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chondrocytes located in middle or deeper zones [Figure 5A] and significantly 
lower values in cells in the superficial layer. Moreover, the intracellular 
fluorescence intensity in chondrocytes located in the middle or deeper zones 
was not above background fluorescence. However, intense intracellular 
fluorescence was measured in chondrocytes in the surface zone. Background 
fluorescence as measured in control sections was low both at the membrane 
and intracellularly in chondrocytes. In all cartilage layers background 
fluorescence was at a similar level. No significant variations in background 
fluorescence were observed between individual experiments. 
Staining with biotinylated IGF-1 was localized diffusely over the 
chondrocytes and was present in some strongly reactive dots. Therefore, 
proper analysis of separate membrane-bound and intracellular fluorescence 
was not possible and therefore measurements were performed per cell 
[Figure 5B]. Biotinylated IGF-1 staining resulted in high levels of fluorescence 
in chondrocytes in the middle and deeper zones. In the surface zones only low 
levels similar to background fluorescence were measured. 
Arthritic articular cartilage 
In addition, we analyzed staining patterns in arthritic cartilage two days 
after induction of joint inflammation. Figure 1 shows the histological changes 
observed two days after induction of arthritis. The experimental arthritis at 
Figure 6 
Digital images of cryostat sections of mouse normal patellar cartilage after staining with 
biotinylated IGF-1 [A] and of cartilage obtained from inflamed joints, after the induction of 
arthritis [B]. Chondrocytes form the middle zone of the cartilage are shown. Bar= 17.5 μιτι 
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day two after induction is characterized by large thickening of the synovial 
lining, a polymorphonuclear cell rich infiltrate in the joint space as well as loss 
of PGs in the upper cartilage layer. After staining with ocIGF-1 receptor 
Figure 7 
Analysis of fluorescence in chondro-
cytes in the middle zones of cartilage in 
sections from normal and arthritic knee 
joints after incubation with biotinylated 
IGF-1. Nonspecific fluorescence was 
assessed in images of chondrocytes in-
cubated with biotinylated, irrelevant 
proteins. The results are expressed as 
percentage of measurements in normal 
cartilage [taken as 100%]. *, mean 
value is significantly different from the 
mean value in normal cartilage [p=0.01 ] 
as determined by Wilcoxon rank test. 
The data represent four independent 
experiments including 5 patellae in each 
group. 
antibody, the fluorescence pattern resembled the immunoreactivity as observed 
in normal cartilage [Table 2]. However, staining with biotinylated IGF-1 
showed that chondrocytes in the middle and deeper layers of cartilage from 
arthritic joints displayed a strikingly higher fluorescence intensity than 
observed in normal cartilage [Figure 6, Table 2]. High amounts of fluorescence 
were found directly below the cell membrane of cells. Quantification of 
fluorescence intensities revealed the difference between control and arthritic 
cartilage to be significant [Figure 7j. Chondrocytes in the surface zone of 
arthritic cartilage exhibited the same low fluorescence levels as in control 
cartilage. 
DISCUSSION 
IGF-1 plays a key role in regulation of chondrocyte biosynthetic functions 
[12, 21, 20, 34]. We have previously demonstrated that chondrocytes from 
experimentally-induced arthritic mouse knee joints exhibit a complete lack of 
IGF-1 anabolic stimulation [33]. This lack of anabolic stimulation during joint 
inflammation may contribute to cartilage destruction. In the present study, we 
Fluorescence signal [%] 
150 
Middle zone Background 
136 Chapter 6 
analyzed in situ distribution patterns of IGF-1 binding sites in murine 
cartilage. Immunostaining with aIGF-1 receptor antibodies and staining with 
biotinylated IGF-1 were applied to localize and quantify IGF-1 binding sites in 
cartilage from normal and inflamed mouse knee joints with the use of CLSM. 
Our data demonstrate that incubations with aIGF-1 receptor antibody and 
with biotinylated IGF-1 yield different staining patterns. Differences were 
found both in terms of expression in the various zones of the cartilage as well 
as membrane-bound versus intracellular localization. Moreover, this 
divergence in staining is even more apparent when the joints are inflamed. An 
upregulation of IGF-1 binding sites was found with biotinylated IGF-1 but not 
with aIGF-1 receptor antibody after induction of arthritis which suggests a 
selective increase in IGF binding molecules but not of receptor molecules. 
These data indicate that studies showing enhanced binding of labeled IGF [1,7, 
19, 36] should be interpreted with caution regarding receptor expression and 
metabolic activity. 
The degree of detecting IGFBPs with labeled IGF probably depends on the 
relative presence of binding proteins and receptors as well as on the affinity of 
IGF for these sites. IGF-1 binds with high affinity to the IGF type 1 receptor. 
On the other hand, recent studies showed that IGFBPs possess a binding 
affinity quite similar to the affinity of IGF-1 for the IGF type 1 receptor [5]. 
After staining with biotinylated IGF-1 lack of intracellular staining of surface 
zone chondrocytes was observed, in contrast to the distinct staining with 
aIGF-1 receptor antibody. This may suggest that intracellular IGF-1 binding 
sites have a low affinity for IGF-1 or that the IGF-1 binding site of the 
receptor is shielded. In fact, it may reflect internalized IGF-IGF receptor 
complexes. 
The amounts of binding sites at the cell membrane or intracellularly in 
various zones of the cartilage may provide further insight into regulation of 
metabolic activity of the cells. Intracellular staining might represent 
internalized, recycling or newly synthesized receptors, whereas staining at the 
chondrocyte surface might reflect receptors actively involved in triggering 
IGF responses. Superficial chondrocytes have low membrane expression, in 
contrast to chondrocytes in deeper zones, which is in agreement with the low 
and marked PG synthesis in superficial and deeper layers, respectively [3, 31, 
35]. The intracellular receptor pool might become important under conditions 
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of stress. It is of interest to note that after culture of human cartilage expiants 
with serum, chondrocytes show a markedly enhanced PG synthesis, mainly in 
the surface zone [16, 17, 22] First observations with immunostaining suggest 
that this shift in metabolic activity coincides with a rapid upregulation of IGF 
receptor expression on the membrane of these superficial chondrocytes 
[manuscript in preparation]. 
Arthritic conditions significantly increase the amounts of biotinylated IGF-1 
as compared with normal cartilage, whereas after staining with ccIGF-1 
receptor antibody the same amounts and distribution patterns of IGF-1 
receptor over the different cartilage zones were observed. These findings may 
indicate the presence of larger amounts of IGFBPs during joint inflammation. 
IGFBPs play a crucial role in modulating actions of IGF-1 biological function. 
IGFBPs can either bind IGF-1 with high affinity and sequester them away 
from the receptor or can present IGF-1 via the IGF-IGFBP complex to the 
receptor, improving receptor interaction. The agnostic or antagonistic nature 
of IGFBP modulation of IGF-1 biological function depends on the distinct 
property of each IGFBP. Moreover, chondrocytes from osteoarthritic cartilage 
were found to exhibit increased IGF-1 binding, higher levels of 
IGF-binding proteins and abundant staining for IGF-1 receptor, which suggests 
a defect IGF-1 bioavailability and IGF-1 anabolic action [8]. However, in 
contrast to chondrocytes from inflamed knee joints, chondrocytes from 
osteoarthritic cartilage show a markedly enhanced PG synthesis. Moreover, in 
osteoarthritic cartilage loss of the superficial layer and attempts to repair often 
disturb clear recognition of the various cartilage zones and hampers 
straightforward interpretation [6, 16, 23]. 
In conclusion, we have shown clear differences in staining after incubation 
with either aIGF-1 receptor antibody and biotinylated IGF-1 in cartilage of 
normal and experimentally-induced arthritic knee joints. Chondrocyte cell 
surface and intracellular receptor staining in chondrocytes in the different 
cartilage layers could be visualized and quantified with the use of aIGF-1 
receptor antibody. The presence of cell surface receptors might reflect 
bioactivity of chondrocytes, whereas the intracellular pool may become 
available under [pathophysiological conditions. In arthritic cartilage, higher 
amounts of intracellular biotinylated IGF-1-binding was observed, whereas 
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similar amounts and distribution patterns of IGF-1 receptor were found as in 
normal and arthritic cartilage 
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ABSTRACT 
The distribution of IGF-1 receptors and the biological response to IGF-1 
stimulation is investigated in articular cartilage of normal mouse knee joints 
and arthritic joints taken at various stages of experimentally-induced arthritis 
In situ IGF-1 receptor expression and responsiveness to IGF-1 stimulation 
were examined in murine articular cartilage at different phases in two models 
of experimentally-induced arthritis IGF-1 receptor expression was visualized 
in joint sections with the use of anti-IGF-1 receptor antibodies and quantified 
by CLSM Chondrocyte PG synthesis was measured by incorporation of 
35S-sulfate 
In control cartilage, the majority of IGF-1 receptors was found on 
chondrocytes localized in the middle and deeper zones of the cartilage, whereas 
receptor expression in surface zone chondrocytes was very low During 
culture of normal articular cartilage, IGF-1 is able to maintain chondrocyte 
PG synthesis at the in vi\o level Concurrently with the development of 
arthritis, cartilage lost its capacity to react to IGF-1, but IGF-1 stimulation 
recovered when the inflammatory response waned Shortly after induction of 
arthritis, IGF-1 receptor expression initially declined, but already returned to 
normal levels at day 1 and remained high afterwards 
The distribution of IGF-1 receptor expression in the different zones of 
normal articular cartilage reflects IGF-1 stimulation and metabolic activity of 
chondrocytes in these layers This correlation is disturbed in arthritic cartilage, 
suggesting inadequate or overruled signaling 
INTRODUCTION 
Destruction of articular cartilage is a prominent feature of inflammatory 
joint diseases such as rheumatoid arthritis [RA] [69] The mechanism 
underlying tissue damage remains largely unknown There is compelling 
evidence that products secreted by inflammatory cells, synovial lining cells or 
chondrocytes themselves are responsible for loss of proteoglycans [PGs], 
denaturation of collagen and chondrocyte death The initial deterioration of the 
cartilage matrix is probably caused by disturbance of the equilibrium between 
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synthesis and degradation of matrix proteoglycans [PGs] [21, 41, 56]. It has 
been demonstrated that mediators such as interleukin-1 [IL-1] and tumor 
necrosis factor [TNF] are important inhibitors of chondrocyte PG synthesis, 
IL-1 being more potent than TNF. Furthermore, evidence is accumulating that 
these cytokines play a crucial role in the pathogenesis of arthritis [7, 39, 42, 
48, 51, 53-55, 63]. In addition, lack of anabolic signaling might contribute to 
decreased chondrocyte PG synthesis during joint inflammation [44, 58]. 
Insulin-like growth factor-1 [IGF-1] is the most important growth factor 
that regulates cartilage PG synthesis [16, 17, 24, 26, 43, 49]. During culture 
IGF-1 is able to maintain cartilage PG synthesis at the in vivo level [16, 24, 26, 
43]. Moreover, selective elimination of IGF-1 from serum or synovial fluid 
with neutralizing antibodies results in a marked decrease in cartilage PG 
synthesis, enhanced PG breakdown and production of alternative PG subtypes 
[43, 59, 64]. IGF-1 regulates the synthesis of PG monomers with large 
dimensions in normal cartilage, whereas in arthritic cartilage the absence of 
induction of PG synthesis accompanies the preferential synthesis of PG 
monomers with only small dimensions [59, 64]. This indicates that IGF-1 
nonresponsiveness during arthritis also results in the production of alternative 
PG monomers, implicating that IGF-1 is an essential signal to maintain 
cartilage integrity. 
The biological actions of IGF-1 are mediated by high affinity binding to 
specific cell surface receptors, such as the IGF-1 type 1 and type 2 receptors 
[10, 14, 29]. These receptors differ markedly in structure and peptide-binding 
specificity [23]. In general, IGF-1 binds preferentially with high affinity to the 
type 1 receptor, which is thought to be especially important in postnatal 
growth and development [47]. The type 2 receptor is considered to be a 
regulator of the glucose and energy metabolism and displays highest affinity 
for IGF-2 [5, 9]. IGF-2 is almost exclusively a fetal peptide and is considered 
to be particularly associated with organogenesis during embryonic 
development [9, 23]. The IGF-1 type 1 receptor is a heterotetrameric 
glycoprotein comprising of 2 extracellular α subunits, that are responsible for 
ligand binding and two β subunits that span the cell membrane and contain 
tyrosine kinase activity in their cytoplasmic region [33, 50]. 
Recently, we reported that murine cartilage of knee joints at days 1 and 2 
after induction of experimental arthritis displays a state of nonresponsiveness 
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towards IGF-1 stimulation, which is not caused by a general impairment of the 
chondrocyte [44, 58]. This suggests that inhibition of chondrocyte PG synthesis 
as found during joint inflammation is at least partly caused by a defect IGF-1 
signaling. Information on IGF-1 receptor expression in normal and diseased 
cartilage is scanty. A recent study demonstrated increased IGF-1 receptor 
immunolocalization on chondrocytes in human osteoarthritic [OA] cartilage 
[12]. Data on arthritic cartilage are lacking. 
In the present study we investigated the IGF-1 receptor expression as well as 
the responsiveness to IGF-1 stimulation. Therefore, we examined patellar 
cartilage from normal and arthritic knee joints in two types of experimentally-
induced arthritis at various phases after induction of joint inflammation. The 
IGF-1 receptor was immunolocalized in different zones of the cartilage with 
the use of an antibody against IGF-1 type 1 receptor and visualized by 
conventional fluorescence microscopy as well as confocal laser scanning 
microscopy [CLSM]. In addition, receptor expression at the chondrocyte cell 
membrane was quantified on the basis of digital CLSM images, as described 
recently [65]. The effect of IGF-1 on chondrocyte PG synthesis was measured 
by incorporation of 35S-sulfate into mouse patellar cartilage. 
MATERIALS AND METHODS 
Animals 
Female C57 black/6 mice [8-12 weeks old, 20-25 g] were used. The animals 
were kept under routine laboratory conditions [21-22°C, relative humidity 
60% and a 12 hours light-dark cycle]. The mice were fed a standard 
commercial pellet diet [RHM, Hope Farms, The Netherlands] and were given 
acidified tap water ad libitum. 
Induction of arthritis 
Arthritis was induced in mouse knee joints with two different methods. 
Firstly, arthritis induction was performed by intra-articular injection of yeast 
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particles, zymosan To this end right knee joints were injected with 180 μg 
sterilized zymosan [Sigma, St Louis, MO, USA] in pyrogen-free saline This 
model is characterized by an early polymorphonuclear cell rich exudate in the 
joint space, loss of cartilage PGs and inhibition of chondrocyte PG synthesis 
Inflammation subsides within a weak and cartilage damage is reversible [44, 
56] Secondly, arthritis was induced with an antigen The antigen-induced 
arthritis, developing shortly after intra-articular injection of the antigen in 
previously immunized mice, is a more prolonged arthritis model than 
zymosan-induced arthritis [56] Mice were immunized with 100 μg methylated 
bovine serum albumin [mBSA, Sigma] emulsified in Freund's Complete 
Adjuvant [Difco Laboratories, Detroit, MI, USA] Four equally large 
subcutaneous injections were given into the flank and footpads of the 
torehmbs As an additional adjuvant 2 χ IO9 heat-killed Bordetella pertussis 
organisms [National Institute of Public Health, Bilthoven, The Netherlands] 
were injected intraperitoneally After 7 days, the mice were boosted with 100 
μg mBSA emulsified in Freund's Complete Adjuvant, divided over two equally 
large subcutaneous injections in the back Arthritis was induced at day 21 by 
intra-articular injection of 60 μg mBSA in 6 μΐ phosphate buffered saline 
[PBS] into the right knee joint, whereas the left contralateral knee joint was not 
injected at all and served as control The antigen-induced arthritis model is 
characterized by an acute synovial inflammation with numerous granulocytes, 
which changes into a chronic type of inflammation, that is characterized by 
mononuclear cells [8, 56] Similar to zymosan-induced arthritis, antigen-
induced arthritis is characterized in the acute phase of the disease by severe 
destruction of the cartilage matrix and inhibition of chondrocyte metabolism 
Mice were killed by cervical dislocation at 6 or 12, 24, 48, 72, 96 and 168 
hours after induction of arthritis and intact patellae were dissected from the 
right arthritic knee joints and left contralateral control knee joints It is known 
from previous studies that the contralateral joints show responses to the 
treatment that is identical to joints in control animals During the dissection 
process, the patellar ligaments were cut, but care was taken to leave the 
cartilage fully intact [56, 57] 
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Joint inflammation 
Joint inflammation was determined during different phases of arthritis by 
measurement of 9 9 m T c pertechnetate uptake of the knee joint Mice were 
sedated in the neck region with chloralhydrate intrapentoneally and injected 
subcutaneously with 9 9 m Tc After 20 minutes radioactivity was assessed by 
measuring both knees in a fixed position Joint swelling was expressed as the 
ratio of the 9 9 m Tc uptake in the right and left knee joints [R/L ratio] [22] A 
ratio higher that 1 1 indicates joint swelling 
Cartilage cultures 
Patellae were cultured in a medium, RPMI 1640 [Flow Laboratories, Irvine, 
Scotland] containing 2 mM glutamine, 40 μg/ml gentamycin. 0 \% ultiapure 
BS A [Sigma], with or without addition of 0 25 μg/ml recombinant human 1GF-
1 jBoehnnger, Mannheim, Germanyl The molarity of 0 25 μg/ml IGF-1 is 
4 38 10 8 All incubations were performed during 24 hours in 24 well cluster 
dishes at 37 С in a humidified atmosphere containing 5% carbon dioxide 
Proteoglycan synthesis in vitro 
Chondrocyte PG synthesis in patellar cartilage oí control joints and ot knee 
joints during different phases of arthritis was measured by the incorporation of 
"S-sulfate as described previously [11, 57] Briefly, cartilage was cultured in 
RPMI 1640 medium containing 0 1% BSA, glutamine and gentamycin in the 
presence of 6 MBq "S-sulfate [Na^SO^ Amersham, Buckinghamshire, UK] 
tor 2 hours at 37 С This was done both immediately after isolation of intact 
patellae to estimate the in vivo level of proteoglycan synthesis and after a 
24 hours culture period to estimate the level of proteoglycan synthesis after 
culture Afterwards, tissues were washed three times with PBS to remove non-
incorporated 3SS-sulfate Subsequently, patellae were fixed in 96% ethanol and 
decalcified in 5% formic acid for 3 hours, followed by stripping of the 
articular cartilage layer trom the remainder of the patellae The patellar 
Chondocyte IGF-1 receptor expression and responsiveness to IGF-1 149 
cartilage was digested in Lumasolve [Perstop Analytical, Oud Beyerland, The 
Netherlands] at 60 C. The quantity of incorporated radioactive sulfate was 
assayed by liquid scintillation counting and expressed per individual patella. 
Preparation of tissue for immunohistochemistry 
Patellae were embedded in 8% gelatin white [Sigma] in distilled water, 
frozen in liquid nitrogen and cryostat sections of the frozen mouse patellae 
were cut [7 μιη thick] on a motor-driven Bright cryostat fitted with a 
microtome with a tungsten carbide tipped knife at a cabinet temp of -25 С and 
attached to adhesive tape [Scotch tape 800, 3M, St. Paul. MN] [1, 18, 31, 37, 
60]. Sections were kept dry over silica gel and stored at -25 С until further 
use. 
Immunohistochemistry 
Cryostat sections were fixed for 10 minutes in 4% paraformaldehyde 
[Sigma], in PBS, pH 7.4, and subsequently washed in PBS containing 10% 
bovine serum albumin [BSA; Sigma], 10% gelatin and 0.3% glycine 
[Pharmacia, Upsala, Sweden]. Then, the sections were incubated for 
30 minutes at 37 С in a solution of 2 mg/ml testicular hyaluronidase [Sigma] in 
PBS to improve antibody penetration into the cartilage matrix. Thereafter, 
sections were washed in PBS, incubated for 30 minutes in PBS containing 10% 
fetal calf serum and 1% BSA in PBS and then for 24 hours at 4 С in the 
presence of the primary antibody in a concentration of 5 μg/ml in PBS in the 
presence of 1% BSA. The polyclonal rabbit anti-human type 1 IGF-1 receptor 
antibody was obtained from UBI [New York, NY, USA] and recognizes mouse 
type 1 IGF-1 receptor [30, 36]. Then, the sections were washed in PBS and 
incubated with biotinylated goat anti-rabbit secondary antibody [Vector 
Laboratories, Burlingame, USA] for 1 hour in a dilution of 1:500 in PBS in 
the presence of 1% BSA and 1% normal mouse serum. Thereafter, the sections 
were washed in PBS and exposed to streptavidin-FITC [Boehringer] in a 
concentration of 40 μg/ml in PBS. Subsequently, the slides were mounted in 
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glycerol-phenylenediamine solution [Sigma] to avoid fading of the 
fluorescence. The slides were kept at -25 С until evaluation with the CLSM. 
Control sections were incubated with either an IgG fraction of normal rabbit 
serum used in the same dilution as the primary antibody or in the absence of 
primary antibody. 
CLSM evaluation and image analysis 
Immunolabelled cryostat sections were examined with a Leica CLSM in 
combination with a Leica Fluovert microscope using the 488 nm line of an 
Argon Krypton laser as described in an earlier study [65]. The CLSM collects 
images that are almost free of out-of-focus signals and the system allows 
optical sectioning of the specimen [15, 67, 68]. In brief, the sections were 
subjected to optical sectioning and the immunofluorescence signal was 
quantified. Quantification of immunofluorescence intensity in the confocal 
images was determined by area measurement at the chondrocyte periphery 
[65]. To assess the contribution of autofluorescence and aspecific binding, the 
fluorescence signal in sections stained with control non-immune-serum was 
measured as well. 
Chondrocytes were analyzed in the deep, middle and surface zones of the 
cartilage. The average fluorescence intensity was expressed as percentage of 
the mean fluorescence intensity of chondrocytes in the control cartilage. 
Statistical evaluation of the experiments was performed with the Wilcoxon 
rank test. A ρ value of less than 5% was considered to be significant. 
RESULTS 
Chondrocyte PG synthesis and joint inflammation 
When normal patellae were cultured for 24 hours in media without serum 
or growth factors, chondrocyte PG synthesis declined to approximately 50% of 
the levels of synthesis immediately after dissection of the cartilage [44]. 
Culturing cartilage during 24 hours in the presence of 0.25-2.0 μg/ml IGF-1 
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induced a significant, dose-dependent stimulation of chondrocyte PG synthesis 
[Figure 1]. In all other experiments we have used 0.25 μg/ml IGF-1, which 
maintains PG synthesis of normal cartilage at in vivo levels. Moreover, this 
concentration is close to the physiological IGF-1 concentration in mouse tissues 
[43, 52]. 
Figure 1 
In vitro response to IGF-1 stimula­
tion of normal and zymosan-induced 
arthritic articular cartilage of mice. 
Chondrocyte PG synthesis was de­
termined by 35S-sulfate incorporation 
either immediately after isolation of 
the patellae [t=0] or, after 24 hours 
culture in media containing 
0-2.0 μg/ml IGF-1. All experiments 
were performed thrice; data represent 
the mean ± SEM expressed as per­
centage of the control value at t=0. 
*, ρ < 0.05. 
At 6 hours after the onset of zymosan-induced arthritis, the ex vivo 
chondrocyte PG synthesis was still at the same level as found in control 
cartilage and no enhanced R/L ratio of 9 9 m Tc uptake, reflecting joint swelling 
was observed [Figure 2A, B]. Within 12 hours after induction of arthritis the 
ex vivo PG synthesis of arthritic cartilage dropped to approximately 80% of 
the levels of 35S-sulfate incorporation in control cartilage, whereas at 24-72 
hours after induction 3 5S incorporation of arthritic cartilage was markedly 
reduced to approximately 50 % of the normal PG synthesis. Joint swelling was 
observed within 12 hours after the induction of zymosan-induced arthritis, 
reached a maximum at 24 hours and disappeared at 4 days after induction 
[Figure 2B]. At day 4, the inflammatory response waned and chondrocyte PG 
synthesis in the arthritic cartilage became restored. Concurrently with the 
development of zymosan-induced arthritis, i.e. reduction of PG synthesis in the 
arthritic cartilage and enhancement of joint swelling, the arthritic cartilage lost 
its capacity to respond to IGF-1 in a 24 hours culture system [Figure 2C]. Even 
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at supraphysiologically high concentrations [2.0 μ§/πι1], IGF-1 was unable to 
induce stimulation [Figure 1]. Four days after induction of arthritis, recovery 
of IGF-1 responsiveness was observed in the arthritic cartilage [Figure 2C]. 
After antigen-induced arthritis a somewhat different response was observed. 
Significant inhibition of PG synthesis in the arthritic cartilage was observed at 
first at one day after arthritis induction, suppression was more pronounced at 
days 2 and 3 and recovery of PG synthesis appeared to be retarded [Figure 2 
A]. Enhanced R/L ratio of 9 9 m Tc uptake was noted at 24 hours after antigen-
induced arthritis. Maximal joint swelling was reached within 3-4 days after 
induction of arthritis. Joint swelling started to disappear at 7 days after the 
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Figure 2 
Proteoglycan synthesis [A, C, D] and joint swelling [B] were determined at different phases 
alter induction of both zymosan-induced arthritis and antigen-induced arthritis. Proteoglycan 
synthesis was measured in patellar cartilage immediately after isolation of the cartilage [A] and 
after culture for 24 hours in the presence or absence of IGF-1 [0.25 μg/ml] [C and D]. The 
patella cultures were pulse labeled with 15S-sulfate to measure PG synthesis. The contralateral 
patellar cartilage was used as control [992 ± 272 cpm was taken as 100 % 1 5S-sulfate 
incorporation]. Joint swelling was measured by 9 9 mTc uptake. Data are expressed as the ratio of 
the 9 4" 'Tc uptake in the right and left knee joints. Data represent the mean of at least 
2 experiments and are expressed as the means ± SEM of five patellae in each group. 
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induction of arthritis [Figure 2B]. This is consistent with the significantly more 
prolonged form of arthritis in the antigen-induced arthritis model as compared 
with zymosan-induced arthritis model [56, 44]. IGF-1 stimulation of 
chondrocyte PG synthesis in the arthritic cartilage disappeared during the 
manifestation of arthritis in the antigen-induced arthritis model and was still 
not restored at day 4 [Figure 2D]. As shown for the zymosan-induced arthritis 
model, high concentrations of IGF-1 were unable to induce stimulation of PG 
synthesis in the antigen-induced arthritis model [data not shown]. 
Immunohistochemical localization of IGF-1 receptor in normal 
cartilage 
Mouse patellar cartilage sections were stained immunohistochemically to 
demonstrate IGF-1 type 1 receptor. Conventional fluorescence microscopical 
evaluation revealed that chondrocytes within the articular cartilage showed the 
presence of the IGF-1 receptor, whereas the cartilage matrix was negative 
[Figure ЗА]. Immunoreactivity was present on the chondrocyte cell surface but 
a diffuse intracellular staining was observed as well. Moreover, diffuse 
autofluorescence was found over the entire cartilage area. Background staining 
in sections that were treated with non-immune rabbit serum was negligible in 
comparison with anti-IGF-1 receptor staining [Figure 3B]. At conventional 
fluorescence microscopical level it was impossible to determine exact amounts 
of IGF-1 receptor immunoreactivity on the chondrocyte plasma membrane. 
Evaluation with CLSM showed that the chondrocyte membrane contained 
intense IGF-1 receptor immunoreactivity [Figure 3C] and allowed for exact 
measurement of non-immune serum as well as aIGF-1 receptor fluorescence 
signal. Nonspecific fluorescence and autofluorescence caused a constant level 
of background fluorescence in all cartilage layers which was consistent in all 
experiments. IGF-1 receptor immunostaining on the chondrocyte cellular 
membrane was particularly observed in chondrocytes of the middle and deeper 
zones of the cartilage, whereas chondrocytes in the surface zone did not show 
any significant specific staining for IGF-1 receptors [Figure 3D]. Chondrocytes 
in surface zones displayed fluorescence intensity similar to background 
fluorescence. 
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Figure 3 
IGF-1 receptor immunolocalization in mouse normal patellar cartilage. Cryostat sections of 
mouse patellar cartilage were stained immunocytochemically with the use of a rabbit polyclonal 
antibody against the α subunit of IGF-1 receptor that was detected with FITC labeling. 
[A] Light microscopical evaluation of the immunolocalization of IGF-1 receptor in mouse 
articular cartilage. Chondrocytes [CH] within the articular cartilage [AC] were distinctly stained, 
whereas the cartilage matrix [CM] was negative. Bar = 21.1 μιτι 
[B] Light microscopical evaluation of control staining with non-immune serum in mouse 
articular cartilage. Background was negligible in comparison with anti-IGF-1 receptor staining. 
Bar = 21.1 μιη 
[C] CLSM evaluation of the middle optical section through the depth of the chondrocyte. The 
chondrocyte membrane contained intense IGF-1 receptor immunoreactivity [arrow]. 
Bar = 3.5 μϊΏ 
[D] Overview of immunolocalization of IGF-1 receptors on chondrocytes located in different 
zones of mouse cartilage as visualized by CLSM. Chondrocytes located in the middle zone 
[MZ] and deeper zones [DZ] show bright positive staining, whereas staining of chondrocytes in 
the surface zone [SZ] was similar to background fluorescence. Bar = 1.3 ц т 
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Immunohistoehemical localization of IGF-1 receptor in arthritic 
cartilage 
Zymosan-induced arthritis 
Quantification of the fluorescence intensity on chondrocyte cell membranes 
revealed that at 6 hours after induction of arthritis chondrocytes in the deeper 
IGF-1 receptor expression [%] 
IGF-1 receptor expression MZ 
IGF-1 receptor expression DZ 
A Zymosan-induced arthritis 
0 12 24 36 48 60 72 
time [h] 
IGF-1 receptor expression [W] 
• - · — IGF-1 recaptor axpreaaion MZ 
t IGF-1 receptor expression OZ 
0 12 24 3β 48 80 72 84 9 192 time [h] 
Figure 4 
Quantification with the use of digitized CLSM images of IGF-1 receptor immunoreactivity in 
mouse patellar cartilage at various stages of either zymosan-induced arthritis [A] or antigen-
induced arthritis [B]. Fluorescence intensity was determined at the cell membranes of 
chondrocytes located in the surface, middle and deeper zones of cartilage. The data are the mean 
± SEM of 3 independent experiments and expressed as percentage of the intensity as detected in 
chondrocytes located in the same cartilage zones of normal cartilage. Background levels are 
defined as the fluorescence signal in sections stained with control non-immune serum. *, 
ρ < 0.05, by Wilcoxon rank lest. 
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Figure 5 
IGF-1 receptor immunolocalizalion in cryostat sections of mouse patellar cartilage at various 
phases of either zymosan-mduced arthritis [A] or antigen-induced arthritis [B] and visualized by 
CLSM. Bars= 1.3 μιτι 
[A] At 12 hours after zymosan-induced arthritis very weak IGF-1 receptor immunoreactivity 
was observed in the surface [S], middle [M] and deep [D] zone in comparison with cartilage 
obtained from control joints. 
[B] At 6 hours after the onset of antigen-induced arthritis low IGF-1 receptor immunoreactivity 
was observed in the surface [SJ, middle [M] and deep [D] zone in comparison with the 
fluorescence intensity found in control cartilage. 
zones still displayed normal fluorescence intensity, while chondrocytes located 
in the middle zone exhibited a reduced fluorescence signal as compared with 
chondrocytes in the middle zone of control cartilage [Figure 4A]. Within 
12 hours after induction of arthritis fluorescence intensity in both middle and 
deeper zones was significantly reduced as compared with control cartilage 
[Figure 4A and 5A]. At 24 hours after induction of arthritis, the same low 
levels of immunofluorescence staining were found. At 48 hours, chondrocytes 
located in both middle and deeper zones showed IGF-1 receptor 
immunoreactivity similar to that in control cartilage and this remained constant 
until the end of the period after induction of arthritis that was studied [Figure 
4A]. 
Antigen-induced arthritis 
In contrast with findings in patellae after zymosan-induced arthritis, 
significant low immunoreactivity was already observed at 6 hours after 
induction [Figure 4B and 5B]. Surprisingly, 24 hours after induction of 
arthritis, IGF-1 receptor staining had returned to normal levels in 
chondrocytes of both middle and deep layers. From this phase of arthritis 
onwards, the immunoreactivity in chondrocytes in the deeper zones of the 
cartilage remained constant at the level of the control cartilage. Chondrocytes 
in the middle zones showed a slight but not significant increase in fluorescence 
intensity. At day seven after induction of arthritis IGF-1 receptor 
immunoreactivity in chondrocytes of both zones had returned to the levels 
found in control cartilage. 
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DISCUSSION 
IGF-1 is known to play a key role in the regulation of chondrocyte 
biosynthetic functions [16, 24, 26, 43, 49] The lack of anabolic signaling 
during arthritis [12, 44] [Figure 1] may contribute to cartilage destruction In 
the present study we show that distribution patterns of IGF-1 receptor 
expression in the different zones of normal cartilage may reflect IGF-1 
stimulation and metabolic activity of chondrocytes in these layers 
Concurrently with the development of arthritis, cartilage looses its capacity to 
react to IGF-1, but when the inflammatory response is waning, IGF 1 
stimulation has recovered Shortly after induction of experimental arthritis a 
clear decrease in IGF-1 receptor expression was observed, whereas at later 
phases of arthritis receptor expression rapidly returned to normal levels 
In a previous study we have shown that nonresponsiveness towards IGF-1 
stimulation occurs at days 1 and 2 after induction of experimental arthritis 
[44] The results from this extended study demonstrate that in both models of 
arthritis the cartilage lost its capacity to react to IGF-1 during inflammation, 
but when the inflammatory response waned, IGF-1 stimulation recovered 
These results indicate that the phenomenon of IGF 1 nonresponsiveness is 
highly correlated with the seventy of arthritis [56] The early start of IGF 1 
nonresponsiveness in zymosan-induced arthritis and the later recovery in 
antigen-induced arthritic cartilage is consistent with the early onset of 
zymosan-induced arthritis and the more prolonged inflammation in antigen-
induced arthritis 
Regarding IGF-1 receptor expression analysis, CLSM optical sectioning of 
sections after immunolocalization of IGF-1 receptor allowed accurate 
localization and quantification of the immunoreactivity in the chondrocyte cell 
membrane 165] The majority of IGF-1 receptor immunoreactivity was 
localized in chondrocytes of the middle and deeper zones of control cartilage 
and it was very low in chondrocytes of the surlace zone [Fig 5] In human, pig 
and bovine cartilage it is known that chondrocytes in the middle and deeper 
cartilage zones display greatest metabolic activity, whereas the metabolic 
activity of superficial chondrocytes is very low [3, 25, 40, 45] On the basis of 
our data it may be concluded that differences in IGF-1 receptor expression in 
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the cartilage layers are correlated with the heterogeneity in IGF-1 stimulation 
and activity of the chondrocytes in these layers 
Moreover, there are data indicating that alterations in chondrocyte 
metabolism under pathophysiological conditions are also not uniform in the 
different zones [13, 27] In human OA cartilage high levels of IGF-1 and 
IGF-1 mRNA have been described, especially in chondrocytes located in clones 
at the surface zone [28] Furthermore, it has been shown that human OA 
cartilage was abundantly stained for IGF 1 receptor in the upper two thirds of 
the cartilage [12] It should be noted that PG synthesis is at a high level in 
osteoarthntic cartilage, in contrast with arthritic cartilage 
In view of our data it may be questioned what factors account for the drop 
in IGF-1 receptor expression shortly after induction of arthritis Under normal 
conditions IGF-1 receptor expression is regulated on the basis of receptor 
occupancy Receptors are rapidly internalized and down-regulated after IGF-1 
binding [34, 35] It remains a matter of speculation whether and how 
inflammatory mediators are involved in the reduction of IGF-1 receptors 
during the early stages of arthritis Many plasma membrane receptors such as 
antigen binding molecules, adhesion molecules as well as cytokine receptors 
have been described to decrease in number during inflammation by shedding 
[38] Portue et al [1990] [32] suggested that shedding of TNF receptors on 
activated polymorphonuclear cells might be due to cleavage by proteases 
released from inflammatory cells or by chondrocytes themselves [2, 61, 62] 
Recently we have shown that oxygen radicals produced by cells in the inflamed 
synovium are unlikely to be involved because they were unable to damage 
IGF-1 receptors in vitto [191 The early loss of receptors coincides with a 
rapid decline in proteoglycan content, which may indicate that it is caused by 
the same proteolytic enzymes released into the extracellular matrix cartilage 
The apparent discrepancy between low levels of IGF-1 receptor expression 
in cartilage from joints in early stages of arthritis versus normal responses to 
IGF-1 at these phases of arthritis may be explained by the time needed for the 
actual translation of IGF-1 receptor binding into changes of chondrocyte PG 
synthesis A lag phase of approximately 8 hours has been reported [20] 
Moreover, PG synthesis is measured after a 24 hours culture period and it is 
likely that in these early stages of arthritis the chondrocytes may recover 
during culture and upregulate their amount of IGF-1 receptors on the cell 
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membrane At present recovery of receptor expression after culture is under 
investigation in our laboratory and preliminary data indeed show a recovery of 
receptor expression in cartilage at early stages of arthritis In addition we are 
now analyzing potential changes in mRNA expression of the IGF-1 receptor 
during early phases of arthritis in our laboratory with the use of polymerase 
chain reaction technology 
Our observations at later stages of arthritis, that amounts of IGF-1 receptors 
rapidly returned to normal levels, while we still observed inhibition of PG 
synthesis, suggest that at this phase of arthritis the IGF-1 signal is overruled by 
suppressive mediators generated by the inflamed synovium Otherwise, the 
type I receptor might be masked or damaged by agents produced by the 
inflamed synovium, preventing proper IGF-1 binding Alternatively, though 
speculative, the IGF-1 receptors present on the chondrocyte cell surface during 
later phases of arthritis may have a defective molecular structure, being 
therefore unable to exhibit normal biological functions 
Taking into consideration our present results and those of previous studies 
[44, 58], we suggest that IGF-1 nonresponsiveness may play a role in 
perpetuating inhibition of chondrocyte PG synthesis Moreover, non-
responsiveness of arthritic chondrocytes is not restricted to IGF-1, but also 
extends to a range of other growth factors Basic fibroblast growth factor 
[bFGF], platelet derived growth factor [PDGF], epidermal growth factor 
[EGF], or transforming growth factor β [TGFß], in the presence or absence of 
IGF-1 were unable to stimulate chondrocyte PG synthesis during early and 
later phases of arthritis [66] It still remains unclear what mediators are 
involved in IGF-1 nonresponsiveness during experimentally induced arthritis 
Intra articular injection of IL-1 into mouse knee joints, causes inhibition of 
chondrocyte PG synthesis and enhanced PG breakdown but does not induce 
IGF-1 nonresponsiveness [4, 53-55] Moreover, when cartilage obtained from 
arthritic knee joints was cultured with anti-IL-1 neutralizing antibodies the 
state of IGF-1 nonresponsiveness was not completely abrogated [55] However, 
normal IGF 1 responsiveness was observed in arthritic cartilage when 
anti-IL-1 treatment was started in vivo, before arthritis induction These 
observations implicate that IL-1 plays an indirect and/or subordinate role in 
IGF-1 nonresponsiveness Alternatively, increased IGF-1 binding protein 
[IGFBP] production may cause IGF-1 nonresponsiveness during 
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experimentally-induced arthritis [6, 46]. Dore et al. [1993] have described that 
during osteoarthritis articular chondrocytes produce increased levels of 
IGFBP. In our experimental design decreased IGF-1 bioactivity could occur 
when tissue IGFBP production is increased. However, we found IGF-1 
nonresponsiveness even at high IGF-1 concentrations, making IGFBP 
overproduction an unlikely explanation for the lack of IGF-1 response during 
inflammation. 
In conclusion, we show that distribution patterns of IGF-1 receptor 
expression in the different zones of normal cartilage reflect IGF-1 stimulation 
and metabolic activity of chondrocytes in these layers. However, our data do 
not reveal a straight forward correlation between receptor expression and 
biological response of chondrocytes from arthritic cartilage. Therefore, the 
present study seems to implicate that caution should be taken drawing 
conclusions from receptor expression investigations without evaluating the 
biological responses triggered by receptor binding. 
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ABSTRACT 
Insulin-like growth factor-1 [IGF-1] plays a key role in the regulation of 
chondrocyte proteoglycan [PG] metabolism We investigated whether 
chondrocyte PG synthetic activity correlates with the presence of chondrocyte 
IGF-1 receptor localization in the surface, middle and deeper zones of normal 
human articular cartilage and in cartilage known to display a shift in 
chondrocyte metabolism, ι e cultured cartilage or osteoarthntic [OA] 
cartilage 
Cartilage specimens were obtained post mortem from human knees within 
18 hours after death from donors without known clinical OA history The 
samples were taken from macroscopically normally looking regions as well as 
from damaged regions with osteoarthntic appearance, yielding a range of OA 
grades from mild to moderate and severe OA We examined chondrocyte PG 
synthesis by in situ autoradiography of incorporated 35S-sulfate and 
chondrocyte IGF-1 receptor localization by immunohistochemistry followed 
by confocal laser scanning microscopical [CLSM] analysis in the same cartilage 
samples 
In normal cartilage, both the amount of chondrocyte PG synthesis and the 
level ol chondrocyte IGF-1 receptor localization are at low levels in the 
surface zone chondrocytes but both are high in middle and deeper zone 
chondrocytes Furthermore, after culture the increase in chondrocyte PG 
synthesis in the surface layer coincides with increase in IGF-1 receptor 
expression However, in mild OA particularly high levels of chondrocyte 
synthetic activity were found in the upper cartilage layer whereas IGF-1 
receptor expression was low in this layer, suggesting that factors other than 
IGF-1 are involved High chondrocyte PG synthetic activity and chondrocyte 
IGF-1 receptor staining were found in the upper and deeper layers of 
moderate OA cartilage, whereas both low levels of chondrocyte activity as well 
as IGF-1 receptors were observed in case of severe OA 
Our data indicate that IGF-1 displays cellular heterogeneity in chondrocyte 
stimulation in the various cartilage zones in normal cartilage Clear zonal 
correlation is lost in OA cartilage and patterns of chondrocyte IGF-1 receptor 
expression and PG synthesis vary with the stage of OA 
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INTRODUCTION 
In degenerative joint diseases such as osteoarthritis [OA] the equilibrium 
between degradation and synthesis of matrix molecules is disturbed [6, 10, 15]. 
Increased proteoglycan [PG] metabolism of chondrocytes in OA cartilage, 
which is probably an attempt to repair damage, is unable to overcome the 
increased losses of PG and leads to focal depletion of PG and eventually loss of 
cartilage and changes in underlying bone [23]. Biosynthetic function of 
chondrocytes is regulated by the complex effects of circulating and locally 
produced growth factors. Understanding of the influence of growth factors on 
chondrocyte metabolism during normal physiological regulation of cartilage 
remodeling, or during pathologic cartilage degradation will be a basis for 
successful intervention of cartilage degeneration. 
Insulin-like growth factor-1 [IGF-1] is an important anabolic stimulus that 
regulates chondrocyte PG biosynthesis during growth and development, 
cartilage hypertrophy and repair during adult life. [9, 14, 22, 27, 37, 40, 41]. 
IGF-1 exerts its effect by high affinity binding with specific IGF-1 type 1 
receptors [3, 21, 30, 33]. 
Chondrocytes in articular cartilage are not a uniform population of cells. 
They vary in metabolic activity and function in the different cartilage zones [2, 
24, 25, 35, 38]. Moreover, there are indications that chondrocyte PG 
metabolism alters in the different cartilage zones in cartilage diseases [4, 8, 20, 
28 ]. In human OA high levels of IGF-1 and IGF-1 mRNA have been found in 
cartilage, especially in chondrocytes of the surface zone [29]. Furthermore, 
Dore et al. [1995] showed in the upper two thirds of human О A cartilage 
abundant immunohistochemical staining of the IGF-1 receptor. 
In the present study, we examined articular cartilage obtained from human 
knees within 18 hours after death, from donors without a clinical history of 
OA. The samples were classified, yielding normal cartilage and a range of OA 
grades from mild via moderate to severe OA. The aim of our study was to 
investigate whether a correlation exists between chondrocyte synthetic activity, 
chondrocyte IGF-1 receptor expression and cartilage PG content in the 
surface, middle and deeper zones of normal cartilage. Moreover, we analyzed 
whether the well known shift in chondrocyte PG synthesis in cultured cartilage 
also coincides with a shift in chondrocyte IGF-1 receptor expression. Finally, 
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we investigated whether in the various grades of OA cartilage also a zonal 
correlation exists between the chondrocyte PG synthetic rate and IGF-1 
receptor expression. 
MATERIALS AND METHODS 
Carti lage 
Cartilage specimens were obtained, post mortem, from the central part of 
human femoral knee condyles within 18 hours after death from donors without 
a known clinical OA history. Within 1 hour post-dissection the cartilage 
samples were cut, excluding the underlying bone. The donors are described in 
Table 1; [n=10] 2 females and 8 males, ranging in age from 59 to 79 years 
with a mean age of 73 ± 6 [SEM] years. From each donor samples from 
macroscopically normal regions or pathological looking "osteoarthritic" 
regions were taken. Cartilage samples from "osteoarthritic" regions were 
classified after tissue processing and histological staining according to the 
slightly modified criteria of Mankin [20, 23][Table 1]. 
Table 1 Details of' donors included in the study 
Donor number Age Sex OA grade 
1 59 M + 
2 72 M + 
3 70 F + 
4 73 F + 
5 77 M + 
6 70 M ++ 
7 79 M ++ 
8 76 M ++ 
9 75 M +++ 
10 77 M +++ 
From each donor samples from macroscopically normal regions or pathological looking 
"osteoarthritic" regions were taken. Cartilage samples from "osteoarthritic" regions were 
classified according to slightly modified Mankin criteria [20, 23]. [+] mild fraying of the 
articular surface without the presence of cell clusters [4 on the Mankin scale]; [++] advanced 
fibrillation of the cartilage surface, characterized by deep clefts and the presence of cell clusters 
[8 on the Mankin scale]; [+++] extreme fibrillation of the cartilage, the upper cartilage layer is 
almost totally lost and chondrocytes arc only found in cell clusters [> 8 on the Mankin scale]. 
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Experimental design 
We aimed to analyze the cartilage PG content, the chondrocyte PG synthesis 
and chondrocyte IGF-1 receptor localization of the same cartilage area. 
Therefore, the isolated cartilage specimens were devided into three smaller 
cartilage pieces. Subsequently, one piece was used for histological Safranin О 
staining, one for autoradiographic localization of incorporated 35S-sulfate and 
one for immunohistochemical localization of IGF-1 receptor followed by 
CLSM analysis. Moreover, cartilage specimens were first labeled with 
35S-sulfate, frozen in liquid N 2 and autoradiographic localization of 
35S-sulfate and IGF-1 receptor immunostaining were analyzed in serial 
sections. 
Light microscopical analysis 
Cartilage samples were fixed in phosphate buffered 4% formalin [pH 7.0] 
containing 2% sucrose. Standard processing of the tissue in an automatic tissue 
processing apparatus was followed by embedding the samples in paraffin wax. 
Histological sections were stained with Safranin О and fast-green or 
Haematoxylin. 
Culture technique 
The cartilage slices were cut into square pieces, weighed [with an accuracy 
of ± 0.1 mg] and cultured individually at random for 4 days in round-
bottomed 96-well microtiter plates [200 μΐ culture medium/well, 37 C, 5% 
C 0 2 in air]. The culture medium was Dulbecco's Modified Eagle's Medium 
[DMEM, Gibco, s'Hertogenbosch, The Netherlands, 074-01600; 0.81 mM 
S 0 4
2
" ; 24 mM NaHC0 3 ] supplemented with ascorbic acid [0.85 mM], 
glutamine [2 mM], penicillin [100 U/ml] and streptomycin sulfate [100 U/ml] 
and 10% of a pool of heat-inactivated adult human male AB+ serum. 
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Radioactive labeling technique 
Immediately after obtaining the cartilage or after a culture period of 4 days, 
the samples were labeled for 4 hours with an amount of 14.8 104 Bq in 10 μΐ/ 
DMEM, N a 2
3 5 S 0 4 [Du Pont NEX-041-H, carrier free in 200 μΐ culture 
medium. After labeling the cartilage samples were rinsed three times [45 
minutes] in 1.5 ml medium and washed in 0.5 ml ice-cold PBS [20]. 
Subsequently the samples were embedded in an aqueous solution of 8% gelatin 
white [Sigma], frozen in liquid nitrogen and kept at -80°C until sectioning [1]. 
Preparation of cryostat sections 
Sections [7 μιη thick] of fresh frozen cartilage were cut in the sagital plane 
on a motor-driven Bright cryostat fitted with a tungsten carbide-tipped knife at 
cabinet temp of -25°C [16, 32]. Serial sections for autoradiography and 
immunohistochemistry were collected on poly-L-lysine coated slides. Sections 
were kept over silica gel and stored at -25 С until further use. 
Autoradiographic localization of incorporated label 
Cryostat sections were air-dried for 30 minutes, fixed for 10 minutes in 4% 
formalin dissolved in water and subsequently washed three times [5 minutes] 
with distilled water. Sections were air-dried overnight and subsequently 
covered with a photographic emulsion [K5, Ilford]; the emulsion was diluted 
1:1 with 6% gelatin and heated to 45 C. After exposure for 7-14 days, 
depending upon the autoradiographic blackening of normal cartilage, the 
autoradiographs were developed [45]. 
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Immunohistochemistry 
Cryostat sections were fixed for 10 minutes in 4% [w/v] paraformaldehyde 
[Sigma], dissolved in phosphate-buffered saline [PBS] pH 7.4, and subsequently 
washed in PBS containing 10% [w/v] bovine serum albumin [BSA; Sigma, St. 
Louis, MO, USA], 10% [w/v] gelatin and 0.3% [w/v] glycine [Pharmacia, 
Upsala, Sweden]. Sections were incubated for 30 minutes at 37 С in a solution 
of 2 mg/ml testicular hyaluronidase [Sigma] dissolved in PBS to obtain a 
comparable penetration of antibody into the matrix of normal and OA 
cartilage. Subsequently, sections were rinsed in PBS and finally treated with 
10% [w/v] fetal calf serum and 1 % [w/v] BSA in PBS for 30 minutes to block 
aspecific binding. Thereafter, sections were incubated for 24 hours at 4 С with 
mouse monoclonal antibody directed against the extracellular α subunit of 
human IGF-1 type 1 receptor [18, 34] in concentrations of 5 μg/ml in PBS 
containing 1% BSA [Oncogene Science, Manhasset., NY]. After incubation 
with the primary antibody, the slides were washed thrice in PBS. Sections were 
incubated with biotinylated horse anti-mouse secondary antibody [Vector 
Laboratories, Burlingame, USA] for 2 hours in a dilution of 1:500 in PBS 
containing 1% BSA and 1% normal human serum and biotin was demonstrated 
by exposing sections to streptavidin-FlTC [Boehringer] in a concentration of 
40 μg/ml in PBS. Subsequently sections were mounted in Vectashield mounting 
medium [Brunschwig Chemie] to avoid fading of fluorescence. As control for 
ccIGF-1 receptor antibody staining, sections were either incubated with mouse 
IgG or stained in the absence of primary antibody. Sections were kept at -25 С 
until evaluation with the use of the CLSM. 
Fluorescence CLSM and Image Analysis 
The CLSM collects images that are almost free of out-of-focus signals and 
the system allows optical sectioning of the specimen [11, 52, 53]. 
Immunostained sections were examined with a Leica CLSM attached to a Leica 
Fluovert microscope using the 488 nm line of an Argon Krypton laser fitted 
with a 510 nm dichroic mirror and a 530 nm band pass filter, as described in 
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an earlier study [48]. In brief, immunolabeled cryostat sections were subjected 
to optical serial sectioning with intervals of 0.5 μπι in the Ζ direction. 
Quantification of immunofluorescence in the confocal images was 
performed by area measurement [47, 48]. In normal cartilage the superficial, 
middle and deeper zones were easily identified [28, Figure 1]. Fluorescence 
intensity of each cartilage zone was measured in ten chondrocytes in each of 
two serial cryostat sections. The chondrocytes were randomly selected in 
horizontal direction with the use of an eyepiece grid. To assess the contribution 
of autofluorescence and aspecific binding, fluorescence signals were measured 
in sections stained with mouse IgGl. To compare the different specimens, for 
each sample the fluorescence signals in the different cartilage zones the average 
fluorescence intensity of ten chondrocytes were measured in each zone and the 
highest value in a particular zone was set at 100%. The fluorescence signals in 
the other zones was expressed as a percentage of this value. Data represent the 
mean ± SEM of 10 different donors. Statistical evaluation of the experiments 
was performed with the Wilcoxon rank test. A ρ value of less than 5% was 
considered to be significant. 
RESULTS 
Normal articular cartilage 
Sample characterization 
Figure 1A shows a representative example of articular cartilage defined as 
normal cartilage. The cartilage samples from macroscopically "normal" 
looking cartilage exhibited a smooth intact articular surface and the superficial, 
middle and deeper cartilage zones could easily be identified [28]. As 
characteristics for the various cartilage zones we used the criteria that 
chondrocytes in the surface zones were relatively small and flat, their long axis 
oriented parallel to the surface, whereas chondrocytes in the middle zone were 
larger, rounded cells existing as single entities randomly distributed in the 
articular cartilage matrix and that chondrocytes in the deeper zones had the 
largest size, usually occurring in groups. Safranin О staining of the normal 
cartilage showed intense staining of the middle and deeper zones of the 
cartilage, whereas the surface zone was devoid of staining [Table 2]. 
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Figure 1 
Human normal cartilage stained with Safranin О and Fast green [A], zonal distribution of in situ 
autoradiographic staining of incorporated 35S-sulfate [B] and digital images of IGF-1 receptor 
immunostaining [C]. Zonal distribution of in situ autoradiographic staining of incorporated 35S-
sulfate [B] and digital images of IGF-1 receptor immunostaining [C]. For in situ 
autoradiography, the cartilage was labeled with 35S-sulfate. For IGF-1 receptor localization 
cryostat sections were stained immunohistochemically and analyzed with CLSM. 
A] The representative example of normal human articular cartilage obtained from 
macroscopically "normal" looking cartilage regions cartilage exhibited a smooth intact articular 
surface and the surface zone [S], middle zone [M] and deeper cartilage zones [D] could easily 
be identified. [Magnification 20 x] 
B] Chondrocytes in the surface zone showed only low levels of 35S-Sulfate incorporation, 
whereas chondrocytes in the middle and deeper zones of the cartilage displayed distinct amounts 
of incorporated label. [Magnification 20 x] 
C] IGF-1 receptor immunostaining of chondrocytes in the surface zone [S] was similar to 
background fluorescence levels, whereas chondrocytes in the middle [M] and deeper zone [D] 
showed clear IGF-1 receptor immunoreactivity. Bars = 8.5 μιτι 
176 Chapter 8 
Autoradiographic localization of 35S-sulfate incorporation 
Figure IB shows the autoradiographic staining of incorporated 35S-sulfate in 
normal cartilage. Chondrocytes in the surface zone show only low levels of 
sulfate incorporation, whereas chondrocytes in the middle and deeper zones of 
the cartilage display distinct amounts of incorporated label [Table 2]. 
IGF-1 receptor staining 
The IGF-1 receptor immunostaining pattern of normal cartilage closely 
corresponded with the autoradiographic localization of incorporated 
35S-sulfate in normal cartilage. Immunostaining with the 0tIR-3 monoclonal 
antibody against the IGF-1 receptor resulted in a clear staining of chondrocytes 
in the middle and deeper zones [Figure 1С]. Staining of chondrocytes in the 
surface zone was similar to background fluorescence levels. Control sections 
stained either with mouse IgGl or in the absence of primary antibody showed 
a faint level of background staining [Table 2]. 
Fluorescence signal • t=0 
Surfte· zone Middle zone Deeper zone Background 
Figure 2 
Quantification of the fluorescence signal expressed as percentage in normal human cartilage 
after incubation with monoclonal cdGF-1 receptor antibody. Fluorescence signal was examined 
in cartilage immediately after isolation of the cartilage or after culture for 4 days in the presence 
of 10% serum. Fluorescence intensity was measured in the surface, middle and deeper zone of 
the cartilage. The highest fluorescence intensity measured in any particular zone was taken at 
100% and fluorescence intensity in the other zones was expressed as a percentage of this value. 
The data are the mean ± SEM of four independent experiments. In all cartilage layers 
background fluorescence was similar. * = mean value is significant different from background 
fluorescence [p < 0.05] as determined by Wilcoxon rank test. 
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Quantification of the immunofluorescence intensity of chondrocytes located in 
the different cartilage zones is represented in Figure 2. The fluorescence 
intensity was determined in the middle optical section of chondrocytes in the 
surface, middle and deeper zones by area measurement. The fluorescence 
intensity of chondrocytes located in the middle or deeper zones of the cartilage 
was significantly higher than that of chondrocytes in the surface zone, while 
the intensity of chondrocytes in the surface zone was similar to background 
intensity. The background fluorescence intensity was at a similar level in all 
cartilage layers with no significant variation between the independent 
experiments. 
ait * TL· 
A 
Figure 3 
Upregulation of the in situ au­
toradiography staining of 
incorporation of 35S-sulfate [A] 
[Magnification 20 x] and IGF-1 
receptor immunostaining [B] 
[Bars = 8.5 μιτι] in the surface 
zone of human normal cartilage 
cultured for 4 days in 10% 
serum. For details see Figure 2. 
Normal articular cartilage after culture 
After culture of normal cartilage for 4 days in the presence of 10% serum a 
pronounced significant increase in 35S-sulfate incorporation was observed in 
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chondrocytes in the superficial zone [Figure 3AJ "S-sulfate incorporation in 
chondrocytes of the middle and deeper zones was slightly increased [Table 2] 
These observations coincide with our findings that the immunostaining of 
the IGF-1 receptor was also enhanced in chondrocytes in the surface zone 
[Figure 3B] Quantification of the fluorescence intensity revealed a significant 
increase in IGF-1 receptor immunostaining in chondrocytes in the surface zone 
as compared with the fluorescence intensity in chondrocytes in the surface zone 
immediately after isolation of the cartilage [Figure 2] 
OA cartilage 
Sample chaiactenzation 
Cartilage specimens were obtained post тонет trom donors without known 
clinical OA history The samples were taken trom damaged regions with an 
"osteoarthntic" appearance and this yielded a wide range of OA grades upon 
microscopical analysis A summary r shown in Table 1, demonstrating that we 
collected samples with severe OA [n=2], moderate OA [n=3], but mainly 
specimens with mild pathology [n=5] 7onal variation in chondrocyte 
appearance as found in normal cartilage, was not present anymore in OA 
cartilage Analysis oí OA cartilage was performed in regions classified as 
upper and deeper layers The characteristic Safranin О staining of the defined 
OA categories is shown in Figure 4 Reduction of Safranin О staining in the 
upper layer of the cartilage was found in all samples [Table 2] Since the 
severity of OA can vary at various sites of one specimen, special care was 
taken to analyze the chondrocyte PG synthesis and chondrocyte IGF-1 receptor 
staining in one area Therefore, the samples were devided in two neighboring 
specimens that were used for either autoradiography or receptor staining 
Autoradiographic localization of 35S-sultate incorporation 
The autoradiographic localization of incorporated 15S-sulfate showed distinct 
patterns in the three OA categories [Table 2] In the cartilage categorized as 
relatively mild OA, autoradiographic localization did not show the zonal 
variation as found in normal cartilage The mild OA cartilage appeared to 
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Figure 4 
Characteristics of cartilage obtained from dam­
aged cartilage regions with an "osteoarthritic" 
appearance stained with Safranin and Fast 
Green. The cartilage samples were classified 
according to slightly modified Mankin criteria 
[23, 20]. 
Mild fraying of the articular surface without 
the presence of cell clones is defined as mild 
OA [+] [A]. Advanced fibrillation of the carti­
lage surface, characterized by deep clefts and 
the presence of cell clones is classified as 
moderate О A [++] [B]. Extreme fibrillation of 
the cartilage, the upper layer is almost totally 
lost and chondrocytes are only found in clus­
ters is defined as severe О A [+++] [C]. All 
OA samples showed reduction of Safranin О 
staining in the upper layer of the cartilage. 
Zonal variation in chondrocyte appearance as 
found in normal cartilage was not present in 
OA cartilage. Therefore, the upper and deeper 
layer were defined as < 150 ц т from the ar­
ticular surface and > 150 μιτι from the articular 
surface, respectively. [Magnification 20 x] 
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Figure 5 
Distribution of in situ autoradiographic localization of incorporated "S-sulfale [A, C, E] 
[Magnification 20 x] and IGF-1 receptor staining [B, D, F] [Bars = 8.5 μιτι] in the three defined 
OA categories; mild OA [A, B], moderate OA [C, D] and severe OA [E, F]. 
Mild OA cartilage shows no zonal variation in chondrocyte PG synthesis but appears to be 
uniformly stained [A]. Chondrocytes in the upper layer of mild OA cartilage display IGF-1 
immunoreactivity similar to background staining, whereas staining of chondrocytes in the 
deeper layer is obviously high [B] Moderate OA cartilage shows an apparent high PG 
synthesis both in upper and deeper cartilage layer [C]. Chondrocytes in moderate OA cartilage 
show an intense IGF-1 receptor staining in upper and deeper layer [D]. Severe OA cartilage 
exhibits only very low levels of chondrocyte PG synthesis [E]. Chondrocytes in severe OA 
cartilage display immunostaining indistinguishable from background fluorescence throughout 
the whole cartilage sample [F]. 
be uniformly stained. Chondrocytes in the upper and deeper layer of the 
cartilage exhibited distinct amounts of incorporated 3 5S-sulfate [Figure 5A]. 
The same staining pattern was evident in more severe OA cartilage lesions. 
The cell clones located in the upper cartilage layer displayed distinct amounts 
of autoradiographic staining and the chondrocytes in the deeper layers showed 
high levels of staining [Figure 5C]. However, О A cartilage categorized as 
extremely severe demonstrated only very low levels of autoradiographic 
staining [Figure 5E]. The upper layer of the cartilage could not be 
distinguished anymore and chondrocytes in the deeper layer showed only faint 
35S-sulfate incorporation. 
IGF-1 receptor immunostaining of cartilage from the three OA categories 
showed a diverse staining pattern between the categories [Table 2]. Relatively 
mild О A cartilage showed zonal variation in IGF-1 receptor immunoreactivity. 
Chondrocytes in the upper layer of the cartilage displayed immunoreactivity 
similar to background staining whereas the staining in chondrocytes in the 
deeper layer was obviously high [Figure 5B]. In more severe OA cartilage the 
zonal variation was lost; chondrocytes in both the upper and deeper layer 
exhibited a prominent intense IGF-1 receptor staining [Figure 5D"|. In the 
extreme OA cartilage samples, when the upper layer had disappeared, the 
immunostaining was indistinguishable from background fluorescence 
throughout the whole cartilage sample [Figure 5F]. 
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Table 2 
Normal 
Normal 
after culture 
OA + 
OA++ 
surface 
middle 
deep 
surface 
middle 
deep 
upper 
deeper 
upper 
deeper 
PG content 
-
++ 
++ 
_ 
++ 
-
++ 
PG synthesis 
-
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
+++ 
IGF-1 receptor 
-
++ 
++ 
++ 
++ 
++ 
_ 
++ 
+++ 
+++ 
OA+++ uppei 
Chondrocyte PG synthesis, chondrocyte IGF-1 receptor immunoreactivity and cartilage PG 
content in human normal cartilage or normal cartilage after culture for 4 days in the presence of 
serum as well as cartilage from different grades ol OA. [-] no staining; [±] very moderate 
staining; [++] distinct positive staining; [+++] extreme intense positive staining. 
DISCUSSION 
Chondrocyte biosynthetic function plays a key role to maintain the integrity 
of the articular cartilage matrix [13]. IGF-1 is the most important anabolic 
factor, regulating chondrocyte PG synthetic rate by binding to the type 1 
IGF-1 receptor on the chondrocyte membrane [3, 9, 14, 21, 22, 27, 30, 33, 37, 
40, 41]. Moreover, articular cartilage chondrocytes located in the various 
cartilage zones exhibit heterogeneity in their metabolic activity [2, 25, 35, 38]. 
We investigated whether chondrocyte PG synthetic activity, chondrocyte IGF-1 
receptor localization and cartilage PG content are correlated in the various 
cartilage zones of normal cartilage human, and in cartilage known to display a 
shift in chondrocyte metabolic activity, i.e. cultured cartilage and OA 
cartilage. Because OA lesions occur focally throughout the cartilage, we 
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analyzed chondrocyte activity and chondrocyte IGF-1 receptor localization in 
the same cartilage samples. 
In normal cartilage both chondrocyte PG synthesis, IGF-1 receptor 
localization as well as cartilage PG content were at low levels in chondrocytes 
located in the surface zone but particularly high in chondrocytes in the middle 
and deeper zones. These data indicate that IGF-1 receptor expression in the 
different cartilage layers reflects heterogeneity in IGF-1 stimulation and 
metabolic activity of chondrocytes in these layers. Surface zone chondrocytes 
have been described to exhibit structural, biochemical and biomechanical 
changes during culture but also in conditions of cartilage pathology [12, 31, 
39, 50, 51]. It remains to be seen whether IGF-1 itself is a regulatory factor in 
some of these pathologic events. After culture of the normal cartilage, high 
levels of both chondrocyte PG synthesis and chondrocyte IGF-1 receptor 
localization were still found; but the distinct zonal distribution of both 
chondrocyte synthetic activity and IGF-1 receptor localization disappeared. 
The shift in distribution of chondrocyte metabolic activity has been reported 
earlier in bovine as well as human cartilage expiant cultures [17, 20, 25]. In the 
present study, we have shown that this shift in chondrocyte synthetic activity is 
correlated with the amount of chondrocyte IGF-1 receptor. Therefore, IGF-1 
stimulation may contribute to upregulation of the biosynthetic activity of 
resting surface zone chondrocytes during culture. 
In earlier studies that examined the role of IGF-1 in the regulation of OA 
cartilage metabolism, cartilage samples were taken from patients undergoing 
knee athroplasty, representing moderate to severe OA cartilage [7, 29]. Our 
OA samples that were obtained post mortem from donors without known 
clinical OA history, ranged from very mild OA lesions to moderate and 
extremely severe OA pathology. The very mild OA lesions analyzed in the 
present study are of particular interest; they display a specific pattern that may 
occur in the very beginning of OA. In mild OA cartilage the synthetic activity 
of chondrocytes in the upper cartilage layer was markedly high: the 
chondrocyte PG synthetic rate was equally distributed over the cartilage 
specimen. These findings are in line with observations in early experimental 
OA [46]. The particularly high levels of synthetic activity in the upper 
cartilage layer indicate that the demand for matrix repair is highest in this 
layer. Remarkably, in the mild OA cartilage, chondrocytes in the upper layer 
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displayed low levels of IGF-1 receptor, whereas chondrocytes in the middle 
and deeper layers displayed pronounced levels of IGF-1 receptor These results 
reveal that the role of IGF-1 in the regulation of chondrocyte PG synthesis in 
the upper cartilage zone in early OA may be of minor importance Of interest, 
cartilage from OA lesions has been proven to be much more sensitive to 
stimulation with TGFß than normal cartilage [19] In addition to these in vitro 
findings, we have recently shown that repeated intraarticular injections of 
TGFß m the murine knee joint caused marked upregulation of chondrocyte PG 
synthesis, a significant rise in cartilage PG content and a clear development of 
osteophytes [42, 43] This situation closely resembles the hypertrophic phase in 
early experimental OA, indicating that TGFß plays an important role in 
processes during early OA [44] 
Furthermore, in moderate OA cartilage both chondrocyte synthetic activity 
and chondrocyte IGF-1 receptor expression were at high levels The high 
chondrocyte synthetic activity is known not to reflect a high cartilage PG 
content in this type of cartilage This discrepancy in quality of the cartilage and 
chondrocyte synthetic activity implies that during this phase of OA the 
chondrocytes synthesize aberrant PG subtypes causing a less stable articular 
cartilage matrix Regarding the severe OA cartilage our data show that both 
chondrocyte metabolism and IGF-1 receptor localization are at low levels This 
points to an end stage of OA in which no longer an attempt at increased matrix 
replacement occurs At later stages of OA focal loss of cartilage, enhanced 
expression of proteolytic enzymes and an imbalance with natural enzyme 
inhibitors have been described [5, 26] 
In addition, in a previous study we have examined chondrocyte synthetic 
activity and chondrocyte IGF-1 receptor expression in experimental 
inflammatory arthritis [36, 49] In contrast to the high chondrocyte metabolic 
activity in OA cartilage, chondrocyte PG synthesis is markedly inhibited 
shortly after the induction of joint inflammation The cartilage had lost its 
capacity to respond to IGF-1 stimulation, whereas the amounts of IGF-1 
receptors were at normal levels [49] In comparison with the data found in 
mild OA cartilage, chondrocyte metabolic activity and chondrocyte IGF-1 
receptor expression correlation were disturbed, suggesting inadequate or 
overruled signaling 
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In summary, in normal cartilage both the amount of chondrocyte PG 
synthesis and chondrocyte IGF-1 receptor localization are at low levels in 
surface zone chondrocytes and high in middle and deeper zone chondrocytes. 
This indicates that IGF-1 displays cellular heterogeneity in chondrocyte 
stimulation in the various cartilage zones. After culture, the shift in 
chondrocyte PG synthesis is correlated with an increased IGF-1 receptor 
expression in the surface zone. Therefore, IGF-1 stimulation contributes to 
upregulation of resting surface zone cells during culture. In mild OA, the 
particularly high levels of chondrocyte synthetic activity in the upper cartilage 
layer did not correlate with amounts of IGF-1 receptor, indicating that other 
factors play a role in the chondrocyte regulation in this phase of О A. The 
pronounced high chondrocyte PG synthetic activity and chondrocyte IGF-1 
receptor staining in moderate OA cartilage may represent an active attempt at 
repair, whereas the low levels of chondrocyte activity and IGF-1 receptor 
localization in severe OA may be indicative of an end stage of OA. 
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ABSTRACT 
The use of immunohistochemical detection techniques and fluorescent 
molecular probes in light and fluorescence microscopy allows accurate and 
specific analysis of a great variety of cell and tissue components However, 
when staining yields only low intensity levels, serious problems may arise with 
discrimination of specific signals against background staining This problem is 
often inherent with articular cartilage research Application of confocal laser 
scanning microscopy [CLSM] can circumvent these problems The CLSM 
collects images that are almost free of out-of-focus signals, which results in 
improved spatial resolution and discrimination as compared with conventional 
microscopy Moreover, CLSM allows optical sectioning of specimens and 
three-dimensional reconstruction of the microscopical object Quantitative 
evaluation oí microscopical images is hampered by out-of-tocus signals 
because they interfere with specific signals in the image Interfeience ot these 
nonspecific signals can be diminished by application of CLSM, in CLSM only 
one single point in micioscopical objects is illuminated at any time and this 
point is than imaged into the pinhole at the entrance of the photo detector and 
subsequently digitized The present review is a discussion ot the present state 
of the ait m digital imaging with the use of CLSM in cartilage research This 
discussion includes aspects such as sensitivity, specificity, spatial resolution and 
accuracy ot quantitative analysis in microscopical nnmunofluorescent objects 
CLSM in articular cartilage research 
In the field ot in situ cartilage research only few reports are available 
describing the use ot CLSM Some recent studies will be highlighted here 
demonstrating the advantage of CLSM over conventional microscopy to 
localize and quantify immunofluorescence in cartilage tissue 
Improved spatial resolution ot immunofluorescent signals in cryostat 
sections of cartilage, cultured cartilage slices or isolated cells has been obtained 
with the use of CLSM This advantage enables to gain detailed information 
about the in situ localization of matrix molecules [58] For instance Wotton et 
al [19911 demonstrated that type IX collagen is localized preferentially in a 
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very small area around individual chondrocytes in cryostat sections of 
chondrons Moreover, type VI collagen distribution patterns were analyzed 
with CLSM by Poole et al [1992] in isolated chondrons embedded in agarose 
monolayers Type VI collagen was found in the pericellular matrix around 
chondrocytes Staining was lower in the tail region of chondrons and in the 
interconnecting segments between adjacent chondrons, whereas lowest amounts 
of staining were observed in territorial and interterritorial matrices On the 
basis of these observations, a dual role of type VI collagen in the maintenance 
of chondron integrity was suggested By binding of the radial collagen network 
it stabilizes collagens, proteoglycans and glycoproteins of the pericellular 
microenvironment Furthermore, it provides anchorage and signaling between 
the pericellular matrix and the nucleus of chondrocytes by mediating 
interactions via specific cell surface receptors on chondrocytes CLSM analysis 
of fixed and stained preparations of isolated chondrocytes revealed 
heterogeneous intracellular distribution patterns of cathepsin В immuno 
fluorescence in relation to differentiation of chondrocytes [60] 
Metabolic events can also be directly monitored with CLSM in living cells, 
cultured tissue or slices of vital tissue Metabolic studies in living biological 
material will become increasingly important in the coming years [11, 28, 51] 
Wuthier et al [1993] measured Ca2+-fluxes over the cell membrane of 
chondrocytes in slices of living cartilage by using a fluorescent Ca2+-probe and 
digital images In that study, the application of CLSM provided the opportunity 
to link calcification processes at the cell membrane with exact localization of 
certain metabolic processes Guilac [1994] reported morpho-metric data of 
living chondrocytes in situ as obtained with CLSM 
The possibility of making optical sections through the depth of specimens is 
another important advantage of CLSM [21, 59] Hirsch and Svoboda [1993] 
demonstrated that evaluation of optical sections obtained by CLSM of intact 
tissue samples after immunohistochemistry or in situ hybridization gave 
similar results as the analysis of conventionally stained tissue sections 
Localization of mRNA of F-actin as part of the cytoskeleton as well as mRNA 
of type II collagen and collagen containing endoplasmatic reticulum could be 
demonstrated in optical sections of intact chicken embryonic sterna This 
indicates that CLSM optical sectioning can replace conventional sectioning with 
advantage of keeping cell and tissue architecture intact 
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Although CLSM implies the digitization of a well-defined volume [30, 52, 
57], surprisingly few attempts have been made to obtain quantitative 
information from digital images in cartilage research [9]. We have used CLSM 
for quantitative evaluation of fluorescence signals in cartilage by localizing and 
quantifying insulin-like growth factor-1 [IGF-1] receptor expression in situ in 
cryostat sections of mouse articular cartilage [54]. Analysis of distribution 
patterns in chondrocytes by conventional microscopical images did not allow 
precise localization of receptor immunoreactivity in relationship with the 
plasma membrane [Figure 1]. However, optical sectioning and CLSM analysis 
enabled us to distinguish IGF-1 receptor immunoreactivity on chondrocyte cell 
membranes from intracellular staining [Figure 2]. Two approaches were 
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Figure 1 
IGF-1 receptor immunolocalization in normal 
mouse patellar cartilage. Cryostat sections 
were stained with the use of a rabbit 
polyclonal antibody against the α subunit of 
the IGF-1 receptor. Antigen-antibody binding 
is demonstrated by FITC labeling and 
evaluated with conventional fluorescence 
microscopy. 
[A] Fluorescence microscopical image of 
chondrocytes [CH] within the articular carti­
lage [AC] were clearly stained, whereas the 
cartilage matrix [CM] was negative after 
staining with the antibody. Bar = 13 μιτι 
[B] Fluorescence microscopical image of con­
trol sections after staining with the use of non­
immune rabbit serum shows low background 
staining. Bar = 13 μτη 
Quantitative CLSM in cartilage research 193 
Figure 2 
CLSM evaluation of 
eight consecutive 
optical sections [1-8] 
of a chondrocyte 
recorded at 0.5 μπι 
intervals after being 
immunohistochemi-
cally stained for the 
IGF-1 receptor. The 
chondrocyte mem­
brane contained in­
tense IGF-1 receptor 
immunore activity 
[arrow], whereas in-
tracellularly a weak 
granular staining was 
displayed. 
Bar= 3.5 μπι 
194 Chapter 9 
applied to quantify the low levels of fluorescence that were obtained after 
IGF-1 receptor staining. In the following sections, we describe our approach to 
analyze and quantify with CLSM in situ localization patterns of IGF-1 receptor 
in murine normal or arthritic intact patellae either or not after culture as well 
as in human normal and osteoarthritic articular cartilage samples. This 
approach yielded information from the chondrocyte in situ that could not be 
obtained either with conventional microscopy or biochemical methods. 
IGF-1 receptor expression in normal mouse articular cartilage 
We have utilized CLSM to analyze the presence of IGF-1 type 1 receptors 
on chondrocytes in different zones of articular cartilage in mouse knee joints 
[54]. IGF-1 is an essential anabolic growth factor for the regulation of 
chondrocyte biosynthetic functions, exerting its effects by binding to the IGF-1 
type 1 receptor on chondrocyte plasma membranes [8, 14, 17, 20, 23, 26, 31, 
33, 35 42, 45, 46]. It is known that chondrocytes in different zones of cartilage 
vary with respect to their metabolic state [1, 5, 25, 39, 40, 44]. Receptor 
expression on membranes of isolated chondrocytes was analyzed with the use 
of affinity labeling [7]. In this study, chondrocytes were isolated by enzymatic 
digestion of the cartilage and subsequently cultured with serum to be used for 
125I-IGF-1-binding studies. However, these biochemical techniques may 
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Figure 3 
Immunolocalization of IGF-1 receptors on chondrocytes localized in different zones of mouse 
cartilage and visualized by CLSM. 
[A] Overview of surface, middle and deeper zones of articular cartilage. Chondrocytes fixed in 
the middle zone [MZ] and deeper zones [DZ] show bright positive staining at the chondrocyte 
periphery. Chondrocytes in the surface zone show fluorescence that is similar to background 
fluorescence. Bar = 8 μιτι 
[B] Higher magnifications of IGF-1 receptor immunolocalization on chondrocytes located in the 
different zones of mouse cartilage as visualized by CLSM. The cell surface of chondrocytes 
located in the middle zone [MZ] and deeper zone [DZ] show bright positive staining, while 
staining of chondrocytes in the surface zone [SZ] display intracellular staining only. 
Bars = 1.5 μτη 
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introduce artifacts due to isolation procedures and give only information about 
the total receptor amount and do not provide topographic information. 
Therefore, we attempted to detect IGF-1 receptors with the use of 
immunofluorescence in cryostat sections of intact undecalcified normal mouse 
patellae [36] using either a polyclonal antibody against the extracellular subunit 
of type 1 IGF-1 receptor [32, 38, 54] or biotinylated IGF-1. Control sections 
were treated with non-immune rabbit serum or irrelevant biotinylated proteins 
with similar isoelectric point [PI] and molecular weight [MW] as biotinylated 
IGF-1. The immunolabelled sections were subjected to optical serial sectioning 
with a Leica CLSM providing images in the X-Y plane; images were recorded 
with intervals of 0.5 μπι in the Z-direction. Chondrocytes located in the 
different zones of the cartilage were randomly selected with the use of a raster. 
For excitation of FITC, the 488 nm line of an argon-krypton laser was used 
and for emission a 510 nm dichroic mirror and a 530 nm band pass filter. The 
use of the anti-fading agent phenylenediamine largely prevented fading of the 
fluorescence caused by laser light excitation [22]. 
Conventional microscopical evaluation of fluorescent IGF-1 receptor 
staining revealed that sections showed a veil of aspecific fluorescence 
interfering with the specific staining of the receptor. Control sections showed 
low background staining and in sections stained for IGF-1 receptor, 
chondrocytes within the articular cartilage were positively stained for the 
receptor, whereas the cartilage matrix remained negative [Figure I]. CLSM 
images demonstrated greater spatial resolution than traditional microscopical 
images. With the use of aIGF-1 receptor antibody intense immunoreactivity 
was found on the chondrocyte periphery and weak staining intracellular^ 
[Figure 2]. CLSM analysis revealed that IGF-1 receptor staining at the 
chondrocyte cell surface was particularly present in chondrocytes of the 
middle and deeper zones of cartilage, whereas chondrocytes in the surface zone 
displayed a distinctly less bright peripheral signal [Figure 3]. On the other 
hand, high IGF-1 receptor immunoreactivity was found intracellularly in 
chondrocytes located in the surface zone of cartilage. 
Evaluation of optical sections revealed that staining with biotinylated IGF-1 
gave consistently higher amounts of intracellular fluorescence intensity after 
staining with biotinylated IGF-1 than with antibodies against the IGF-1 
receptor, although the exact intracellular localization, e.g. localization in 
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endoplasmatic reticulum or other cellular compartments, could not be 
established [Figure 4] An explanation for this phenomenon might be that 
biotinylated IGF-1 may also bind to IGF-1-binding proteins [IGFBP] IGFBPs 
show binding affinity for IGF-1 which is comparable to that of IGF-1 for the 
IGF-1 type 1 receptor [2] Therefore, our observations seem to indicate that 
when labeled growth factors are used, caution should be taken when drawing 
conclusions about the expression of a particular type of receptor, because this 
method may not solely detect the receptor only Along this line it is 
noteworthy that labeled growth factors are frequently used to detect the 
growth factor receptor in cancer research, and that enhanced expression is 
often interpreted as an indication of growth Future studies with anti-receptor 
antibodies would establish whether this is the case 
Quantification of immunofluorescence indicating IGF-1 receptor expression 
was performed in two ways [54] One approach was point measurement by 
determining in the sections of a series of optical sections the fluorescence 
intensity of eight pixels evenly distributed over the chondrocyte periphery 
The mean fluorescence intensity of these pixels was taken as a measure of 
immunoreactivity To assess the contribution of autofluorescence and aspecific 
binding, the fluorescence signal in sections stained with control non-immune 
serum was measured as well The second approach was area measurement by 
determination of fluorescence intensity of the chondrocyte periphery by 
manually setting a window over the chondrocyte periphery with a width of 
0 2μπι The CLSM instrument software provides the averaged intensity 
[χ/μπι2] as found in the window Again, nonspecific fluorescence was 
determined in control sections In general, both methods yielded comparable 
and reproducible results, demonstrating the validity of the quantitative 
approach The amount of background fluorescence in the different cartilage 
layers as determined with both methods was relatively high in comparison with 
total fluorescence This is an inherent problem of low levels of antigen and 
high levels of autofluorescence in cartilage specimens However, both 
quantification methods clearly demonstrated that the fluorescence intensity of 
chondrocytes located in middle and deeper zones of the cartilage was 
significantly higher than that of chondrocytes located in the surface zone 
[Figure 5] The fluorescence intensity signals of chondrocytes in the surface 
zones did not raise above levels of control fluorescence [Figure 5] The 
Figure 4 
CLSM evaluation of 
the localization of IGF-
1 receptor in mouse 
normal articular 
cartilage stained with 
either a polyclonal 
antibody against IGF-1 
receptor [A] or with 
biotinylated IGF-1 [Bl 
in consecutive optical 
sections [1-8] through 
the depth of the 
chondrocyte. 
Bars = 4 (im 
[A] Chondrocytes 
stained with a poly­
clonal antibody against 
the α subunit of the re­
ceptor showed that the 
cell membrane con­
tained intense IGF-1 
receptor immunoreac-
tivity, whereas intracel-
lularly a weak granular 
staining was displayed. 
[B] Chondrocytes 
stained with biotiny­
lated IGF-1 showed a 
higher amount of intra­
cellular fluorescence in 
comparison with an an­
tibody against the 
IGF-1 receptor. 
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application of CLSM was essential to find these differences in receptor 
expression in chondrocytes in the different zones of intact murine articular 
cartilage, indicating that probably IGF-1 stimulation and metabolic activity of 
chondrocytes in these layers is heterogeneous. 
Fluorescence signal 
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Area measurement 
Point measurement 
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Figure 5 
Quantification of the fluorescence 
signal of IGF-1 receptor im-
munoreactivity on chondrocyte 
membranes as detected in confo-
cal images after incubation with 
polyclonal anti-IGF-1 receptor 
antibody. Nonspecific fluores­
cence is assessed in images of 
chondrocytes incubated with non­
immune rabbit serum. Point mea­
surement of fluorescence intensity 
on chondrocytes located in the 
different zones of the cartilage, 
i.e. the surface, middle and 
deeper zones, is compared with 
area measurement. Fluorescence 
intensity was measured in ten 
chondrocytes in each cartilage 
layer in two serial sections. The 
data are the mean ± SEM of four 
i n d e p e n d e n t exper iments , 
expressed as percentage of the 
highest value of each experiment. 
*, mean value is significantly 
different from the mean value in 
the surface zone [p < 0.05] by 
Wilcoxon rank test. 
IGF-1 receptor expression in diseased mouse arthritic cartilage 
In knee joints with experimentally-induced arthritis the articular cartilage is 
severely destroyed, which is thought to be evoked by accelerated degradation 
of matrix components accompanied by inhibition of chondrocyte proteoglycan 
synthesis and synthesis of proteoglycan molecules with inferior integrity [41, 
50, 55]. Moreover, there is compelling evidence that lack of anabolic signaling 
might contribute to the decrease in chondrocyte proteoglycan synthesis. In 
contrast with the ability of IGF-1 to sustain chondrocyte proteoglycan synthesis 
in normal murine cartilage during culture, chondrocytes from experimentally-
induced arthritic knee joints do not respond to IGF-1 in culture [43, 49, 56]. 
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Figure 6 
IGF-1 receptor immunolocalization in cryostat sections of mouse patellar cartilage at various 
phases of zymosan-induced arthritis and visualized by CLSM. 
[A] At 12 hours after zymosan-induced arthritis very weak IGF-1 receptor immunoreactivity 
was observed in the surface [S], middle [M] and deeper [D] zones. Bar = 8 μιη 
[B] Quantification with the use of digitized CLSM images of IGF-1 receptor immunoreactivity 
in mouse patellar cartilage at various stages of zymosan-induced arthritis. Fluorescence intensity 
was determined at the cell membranes of chondrocytes located in the middle zone [MZ] and 
deeper zones [DZ] of cartilage. The data are the mean ± SEM of 3 independent experiments and 
expressed as percentage of the intensity as detected in chondrocytes located in the same cartilage 
zones of normal cartilage. *, ρ < 0.05, by Wilcoxon rank test. 
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We hypothesized that nonresponsiveness to IGF-1 stimulation as observed in 
experimentally-induced arthritis may reflect reduced levels of chondrocyte 
IGF-1 receptors during the inflammatory response in the joint. With the use of 
CLSM we were able to demonstrate that after induction of arthritis, receptor 
expression declines during a short period of time in all cartilage layers [6-24 
hours after induction of arthritis] [Figure 6]. In later stages of arthritis, 
amounts and localization patterns of IGF-1 receptor in the various cartilage 
layers were not different from that in control cartilage [Figure 6]. Thus at 
these later stages of arthritis, a significant decrease in IGF-1 receptor 
expression could not be found when chondrocytes have lost their capacity to 
respond to IGF-1 and chondrocyte synthesis is low. This implies that in these 
stages of arthritis either a defect in the expressed receptor or a disturbance in 
post-receptor signaling is responsible for the lack of IGF-1 stimulation. 
Furthermore, it shows that IGF-1 receptor expression does not necessarily 
correlate with chondrocyte IGF-1 stimulation. Apparently, data from studies 
of receptor expression without evaluation of the biological responses as 
triggered by receptor-ligand binding should be interpreted with caution. 
IGF-1 receptor expression in cultured mouse cartilage 
When normal mouse patellar cartilage is cultured in the absence of serum or 
growth factors proteoglycan synthesis declines rapidly. Proteoglycan synthesis 
is stimulated when cartilage is cultured in the presence of IGF-1 [43, 56]. A 
shift in metabolic activity in the different cartilage layers has been found after 
prolonged culture of human cartilage expiants [18, 19, 27]. We have 
performed CLSM analysis to measure shifts in IGF-1 receptor expression, in 
normal patellae and patellae isolated from knee joints in very early stages of 
experimentally-induced arthritis in mice after 24 hours of culture. Culture in 
the absence of IGF-1 caused a striking loss of receptors in all layers of normal 
and arthritic cartilage. Only a low level of expression remained at the tendon 
insertion sites. Normal cartilage showed enhanced expression of IGF-1 
receptors in both middle and deeper zones of the cartilage after culture in the 
presence of IGF-1. However, chondrocytes in the surface zones, which 
normally show low expression, now displayed intense expression of IGF-1 
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receptors after culture in the presence of IGF-1 [Figure 7]. The effect of 
24 hours culture in the presence of IGF-1 was strikingly different in arthritic 
cartilage isolated 12 hours after induction of arthritis. The pattern was highly 
heterogeneous with extremely high receptor expression in some chondrocytes 
in the middle and deeper zones of the cartilage, while chondrocytes in the 
surface zones still showed a total lack of receptor expression [Figure 7]. These 
data indicate that shifts as observed in proteoglycan synthesis after culture may 
originate from an increase in receptor expression of chondrocytes located in 
Figure 7 
IGF-1 receptor immunolocalization in cryostat 
sections of mouse patellar cartilage cultured for 
24 hours in the presence or absence of IGF-1. 
Normal cartilage and cartilage isolated 12 hours 
after induction of zymosan-induced arthritis 
were analyzed by CLSM. 
[A] Normal cartilage cultured in the presence of 
IGF-1 showed the presence of receptors on 
chondrocytes in the surface zone of cartilage and 
increased receptor staining in the middle and 
deeper zones. Bar = 8 μιτι 
[B] Cartilage from knee joints during an early 
phase of arthritis cultured in the presence of 
IGF-1 showed enhanced receptor staining in 
some chondrocytes located in the middle and 
deeper zones of the cartilage. Bar = 4 μτη 
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the various zones It also underlines that receptor expression may change 
considerably after culture and that data on receptor expression as obtained 
from either cultured chondrocytes or cultured cartilage specimens should be 
interpreted with great care, their relevance to the situation in vivo may be 
limited 
IGF-1 receptor expression in human articular cartilage 
Chondrocyte metabolism is elevated in human osteoarthntic [OA] cartilage, 
which can be explained as an attempt to repair cartilage damage and to limit 
net cartilage loss [4, 6, 16] In line with this, levels of IGF-1, IGF-1 mRNA 
and IGF-1 receptor expression are also increased in human OA cartilage [7, 
291 We examined IGF-1 receptor expression on the chondrocyte membrane in 
different cartilage ¿ones of normal and osteoarthntic human cartilage with 
CLSM and compared it with chondrocyte proteoglycan synthesis as determined 
by "S-sulfate incorporation and proteoglycan content by Safranin О staining 
[37] Cartilage expiants, obtained either by obduction from human knee joints 
within 18 hours after death without a clinical history or from patients 
undergoing knee arthroplasty, were defined according to established criteria as 
"normal or mild to "severe" OA cartilage on the basis of histology [19, 24] 
Both IGF-1 receptor staining [Figure 8A], Safranin О staining [Figure 9A] and 
35S-sulfate incorporation [Figure 9C] were low in the surface zone of normal 
cartilage expiants Strong IGF 1 receptor staining [Figure 8B] and high 
35S-sulfate incorporation [Figure 9C] and Safranin О staining IFigure 9A] were 
found in the middle and deeper zones of human normal cartilage A similar 
distribution pattern of receptor staining, proteoglycan synthesis and 
proteoglycan content were found in cartilage expiants defined as "mild OA" 
"Severe OA" cartilage samples showed a distinct heterogeneity both with 
respect to intensity and distribution patterns of IGF-1 receptors between the 
different donors In some OA donors all cartilage layers showed very low or 
even lack ol staining [Figure 8C, D], whereas in other donors very high 
receptor staining was observed especially in the deeper zones of the cartilage 
[Figure 8E, F] All cartilage expiants of these OA donors showed severe 
pathological deviations histologically [Figure 9B, D] Superficial zones of the 
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Figure 8 
IGF-1 receptor expression was determined by immunolocalization and CLSM analysis in 
sections of human normal [A] and "severe" osteoarthritic cartilage [B, C]. 
In the surface zone low amounts of receptor were observed [A], whereas IGF-1 receptors were 
mainly found in the middle and deeper zones of the cartilage [B]. 
The amount of IGF-1 receptors showed marked donor-dependent heterogeneity in sections of 
"severe" osteoarthritic human cartilage. In some OA donors all cartilage layers showed very low 
or undetectable levels of staining [C, D]. In other donors, high receptor staining was observed 
especially in the deeper zones of the cartilage [E, F]. Bars = 8.5 μπι 
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Figure 9 
Proteoglycan content was detected by Safranin О staining [A and B] and proteoglycan synthesis 
levels were analyzed by in situ autoradiography after 35S-sulfate incorporation [C and D] in 
sections of human normal cartilage [N] and cartilage that was defined as "severe" osteoarthntic 
[OA] 
[A] Reduced Safranin О staining was noted in the surface zone of human normal cartilage. 
Bar = 60 μπι 
[B] Superficial zones of cartilage samples of "severe" osteoarthntic cartilage was considerably 
damaged and fibrillateci Cell clusters were present in the surface zone and perpendicular to the 
surface Safranin О staining was strongly reduced. Bar = 30 μια 
[C] 35S-sulfate incorporation was mainly found in the middle and deeper zones of normal 
human cartilage, whereas the 35S-sulfate incorporation in the surface zone was very low 
Bar = 30 μπι. 
[D] In situ autoradiography after 35S-sulfate incorporation, showed a relatively high level of 
proteoglycan synthesis in "severe" osteoarthntic human cartilage Bar = 60 μπι 
cartilage were strikingly damaged and fibrillated. A strong reduction of 
Safranin О staining [Figure 9B] and high 35S-sulfate incorporation [Figure 9D] 
was found. Cell clusters were present in the surface zones as well as close to 
the lesions perpendicular to the surface. These results demonstrate clearly that 
the CLSM allows comparison of receptor localization with site-specific 
synthesis and content. 
FINAL CONSIDERATIONS AND FUTURE APPLICATIONS OF 
CLSM IN CARTILAGE RESEARCH 
We have considered the potential of CLSM in the field of cartilage research. 
The exact mechanisms underlying cartilage destruction and eventually joint 
failure during rheumatoid arthritis [RA] and osteoarthritis [OA] still need to be 
unraveled. There is substantial evidence to suggest that interleukin-1 acts as a 
key mediator in the inhibition of chondrocyte synthetic activity [3, 12, 46-48, 
53], although the exact roles of growth factors in these processes are still far 
from understood. 
Quantification of chondrocytes labeled in situ with immunofluorescence 
implies measuring their response in an environment characterized by high 
autofluorescence and high background staining. Although autofluorescence can 
be reduced by adequate optical filtering and the choice of an appropriate 
probe, it remains a complicating factor in cartilage research. Background 
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fluorescence is a problem due to the properties of the matrix and the presence 
of various binding proteins In case of probes that bind to or in the vicinity of 
cellular membranes an additional problem arises concerning cellular 
membrane-related fluorescence at the periphery of chondrocytes Using 
CLSM, thin optical sections can be made Consequently, interference of over-
and underlying matrix can be reduced significantly With the use of CLSM the 
measuring volume of a compartment of interest can be optimized by selecting 
for each chondrocyte the ideal cross section, which ensures that the 
compartment of interest is displayed at best These properties of confocal 
imaging, ι e optical isolation of chondrocytes from their environment and 
optimizing the amount of cellular constituents to be measured, allows reliable 
measurement of immunofluorescence in such a way that was not possible in 
any other way Moreover, CLSM analysis of metabolic events in living 
cartilage expiants will become increasingly important in cartilage research In 
conclusion, CLSM imaging will attribute to a better understanding of 2D and 
3D morphology of cartilage in relation to physiological responses 
The application of CLSM gave us the tools to correlate chondrocyte growth 
factor receptor expression with chondrocyte biological response As shown for 
the IGF-1 receptor, the presence of receptor may at best be an indication for 
receptor activity The actual receptor, signal transduction, e g phosphorylation 
patterns, should be investigated in concert Regarding future perspectives, 
application of CLSM may become of vital importance to study in situ 
immunolocalization in intact cartilage of factors involved in joint pathology 
The availability of antibodies suited for immunohistochemistry will determine 
the rate of progress in these studies Our CLSM studies indicated that caution 
should be taken when drawing conclusions from receptor expression studies 
without evaluating biological responses triggered by receptor binding 
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SUMMARY 
Rheumatoid arthritis [RA] is a joint disease characterized by progressive 
inflammation, which leads to erosion of the articular cartilage and injury of 
the surrounding tissues. The initial deterioration of the cartilage matrix is 
probably caused by disturbances in the equilibrium between synthesis and 
degradation of matrix proteoglycans [PGs]. Inflammatory mediators that are 
produced by the inflamed synovium, such as interleukin-1 [IL-1], tumor 
necrosis factor α [TNFa], proteolytic enzymes or reactive oxygen metabolites, 
can all cause inhibition of chondrocyte PG synthesis as well as degradation of 
cartilage. In addition, interference with anabolic factors may contribute to 
impaired chondrocyte PG metabolism. It was previously demonstrated in our 
laboratory that insulin-like growth factor-1 [IGF-1] is able to maintain PG 
synthesis of murine patellar cartilage during culture. However, during 
experimentally-induced arthritis, articular cartilage exhibited a state of 
nonresponsiveness towards IGF-1 stimulation of chondrocyte PG synthesis. 
Therefore, the exact role of IGF-1 and the mechanism by which IGF-1 
regulates chondrocyte PG metabolism in normal and experimentally-induced 
arthritic cartilage was studied to provide insight in IGF-1-related processes 
underlying cartilage destruction. 
In Chapter 1, the processes that are known to be involved in cartilage 
breakdown during RA and experimentally-induced arthritis are reviewed. 
In Chapter 2, the in vitro effect of IGF-1 and the glucocorticoid 
triamcinolone acetonide [TA] on the hydrodynamic volume of newly 
synthesized PGs in mouse normal and arthritic cartilage was investigated. It 
appeared that IGF-1 stimulation of chondrocyte PG synthesis in normal 
cartilage resulted in synthesis of hydrodynamically large PGs, in a similar way 
as it does immediately after dissection. The failure of IGF-1 to stimulate PG 
synthesis in arthritic cartilage was accompanied by synthesis of small 
molecular PG monomers, demonstrating that in arthritic cartilage not only the 
amount of synthesized PG is decreased but also the quality of synthesized PG is 
inferior. However, in the presence of TA, hydrodynamically large PG were 
synthesized both in normal and arthritic cartilage. It is concluded that steroids 
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may play an essential role to maintain cartilage integrity in both normal and 
arthritic cartilage. 
In Chapter 3, investigations were carried out on the effects of other 
growth factors besides IGF-1, i.e. basic fibroblast growth factor [bFGF], 
epidermal growth factor [EGF], platelet derived growth factor [PDGF] or 
transforming growth factor β [TGFß] on the regulation of chondrocyte PG 
metabolism after IL-1 exposure and during early and later phases of arthritis. 
In normal cartilage, none of the tested growth factors elicited stimulatory 
effects on in vitro chondrocyte PG synthesis in a similar way as IGF-1. EGF 
and TGFß inhibited even chondrocyte PG synthesis. Combinations of bFGF or 
PDGF with IGF-1 exerted significant additional stimulation of chondrocyte PG 
synthesis. Cartilage that was previously exposed to IL-1 was responsive to 
IGF-1 and to other growth factors in a similar way as in normal cartilage. 
However, cartilage from joints after experimentally induced arthritis exhibited 
a state of nonresponsiveness to all growth factors tested as well as to growth 
factor combinations. It is concluded that the inflammatory process in the joint 
does not induce upregulation of chondrocyte PG synthesis by other growth 
factors simultaneously with chondrocyte IGF-1 nonresponsiveness and that 
chondrocytes from the diseased joint seem to display a general deficiency of 
receptor functions. This revealed that inflammatory processes during 
experimental arthritis are more complex than processes caused by injecting 
IL-1 into the knee joints alone. 
The first attempt to elucidate the mechanism underlying the state of 
unresponsiveness to IGF-1 during arthritis was the investigation of the role of 
inflammatory mediators IL-1, TNFcc, proteolytic enzymes or reactive oxygen 
species in the induction and maintenance of the nonresponsiveness of 
chondrocytes to IGF-1 in arthritis [Chapter 4]. Mediators from surrounding 
tissues were able to suppress in vitro responses of chondrocytes to IGF-1. 
Priming of the cartilage with IL-1 did not completely induce IGF-1 
nonresponsiveness but enhanced the ability of suppressive mediators to 
downregulate the IGF-1 response. Antibodies against IL-la and IL-Iß, IL-1 
receptor antagonist [IL-Ira], anti-TNF antibody, selective inhibitors of 
enzymes or of reactive oxygen species did not improve the disturbed IGF-1 
response in vitro. However, treatment with anti-IL-1 α/β antibodies before the 
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induction of arthritis abolished nonresponsiveness to IGF-1. It is concluded 
that metalloproteinases and cysteineproteinases or oxygen species are no key 
factors in IGF-1 nonresponsiveness, that IL-1 and TNFoc alone are not essential 
for the maintenance of nonresponsiveness; and that IL-1 does not induce IGF-1 
nonresponsiveness but is indirectly involved in the generation of this 
phenomenon. 
In addition, impairment of IGF-1 effects on chondrocytes during arthritis 
may be due to a defect at the level of IGF-1 receptor binding or postreceptor 
signaling. To investigate the amount and distribution patterns of IGF-1 
receptors on the cell membrane of chondrocytes in normal and arthritic 
cartilage we established an approach to allow localization and quantification of 
IGF-1 receptor immunostaining [Chapter 5]. Immunohistochemical staining 
of the IGF-1 receptor in cryostat sections of the mouse patella with antibodies 
against the α subunit of the receptor was visualized with confocal laser 
scanning microscopy [CLSM]. CLSM optical sectioning resulted in improved 
localization of the IGF-1 receptor and enabled to distinguish membrane 
staining from intracellular staining. Two approaches were followed to quantify 
in confocal images low levels of fluorescence intensity of immunolocalized 
IGF-1 receptor at the chondrocyte membrane. Moreover, the use of CLSM 
allowed examination of IGF-1 receptor localization in the various cartilage 
zones. The majority of IGF-1 receptor fluorescence was found on 
chondrocytes of the middle and deeper zones of the cartilage, whereas surface 
zone chondrocytes exhibited negligible fluorescence. The variable distribution 
of IGF-1 receptor in chondrocytes of articular cartilage suggests that effects of 
IGF-1 on chondrocytes may be distinctly heterogeneous in the specific 
cartilage zones. 
The established CLSM approach to localize and quantify IGF-1 receptors on 
the chondrocyte membrane was used to study IGF-1 receptor expression in 
mouse normal and arthritic cartilage [Chapter 6 and Chapter 7] as well as 
in human normal and osteoarthritic cartilage [Chapter 8]. Besides, in 
Chapter 9 the present state of the art in digital imaging with CLSM in 
cartilage research is reviewed. Problems of discrimination of specific signals 
against background staining, which often arises when structures are stained at 
low intensity levels can be avoided by the application of CLSM. This problem 
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is inherent to articular cartilage and therefore, CLSM will become increasingly 
important in cartilage research. 
In Chapter 6, CLSM was applied to compare staining of IGF-1 binding 
sites with anti-IGF-1 receptor antibody versus staining with biotinylated IGF-1 
in the various cartilage zones of normal and experimental arthritic knee joints. 
Using anti-IGF-1 receptor antibody, IGF-1 receptors were found at the cell 
membrane of chondrocytes of the middle and deep cartilage zones, whereas 
intracellular staining was highest in chondrocytes of the surface zone. After 
incubation with biotinylated IGF-1 distinct membrane staining was not present. 
Fluorescence was found to be homogeneously distributed in chondrocytes of 
the middle and deep zones but not in the surface zone. Staining with anti-IGF-1 
receptor antibody was significantly different in cartilage from inflamed knee 
joints, whereas staining with biotinylated IGF-1 was increased in chondrocytes 
of the middle and deeper zones of cartilage. The lack of intracellular staining 
with biotinylated IGF-1 of surface zone chondrocytes may suggest that 
intracellular IGF-1 binding sites have low affinity for IGF-1, or that the 
binding site of the receptor is shielded. Staining patterns obtained with 
biotinylated IGF-1 also display IGF-1 binding proteins [IGFBPs]. It is 
suggested that during joint inflammation larger amounts of IGFBP are present. 
In Chapter 7 both distribution patterns of IGF-1 receptor and in vitro 
IGF-1 stimulation of chondrocyte PG synthesis were examined in articular 
cartilage of normal and experimental arthritic mouse knee joints during 
various phases of arthritis. The distribution of IGF-1 receptor expression in 
the different cartilage zones of normal cartilage reflected IGF-1 stimulation 
and PG synthetic activity of chondrocytes in these layers. Concurrently with 
the development of arthritis, cartilage lost its capacity to react to IGF-1 but 
when the inflammatory response was waning IGF-1 stimulation recovered. 
Shortly after induction of experimental arthritis, a clear decrease in IGF-1 
receptor expression was observed, whereas in later phases of arthritis receptor 
expression returned rapidly to normal levels. It was found that IGF-1 
nonresponsiveness was highly correlated with severity of arthritis. The 
correlation of IGF-1 receptor expression with IGF-1 stimulation and metabolic 
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activity is disturbed in arthritic cartilage, suggesting inadequate or abolished 
chondrocyte intracellular signal transduction. 
In Chapter 8, it was studied whether chondrocyte PG synthesis correlates 
with chondrocyte IGF-1 receptor localization in human normal cartilage as 
well as in cartilage known to display a shift in PG synthesis, such as cultured 
cartilage and osteoarthritic cartilage. OA cartilage shows markedly enhanced 
PG synthesis. Cartilage specimens were obtained post mortem from human 
knees within 18 hours after death of donors without known clinical OA 
history. The samples were taken out of macroscopically normally looking 
regions as well as from damaged regions. This procedure yielded a range of 
OA grades from mild to moderate and severe OA. In normal cartilage, both 
chondrocyte PG synthesis and the amount of chondrocyte IGF-1 receptor were 
low in the surface zones, and high in the middle and deep zone of the cartilage. 
After culture, the increase in chondrocyte PG synthesis in the surface zone 
coincided with upregulation of IGF-1 receptor localization. In mild OA, 
particularly high levels of chondrocyte synthetic activity were found in the 
upper cartilage layer, whereas IGF-1 receptor expression was low in this 
layer, suggesting that factors other than IGF-1 are involved to enhance 
chondrocyte PG synthesis. High PG synthesis activity and chondrocyte IGF-1 
receptor staining were found in moderate OA, whereas low levels of PG 
synthesis and IGF-1 receptor staining were observed in severe О A. 
CONCLUSIONS 
Normal cartilage 
- IGF-1 is able to maintain in vitro synthesis of PG monomers with large 
hydrodynamic size at similar levels as occur in vivo. 
- Glucocorticoids are able to exert similar effects as IGF-1 on the regulation 
of in vitro chondrocyte PG metabolism. 
- PDGF and bFGF have an additional effect on IGF-1 regulation of 
chondrocyte PG synthesis during culture. EGF and TGFß have an inhibitory 
effect on chondrocyte PG synthesis. 
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- IGF-1 receptors are located at the cell membrane of chondrocytes in the 
middle and deeper zones of cartilage, whereas intracellular staining is found in 
surface zone chondrocytes. 
Arthritic cartilage 
- IGF-1 nonresponsiveness during arthritis is highly correlated with the 
severity of arthritis. 
- The failure of IGF-1 to stimulate in vitro chondrocyte PG synthesis in 
arthritic cartilage accompanies the synthesis of small PG monomers, 
demonstrating that not only the amount but also the quality of synthesized PG 
is deteriorated in arthritic cartilage. 
- Chondrocytes from arthritic cartilage do not response to other growth 
factors besides IGF-1 during culture. 
Glucocorticoids are able to bypass disturbed IGF-1 responsiveness and may 
therefore play an important role in maintaining cartilage integrity in arthritic 
cartilage. 
- Metalloproteinases and cysteineproteinases, reactive oxygen species, IL-1 
and TNFa are not key factors in the maintenance of IGF-1 nonresponsiveness. 
IL-1 does not induce IGF-1 nonresponsiveness but is indirectly involved in the 
generation of this phenomenon. 
- The correlation of chondrocyte IGF-1 receptor expression with in vitro 
IGF-1 stimulation and metabolic activity is disturbed in arthritic cartilage. 
- Chondrocytes in arthritic cartilage do not exhibit decreased amounts of 
IGF-1 receptor on their cell membrane. Therefore, IGF-1 nonresponsiveness 
can not be explained by a decreased receptor expression. 
Osteoarthritic cartilage 
- IGF-1 has different effects on chondrocytes in the different cartilage zones 
in normal cartilage. This metabolic heterogeneity is lost in OA cartilage. In 
OA cartilage, chondrocyte PG synthesis and IGF-1 receptor distribution are 
dependent on the stage of OA. 
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Confocal laser scanning microscope 
- The application of CLSM enables to distinguish between membrane and 
intracellular staining of the IGF-1 receptor. Therefore, the CLSM approach 
allows evaluation and quantification of IGF-1 receptor localization on the 
chondrocyte membrane. Moreover, the use of CLSM allows examination of 
IGF-1 receptor localization in the different cartilage zones. 
FINAL CONSIDERATION 
A critical aspect of the structural integrity of articular cartilage is the ability 
of chondrocytes to synthesize and degrade proteoglycans [9, 10]. IGF-1 is the 
most important growth factor that regulates chondrocyte PG metabolism [6, 8, 
11, 12, 25, 28, 35, 36, 44] by binding to the type 1 receptor [23, 30, 43, 45]. 
In the present study it is shown that IGF-1 receptor distribution patterns in 
surface, middle and deeper zones of cartilage appears to reflect the 
heterogeneity in IGF-1 stimulation and PG synthesis of chondrocytes in these 
layers [2, 22, 26, 27, 33, 38, 55]. Intracellular IGF-1 receptors which are 
mainly found in chondrocytes of the surface zone, might represent 
internalized, recycling or newly synthesized receptors. This intracellular pool 
of receptors might become important under conditions of stress. The cell 
surface receptors on chondrocytes of the middle and deeper zones might 
reflect receptors actively involved in triggering IGF-1 responses. After culture 
of human cartilage expiants in the presence of serum, chondrocytes show a 
markedly enhanced PG synthesis mainly in the surface zone and that this shift 
in metabolic activity coincides with a rapid upregulation of IGF-1 receptor 
expression on the membrane of these cells [18, 20, 21, 27, 50]. 
The amounts of receptors at the cell membrane or intracellularly in various 
cartilage zones may provide further insight regarding the regulation of 
chondrocyte metabolic activity. The application of CLSM provides a valuable 
tool to obtain more detailed information on the intracellular distribution of 
IGF-1 receptor expression in articular cartilage chondrocytes [48, 53, 54, 55, 
57, 59]. The CLSM may become of vital importance to study the in situ 
immunolocalization in intact cartilage of factors involved in joint pathology. 
However, in this thesis, CLSM analysis of cartilage from diseased joints 
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indicates that caution should be taken drawing straight forward conclusions 
from receptor expression investigation without evaluating biological responses 
triggered by receptor binding. 
Chronic interference with IGF-1-dependent regulation of chondrocyte PG 
synthesis during arthritis contributes to severe depletion of articular cartilage 
[34, 44, 46, 51, 56]. IGF-1 intra-articular administration in the treatment of 
RA revealed an improvement in pain and joint function [39]. However, the 
present investigation did not provide evidence for beneficial effects of IGF-1 
treatment during arthritis with the potential to protect against articular 
cartilage damage. Treatment with glucocorticoids or blocking of IL-1 effects 
seem to provide a more promising therapeutic approach. 
The exact mechanism underlying IGF-1 nonresponsiveness during arthritis 
remains unclear. Many possible candidates, such as metalloproteinases and 
cysteineproteinases, reactive oxygen species, TNFa or IL-1 do not override 
IGF-1 signaling, although IL-1 seems to play an indirect role in the generation 
of the phenomenon [4, 16, 24, 49]. The lack of IGF-1 response can not be 
explained by receptor downregulation either. During the phase of arthritis that 
chondrocyte PG synthesis is at a low level and that chondrocytes do not 
respond to IGF-1, the amount and distribution of IGF-1 receptors appeared to 
be at normal levels [52]. This may indicate that although IGF-1 receptors are 
present on the chondrocyte membrane their biological function is hampered. 
The receptors might be masked or damaged by agents produced by the 
inflamed synovium [3, 14, 17, 19]. For instance, IGFBPs might play a role in 
this process [5, 42]. In osteoarthritic cartilage enhanced IGFBP levels are 
thought to be involved in capturing IGF-1 and therefore in reduced 
bioavailability of IGF [7]. In this thesis, we observed in arthritic chondrocytes 
elevated staining after incubation with biotinylated IGF-1, which may be 
indicative for enhanced levels of IGFBPs [54]. However, during culture, even 
at unphysiologically high concentrations of IGF-1, chondrocytes are not 
responsive to IGF-1 [51] Therefore, unless IGFBPs are produced in extremely 
high concentrations they might be involved in the IGF-1 nonresponsive state 
during arthritis. 
Alternatively, IGF-1 receptors may be defective and unable to exhibit 
normal biological functions [1, 29, 32, 40, 58, 61]. In this respect, Yee et al. 
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[1989] have defined an alternative IGF-1 receptor transcript with a three base 
deletion that was found in many tissues and cell lines. It would be intriguing to 
show the presence of this alternatively spliced IGF-1 receptor in arthritic 
chondrocytes. At present, this hypothesis is investigated by detecting the two 
different spliced IGF-1 receptor mRNAs with the use of polymerase chain 
reaction. In addition, defects in the phosphorylation pathways that lead to 
receptor signaling will be an other interesting item for further research. 
However, these experiments may introduce complications; isolation and 
subsequent culture of chondrocytes from arthritic knee joints may change the 
"arthritic" phenotype of the cells. Moreover, analysis of the whole chondrocyte 
population will lead to loss of information about the chondrocytes located in 
the different cartilage layers. 
Although arthritis seemed to cause a nonresponsive state to a whole range of 
potential anabolic growth factors, the steroid triamcinolone acetonide [TA] is 
able to maintain in vitro chondrocyte PG metabolism [47, 56]. Steroids may 
have an indirect effect on chondrocytes in the arthritic cartilage. Steroids are 
known to be able to modulate the production of inflammatory mediators [37, 
41]. Moreover, steroids seem to have a priming effect on the biological action 
of IGF-1 in cartilage metabolism [13, 31]. In a previous study, it was shown 
that a single intra-articular injection in arthritic joints of a depot preparation 
of the steroid triamcinolone hexacetonide or rimexolone counteracted severe 
suppression of chondrocyte PG synthesis in arthritic cartilage [15]. These 
steroid-treated arthritic joints did show normal responsiveness to IGF-1 
[Joosten et al. in preparation]. Steroids may have changed the chondrocyte in a 
way that they regain their normal function. In this regard it will be of interest 
to analyze whether at later stages of arthritis or after renewed exacerbation's 
chondrocytes still display their responsiveness induced by steroids. 
REFERENCES 
1. Attisano L, Wrana JL, Chelfetz S, Massague J: Novel activin receptors: Distinct genes 
and alternative mRNA generate a repertoire of serin/threonin kinase receptors. Cell 1992; 
68.97-108. 
Summary, conclusions, final consideration 223 
2. Aydelotte MB, Keuttner KE: Heterogeneity of articular chondrocytes and cartilage matrix. 
In: Woessner, JF, Howell, DS, eds. Cartilage degradation: basic and clinical aspects : 
New York, Marcel Dekker, 1991.37. 
3. Bergstedt K, Wieloch Τ: Changes in insulin-like growth factor 1 receptor density after 
transient cerebral ischemia in the rat: Lack of protection against ischemic brain damage 
following injection of insulin-like growth factor 1. J Cerebral Blood Flow and Metab 
1993; 13:859-898. 
4 Blount S, Crawford A: Regulation of IGF-1 receptors on rabbit articular chondrocytes by 
lnflammatoy mediators. Agents Actions 1994; 41:C177-C179 
5 Chevalier X, Tyler J. Production of IGF binding proteins by human cartilage expiants and 
role of the IGFBP-3 in the modulation of proteoglycan synthesis caused by IGF-1 
Arthritis Rheum 1994; 37:S 293. 
6. Curtis AJ, Keng C, Handley CJ, Robinson HC: Effect of insulin-like growth factor-1 on 
the synthesis and distribution of link protein and hyaluronan in expiant cultures of 
articular cartilage. Biochem Biophys Acta 1992; 1135:309-317. 
7. Dore S, Pelletier J-P, DiBattista JA, Tardif G, Brazeau Ρ, Martel-Pelletier J: Human 
osteoarthntic chondrocytes possess an increased number of insulin-like growth factor 1 
binding sites but are unresponsive to its stimulation. Arthritis Rheum 1994; 37:253-263. 
8. Froesch ER, Schmid С, Schwander J, Zapf J: Actions of insulin-like growth factor. Ann 
Rev Physiol 1985; 47:443-467 
9. Hardingham ТЕ. Biosynthesis and turnover of cartilage proteoglycans. In: Glauert, eds. 
The control of tissue damage : Elsevier Science Publishers BV [Biomedical Division], 
1988:41-54. 
10. Hardingham Τ, Bayliss M: Proteoglycans of articular cartilage: Changes in aging and in 
joint disease. Seminars in Arthritis & Rheum. 1990, 20 [1 ]: 12-33. 
11. Hascall VC, Handley CJ, McQuillan DJ, Hascall GK, Robinson HC, Lowther DA: The 
effect of serum on biosynthesis of proteoglycans by bovine articular cartilage in culture. 
Arch Biochem Biophys 1983, 224:206-223. 
12. Isaksson OG, Ohlsson C, Nilsson A, Isgaard J, Lindahl A: Regulation of cartilage 
growth by growth hormone and insulin-like growth factor 1. Pathology 1991; 5:451-
453. 
13. Itagane Y, Inada H, Fujita K, Isshiki G. Interactions between steroid hormones and 
insulin-like growth factor-1 in rabbit chondrocytes Endocrinology 1991; 128:1419-
1424. 
14. Jansen J, Buul-Offers SC, Hoogerbrugge CM, Van den Brande JL: Effects of a single 
cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins 
and antibodies. Biochem J 1990; 266513-520. 
15. Joosten LAB, Helsen MA, Van den Berg WB: Protective effect of Rimexolone on 
cartilage damage in arthritic mice: A comparative study with Triamcinolone hexacetonide. 
Agents & Actions 1990; 31135. 
16. Joosten LAB, Helsen HA, Van den Berg WB' Transient chondrocyte non-responsiveness 
to insulin-like growth factor-1 upon H 2 O z exposure is not related to IGF-1 receptor 
damage. J Rheum 1991 ; 18585-590. 
17. Kato H, Fana TN, Stannard B, Levy-Toledano R, Taylor SI, Roberts Jr CT, Le Roith D: 
Paradoxical biological effects of overexpressed insulin-like growth factor-1 receptors in 
chinese hamster ovary cells. J Cell Physiol 1993; 156:145-152. 
18 Korver GHV, Van de Stadt RJ, Van Kampen GP, Kiljan E, Van der Korst JK-
Composition of proteoglycans synthesized in different layers of cultured anatomically 
intact articular cartilage. Matrix Biol 1990; 10:394-401. 
224 Chapter 10 
19 Kwok CF, Goldstein BJ, Muller-Weiland DM, Lee T-S, Kahn R, King GL Identification 
of persistent defects in insulin receptor structure and function in capillary endothelial cells 
from diabetic rats J Clin Invest 1989,83 127-136 
20 Lafeber FPJG, Van der Kraan PM, Roy JLAM, Huber-Bruning O, Bijlsma JWJ 
Articular cartilage explant culture, an appropriate in vitro system to compare osteoarthntic 
and normal human cartilage Connective Tissue Research 1990,29 287-299 
21 Lafeber FPJG, Van der Kraan PM, Van Roy HLAM, Vitters EL, Huber-Bruning O, Van 
den Berg WB, Bijlsma JWJ Local changes in proteoglycan synthesis during culture are 
different for normal and osteoarthntic cartilage American J Pathology 1992, 140 1421-
1429 
22 Lazowski DA, Fraher LJ, Hodsman A, Steer B, Modrowski D, Han VKM Regional 
variation of insulin-like growth factor-1 gene expression in mature rat bone and cartilage 
Bone 1994, 15 563-576 
23 Le Roilh D, Adamo M, Werner H, Roberts CT Insulin-like growth factors and their 
receptors as growth regulators in normal physiology and pathologic states ТЕМ 1991, 
2 134-139 
24 Lin T, Wang D, Nagpal ML, Chang W, Calkins JH Down regulation of Leydig cell 
insulin-like growth faclor-1 gene expression by interleukin-1 Endocrinology 1992, 
130 1217-1224 
25 Luyten FP, Hacall VC, Nissley SP, Morales TI, Reddi AH Insulin-like growth factors 
maintain steady state metabolism of proteoglycans in bovine articular cartilage expiants 
Arch Biochem Вюрпм 1988, 267 416-425 
26 Maries PJ, Hoyland JA, Parkinson R, Freemont AJ Demonstration of variation in 
chondrocyte activity in different zones of articular cartilage an assessment of the value of 
m-situ-hybndisation Int J Exp Pathol 1991, 72 171-182 
27 Maroudas A, Schneiderman R, Weinberg С Comparison between effects of serum and 
insulin on GAG synthesis in different zones of cultured human articular cartilage Trans 
OrthopResSoc 1990, 15 315 
28 McQuillan DJ Handley CJ, Campbell MA, Bolis S, Milway VE, Herington AC 
Stimulation of proteoglycan synthesis by serum and insulin like growth factor-1 in 
cultured bovine articular cartilage Biochem J 1986,240 424-430 
29 Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AMP, Aaronson SA 
Determinination of hgand-binding specificity by alternative splicing Two distinct growth 
factor receptors encoded by a single gene Proc Natl Acad Sci USA 1992, 89 246-250 
30 Neely EK, Beukers MW, Oh Y, Cohen Ρ, Rosenfeld RG Insulin-like growth factor 
receptors Acta Paediatr Scand 1991,372 116-123 
31 Price WA, Stiles A, Moats Staats BM Gene expression of insulin-like growth factors 
[IGF 1 s], the type 1 IGF-1 receptor, and IGF-1-binding proteins in dexamethasone-
induced fetal growth retardation Endocrinology 1992, 130 1424 1432 
32 Raz V, Kelman Z, Zvivi A, Neufeld G, Gicol D, Yarden Y PCR based identification of 
new receptors molecular cloning of a receptor for fibroblast growth factors Oncogene 
1991,6 153-760 
33 Sampson HW, Cannon MS Zonal analysis of metabolic profiles of articular-epiphyseal 
cartilage chondrocytes HistochemJ 1986, 18 265-270 
34 Schalkwijk J, Joosten LAB, Van den Berg WB, Van de Putte LBA Chondrocyte 
nonresponsiveness to insulin-like growth factor 1 in experimental arthritis Arthritis 
Rheum 1989,32 894-900 
35 Schalkwijk J, Joosten LAB, Van den Berg WB, Wijk JJ, Van de Putte LBA Insulin like 
growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid 
Arthritis Rheum 1989, 32 66-71 
Summary, conclusions, final consideration 225 
36 Schoenle E, Zapf J, Humbel RE, Froesch ER Insulin-like growth factor stimulates 
growth in hypophysectormzed rats Nature 1982, 296 252-253 
37 Sheppard L, Pilsworth LCM, Hazlemen B, Dingle JT Effects of antirheumatoid drugs on 
the production and action of porcine catabolm Ann Rheum Dis 1982, 41 463-468 
38 Siczkowski M, Watt FM Subpopulations of chondrocytes from different zones of pig 
articular cartilage Isolation, growth and proteoglycan synthesis in culture J Cell Sci 
1990, 97 349-360 
39 Silven F, Morosini P, Brecciaroli D, Cervini С Intra-articular injection of somatostatin in 
knee osteoarthritis clinical results and IGF-1 serum levels In J Clin Pharm Res 1994, 
14 79-85 
40 Soos MA, Siddle К Immunological relationships between receptors for insulin and 
insulin-like growth factor receptor 1 Evidence for structural heterogeneity of insulin-like 
growth factor 1 receptors involving hybrids with insulin receptors Biochem J 1989, 
263 553-563 
41 Steinberg J, Sledge CB Synovial factors and chondrocyte-meduted breakdown of 
cartilage Inhibition by hydrocortisone J Orthop Res 1983, 1 13-21 
42 Tesch HG, Handley CJ, Cornell HJ, Hemngton AC Effects of free and bound insulin­
like growth factors on proteoglycan metabolism in articular cartilage explants J Orthop 
Res Soc 1992, 10 14-22 
43 Trippel SB, Chemausek SD, Van Wijk JJ, Moses AC, Mankin HJ Demonstration of type 
1 and type 2 somatomedin receptors in bovine growth plate chondrocytes J Orthop Res 
1988,6 817-826 
44 Tyler JA Insulin-like growth factor 1 can decrease degradation and promote synthesis of 
proteoglycan in cartilage exposed to cytokines Biochem J 1989, 260 543-548 
45 Ullrich A, Gray A, Tarn AW, Yang-Feng T, Tsubokawa M, Collins C, Henrel W, Le 
Bon T, Kathuna S, Chen E, Jacobs S, Francke U, Ranchandran J, Fujita-Yamaguchi Y 
Insulin-like growth factor 1 receptor primary structure Comparison with insulin receptor 
suggests structural determinants that define functional specificity EMBO J 1986, 5 2503-
2512 
46 Van den Berg WB, Joosten LAB, Schalkwijk J, Van de Loo FAJ, Van Beuningen HM 
Mechanism of cartilage destruction in experimental arthritis lack of IGF-1 
responsiveness In Lewis AJ, Doherty NS, Ackerman NR, eds Therapeutic Approaches 
to Inflammatory Diseases 1998 47-54 
47 Van der Kraan PM, Vitters EL, Verbunt J, Van den Berg WB Maintenance of the 
synthesis of large proteoglycans in anatomically intact murine articular cartilage by 
steroids and insulin-like growth factor-1 Ann Rheum Dis 1993, 52 734-741 
48 Van Oostvelt P, Bauwens S Quantitative fluorescence in confocal microscopy J 
Microscopy 1990, 158 121-132 
49 Verschure PJ, Joosten LAB, Van de Loo FAJ, Van den Berg WB IL 1 has no direct role 
in the IGF-1 nonresponsiveness during experimentally-induced arthritis Ann Rheum Dis 
1995, 54 976 982 
50 Verschure PJ, Joosten LAB, Helsen MMA, Lafeber FPJG, Van den Berg WB Insulin­
like growth factor-1 receptor immunolocalization by confocal scanning laser microscopy 
in human normal and osteoarthritic cartilage in comparison with proteoglycan synthesis 
and content submitted 
51 Verschure PJ, Joosten LAB, Van der Kraan PM, Van den Berg WB Responsiveness of 
articular cartilage from normal and inflamed mouse knee joints to various growth factors 
Ann Rheum Dis 1994, 53 455-460 
226 Chapter 10 
52. Verschure PJ, Van Marie J, Joosten LAB, Van den Berg WB. Chondrocyte IGF-1 
receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage 
during various phase of experimentally-induced arthritis. Ann Rheum Dis 1995; 54:645-
653. 
53. Verschure PJ, Van Marie J, Van Noorden CJF, Van den Berg WB: The contribution of 
quantitative confocal scanning laser microscopy in cartilage research. Chondrocyte 
insulin-like growth factor-1 receptors in health and disease. Microscopy Research and 
Technique, special issue "Microscopy of bone joints and arthritis" in press. 
54. Verschure PJ, Van Marie J, Joosten LAB, Van den Berg WB: Histochemical analysis of 
IGF-1 binding sites in normal and experimentally-induced arthritis. Histochem J in press. 
55. Verschure PJ, Van Marie J, Joosten LAB, Van den Berg WB: Localization and 
quantification of the insulin-like growth factor-1 receptor in mouse articular cartilage by 
confocal laser scanning microscopy. J Histochem Cytochem 1994; 42:765-773. 
56. Verschure PJ, Van der Kraan PM, Vitters EL, Van den Berg WB: Stimulation of 
proteoglycan synthesis by triamcinolone acetonide and insulin-like growth factor in 
normal and arthritic murine articular cartilage. J Rheumatol 1994; 21.920-925. 
57 Wells SK, Sandison D, Strickler J, Webb WW: Quantitative fluorescence imaging with 
laser scanning confocal microscopy In· Pawley J, eds. The handbook of confocal 
microscopy USA, Madison, WI, IMR Press, 1989:27-39. 
58 Werner S, Duan D-S, De Vries С, Peters KG, Johnson DE, Williams LT: Differential 
splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor 
variants with different hgand-binding specificity. Mol Cell Biol 1992, 12:89-102. 
59 Wilson T: The role of the pinhole in confocal imaging systems. In· Pawley J, eds. The 
handbook of confocal microscopy: USA, Madison, WI, IMR Press, 1989.133-126 
60 Yee D, Lebovic GS, Marcus RR, Rosen N: Identification of an alternate insulin-like 
growth factor β subumt mRNA transcript. J Biol Chem 1989; 25.21439-21441 
61 Zhang B, Roth RA: Binding properties of chimeric insulin receptors containing the 
cysteine rich domain of either the insulin-like growth factor-1 receptor or the insulin 
related receptor. Biochemistry 1991; 305113-5117. 
CHAPTER 11 
DUTCH SUMMARY 
228 Chapter 11 
NEDERLANDSE SAMENVATTING 
Rheumatoide artritis [RA] wordt ondermeer gekenmerkt door een 
chronische gewrichtsontsteking, die op den duur ernstige beschading van het 
articulaire kraakbeen veroorzaakt. Aanmaak en afbraak van de kraakbeen 
component proteoglycaan [PG] wordt verzorgt door de kraakbeencellen; de 
chondrocyten. Chondrocyten spelen daarom een kritische rol in het behouden 
van de structurele integriteit van de kraakbeenmatrix, die is opgebouwd uit 
geaggregeerde PGs en collagene vezels. Het collageen in kraakbeen heeft een 
laag metabolisme en verzorgt de trekkracht van het kraakbeen. De PGs zijn 
complexe, negatief geladen moleculen die een hoge osmotische druk 
bewerkstelligen zodat het kraakbeen druk en vervorming kan weerstaan. De 
beginnende beschadiging van de kraakbeenmatrix tijdens RA wordt 
waarschijnlijk veroorzaakt door een verstoorde balans tussen aanmaak en 
afbraak van kraakbeen matrix PGs. 
Ontstekingsmediatoren zoals interleukine-1 [IL-1], tumornecrose factor α 
[TNFa], eiwitafbrekende enzymen en reactieve zuurstofmetabolieten zijn in 
staat het kraakbeen af te breken en de aanmaak van nieuw kraakbeen te 
remmen. Naast de werking van deze ontstekingsmediatoren kan een storing van 
de werking van anabole factoren tevens bijdragen aan een verstoorde aanmaak 
van nieuwe PGs. 
IGF-1 [insulin-like growth factor-1] is de belangrijkste anabole groeifactor 
die continue PG aanmaak en afbraak van de chondrocyt reguleert door zich te 
binden aan specifieke IGF-1 receptoren op de chondrocyt celmembraan. 
Tijdens weefselkweek van muizen knieschijfjes, patellae, is IGF-1 in staat de 
kraakbeen PG aanmaak van muis patellair kraakbeen te onderhouden. Het 
kraakbeen uit een experimenteel geïnduceerd artritisch gewricht reageert 
echter niet meer op deze belangrijke anabole groeifactor. Inzicht in de rol van 
IGF-1 en het mechanisme waarmee IGF-1 de chondrocytaanmaak reguleert 
zou kunnen bijdragen aan een klinische therapie om kraakbeenafbraak te 
voorkomen [hoofdstuk 1]. 
In hoofdstuk 2 is het in vitro effect van IGF-1 en het glucocorticosteroid 
hormoon triamcinolon acetonide [TA] op de hoeveelheid en de 
hydrodymamische afmeting van nieuw aangemaakte PGs bestudeerd in 
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normaal en artritisch muizenkraakbeen. IGF-1 ongevoeligheid van het 
artritische kraakbeen blijkt te zijn gekoppeld aan de aanmaak van PGs met 
geringe hydrodynamische afmeting. Het glucocorticoid TA bleek echter in 
staat in normaal en artritisch kraakbeen de chondrocyt aan te zetten tot het 
maken van PGs met goede kwaliteit en met normale afmeting. 
In hoofdstuk 3 is de rol van andere groeifactoren zoals bFGF [basic 
fibroblast growth factor], EGF [epridermal growth factor], PDGF [platelet 
derived growth factor], TGFß [transforming growth factor β] op de regulatie 
van het chondrocyt PG metabolisme bestudeerd tijdens vroege en late 
experimentele artritis en tijdens herstel na de blootstelling aan IL-1. Uit de 
onderzoeksresultaten blijkt dat deze groeifactoren niet in staat zijn de 
ongevoeligheid voor IGF-1 tijdens artritis te compenseren; chondrocyten in 
artritisch kraakbeen vertonen een algeheel uitblijven van groeifactor stimulatie 
van PG aanmaak. Het met IL-1 behandelde kraakbeen blijkt op dezelfde wijze 
op de groeifactoren te reageren als normaal kraakbeen, daarom kan worden 
geconcludeerd dat het ontstekingsproces tijdens experimentele arthritis een veel 
complexer proces is dan de pathologische situatie in het gewricht na IL-1 
injectie. 
Vervolgens is getracht het mechanisme dat ten grondslag ligt aan IGF-1 
ongevoeligheid tijdens artritis te doorgronden. In hoofdstuk 4 is de rol van 
de ontstekingsmediatoren IL-1, TNFa, reactieve zuurstofmetabolieten en eiwit 
afbrekende enzymen zoals metallo- en cysteineproteinases in het ontstaan en 
onderhouden van de chondrocyt IGF-1 ongevoeligheid tijdens artritis 
onderzocht. Uit de resultaten van het onderzoek blijkt dat metallo- en 
cysteineproteinases of zuurstofmetabolieten niet als sleutelfactoren fungeren 
voor IGF-1 ongevoeligheid, dat TNFa en IL-1 afzonderlijk niet in staat zijn 
om IGF-1 ongevoeligheid te induceren, maar dat IL-1 wel indirect is 
betrokken bij het ontstaan van het IGF-1 ongevoel igheidsfenomeen. 
Daarnaast is de mogelijkheid onderzocht dat IGF-1 ongevoeligheid wordt 
veroorzaakt door een defect in de IGF-1 receptorbinding of in de postreceptor 
signalering. In hoofdstuk 5 is een tijdens het onderzoek toegepaste 
microscopische methode met behulp van de confocale scanning laser 
microscoop [CLSM] beschreven om de hoeveelheid IGF-1 receptoren op de 
chondrocytcelmembraan te bepalen. De IGF-1 receptor is immuno-
histochemisch gedetecteerd op vriescoupe's van de intacte muizen patella's met 
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behulp van antilichamen tegen de α subunit van de receptor; de IGF-1 
receptordetectie is vervolgens geanalyseerd met behulp van de CLSM. Het 
gebruik van de CLSM maakt het mogelijk om de IGF-1 receptorlocatie in de 
verschillende dieptezones van het kraakbeen op de chondrocyt celmembraan te 
bestuderen. IGF-1 receptorfluorescentie is vooral op chondrocyten in de 
midden en diepere zone van het kraakbeen gevonden. 
Deze CLSM immunohistochemische detectie van de IGF-1 receptor op de 
chondrocytcelmembraan is vervolgens gebruikt om ook de IGF-1 receptor in 
het normale en artritische kraakbeen te bestuderen [hoofdstuk 6 en 7] en 
tevens om humaan normaal en osteoartrotisch kraakbeen van muizen te 
analyseren [hoofdstuk 8]. In hoofdstuk 9 is het gebruik van CLSM in 
kraakbeenonderzoek beschreven in de context van zwakke signaaldetectie ten 
opzichte van hoge achtergronddetectie. 
In hoofdstuk 6 is detectie van IGF-1 bindingsplaatsen in normaal en 
artritisch muizenkraakbeen met een antilichaam tegen de IGF-1 receptor 
vergeleken met detectie door middel van gebiotinyleerd IGF-1. Deze 
vergelijkende studie is uitgevoerd om de relatieve hoeveelheid IGF-1 
bindingseiwit [IGFBP] in artritisch kraakbeen te bepalen. Met het 
gebiotinyleerde IGF-1 blijkt een verhoogde aankleuring in artritisch kraakbeen 
aanwezig te zijn hetgeen wijst op een hogere IGFBP concentratie in artritisch 
kraakbeen. 
In hoofdstuk 7 is de chondrocyt IGF-1 receptorexpressie en de biologische 
respons op IGF-1 stimulatie van chondrocyt PG aanmaak tijdens verschillende 
fasen van artritis bestudeerd. Het blijkt uit de resultaten dat de verdeling van 
de IGF-1 receptoren in de verschillende dieptezones van normaal kraakbeen 
overeenkomt met de chondrocyt IGF-1 stimulatie in deze zones. Tijdens het 
ontstaan van de artritis wordt het kraakbeen ongevoelig voor IGF-1 stimulatie 
maar in een latere fase van artritis herstelt de IGF-1 reactiviteit zich. Kort na 
de inductie van artritis wordt een duidelijke afname van het aantal IGF-1 
receptoren in het kraakbeen waargenomen, maar tijdens latere fasen van de 
ontsteking herstelt de receptorexpressie zich. De correlatie tussen chondrocyt 
IGF-1 receptorexpressie en IGF-1 stimulatie van chondrocyt PG aanmaak 
blijkt te zijn verstoord. 
In hoofdstuk 8 is de chondrocyt IGF-1 receptorexpressie en de chondrocyt 
PG aanmaak bestudeerd in humaan normaal kraakbeen en in humaan 
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kraakbeen dat een veranderde PG aanmaak vertoont zoals gekweekt kraakbeen 
of osteoartritisch kraakbeen. Het humane kraakbeen werd verkregen van de 
humane knie van donoren zonder een klinisch osteoartritis verleden binnen 18 
uur na overlijden. De biopten waren afkomstig uit delen in het kraakbeen die 
er normaal of beschadigd uitzagen. Hierdoor werd materiaal verkregen met 
gradaties van kraakbeenbeschadiging. In het normale kraakbeen blijkt de 
receptorexpressie heterogeen verdeeld te zijn in chondrocyten uit de 
verschillende kraakbeendieptezones; dit patroon correleert met de chondrocyt 
PG aanmaak in deze zones. Na weefselkweek van het normale kraakbeen wordt 
in de oppervlakkige kraakbeenlaag een verhoging van receptorexpressie en PG 
aanmaak gevonden in chondrocyten. In mild beschadigd kraakbeen wordt een 
hoge chondrocyt PG aanmaak in de oppervlakkige kraakbeenlaag gevonden 
terwijl de chondrocyt IGF-1 receptorexpressie in deze laag juist is afgenomen. 
Dit zou er op kunnen wijzen dat andere factoren een rol spelen in deze fase van 
osteoartritis. In het tamelijk ernstig beschadigde kraakbeen wordt een hoge 
chondrocyt PG aanmaak en een hoge chondrocyt IGF-1 receptorexpressie 
gevonden, terwijl in het zeer ernstig beschadigde kraakbeen een zeer lage PG 
aanmaak en een zeer lage IGF-1 receptorexpressie wordt gevonden. 
Vele mogelijke stoffen waarvan wel werd aangenomen dat zij die een rol 
zouden kunnen spelen in de IGF-1 ongevoeligheid tijdens artritis, zoals 
metallo- en cysteineproteinases, reactieve zuurstofmetabolieten, IL-1 en TNFa 
blijken niet verantwoordelijk voor het verstoren van IGF-1 signalering. IL-1 
blijkt echter indirect betrokken te zijn bij het ontstaan van het IGF-1 
ongevoeligheidsfenomeen. Het uitblijven van de IGF-1 respons kan ook niet 
worden verklaard door receptordownregulatie; omdat wanneer tijdens artritis 
de chondrocyt PG aanmaak zeer laag is, de chondrocyten niet reagereren op 
IGF-1 stimulatie en toch de hoeveelheid en de verdeling van de IGF-1 
receptoren normaal is. Deze IGF-1 receptoren zouden echter toch wel een 
deficiente biologische functie kunnen hebben gekregen. Ontstekingsmediatoren 
zouden deze receptoren mogelijk hebben beschadigd of afgeschermd. 
Anderszijds zouden deze IGF-1 receptoren een verandering in hun 
aanmaakprocedure kunnen hebben ondergaan en daardoor een veranderde 
moleculaire structuur hebben gekregen. 
Concluderend, hoofdstuk 10, blijkt tijdens experimentele artritis een 
ongevoeligheid voor een groot aantal potentiële groeifactoren te ontstaan. Het 
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glucocorticoid TA is echter nog wel in staat in vitro PG aanmaak in artritisch 
kraakbeen te handhaven. Behandeling met glucocorticoiden en het remmen van 
door IL-1 geïnduceerde effecten lijken daarom een veelbelovender 
therapeutische benadering te zijn om kraakbeen tegen afbraak te beschermen. 
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STELLINGEN 
behorende bij het proefschrift 
INSULIN-LIKE GROWTH FACTOR-1 REGULATION OF CHONDROCYTE 
PROTEOGLYCAN METABOLISM IN EXPERIMENTAL ARTHRITIS 
1. Interleukine-1 speelt geen sleutelrol in het onderhouden van het IGF-1 on-
gevoeligheidsfenomeen tijdens artritis in de muizenknie, maar is wel indirect 
betrokken bij het ontstaan van dit fenomeen, (dit proefschrift) 
2. Het IGF-1 ongevoeligheidsfenomeen in experimentele artritis wordt niet ver-
oorzaakt door een verminderd aantal IGF-1 receptoren op de chondrocyt 
celmembraan, (dit proefschrift) 
3. Het glucocorticoid Triamcinolone acetonide is in staat de verstoorde IGF-1 
respons te omzeilen, (dit proefschrift) 
4. De veronderstelling dat het IGF-1 ongevoeligheidsfenomeen in artritisch en 
osteoartritisch kraakbeen hetzelfde voorstelt, (Dore et al., 1994), is niet 
alleen onjuist maar tevens kortzichtig. 
5. Een hypothese die níet wordt bevestigd lijkt veelvuldiger op andere 
manieren te worden uitgetest dan een hypothese die wèl wordt bevestigd. 
6. In studiis labor est etiam ipse voluntas. (Manilius, Astronomica) 
Studeren is werken voor je plezier; in deze context lijkt het logisch om 
onderzoekers een grote financiële bijdrage aan de wetenschap te laten leveren. 
7. Γνώθι σεαυτον μηδέν άγαν. (Plato, Protagoras) 
Leer jezelf kennen, maar overdrijf nooit; met andere woorden: er zijn 
grenzen aan de effectieve werktijd. 
8. Het belangrijkste van de muziek staat niet in de noten. (Gustav Mahler); 
persoonlijke inbreng is het fundament voor zowel kunst als wetenschap. 
9. Tijdelijke aanstellingen dragen bij tot grotere inzet en alertheid van 
medewerkers. 
10. De schaarse vertragingen tijdens treinvervoer staan in geen verhouding tot de 
vertragingen ten gevolge van de dagelijkse kilometerslange files op de 
auto(snel)wegen. 
11. It is difficult to see the picture when you are inside the frame. 
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